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Basic immunisation coverage for children between 12-23 months in Zambia was 68% in 2013. Nevertheless, a 
substantial number of child deaths persist as a result of preventable disease. This study assesses the relationship 
between women empowerment and immunisation coverage in Zambia. It also investigates socio-economic 
inequality in full, partial, and immunisation intensity. Thus, the findings will support improved immunisation 
coverage, especially for those who are the poorest in Zambia. 
 
The study uses the 2013-14 Zambia Demographic and Health Surveys (ZDHS), which are nationally 
representative household surveys [12]. This dataset incorporates information regarding children from 0 to 59 
months and for men and women aged 15- 49 years old. The two main study variables are women empowerment 
and immunisation. Immunisation was divided into three categories namely, full, partial and no immunisation. 
Concentration indices are used to assess inequality in full, partial and no immunisation coverage as well as in 
the intensity of immunisation coverage. Briefly, a positive concentration index means that immunisation 
coverage is pro-rich as richer children are more likely to be immunised. A negative index indicates the opposite.  
 
The main finding of this study was that socioeconomic status has a significant impact on the immunisation 
coverage of a child. For children who were fully immunised, immunisation was found to be pro-rich 
(concentration index = 0.046). The distribution of partially immunised children (concentration index = -0.114) 
and not immunised children (concentration index = -0.138) is pro-poor. This confirmed that poorer women were 
more likely to have a partially immunised/not immunised children compared to a child whose mother is richer. 
Immunisation intensity had a pro-rich outcome (concentration index = 0.153). In addition, the study confirmed 
the importance of household decision making as a determinant of a child's likelihood of being fully immunised 
(p-value<0.01).  
 
This study has shown that close attention to factors such as women empowerment and a mother’s education can 
support improved immunisation coverage, especially for those who are the poorest in Zambia. This paper further 
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Women empowerment and socio-economic inequality in immunisation 
coverage: a case study of Zambia 
 
1. Introduction 
Child mortality is a health concern that affects many countries, with the sub-Saharan African (SSA) and 
the Middle Eastern regions being most acutely impacted [1]. Although there has been a marked decline 
in deaths compared to more recent decades, 5.6 million children under the age of 5 years died in 2016 
[2]. This statistic explains why national governments as well as international agencies, including the 
United Nations, were compelled to move towards maternal and child health prioritisation. As a result, 
emphasis on maternal and child health has contributed to the rapid reduction in child mortality around 
the world [3]. Millennium Development Goal 4 (MDG-4) aimed to reduce under-five mortality rates by 
two–thirds worldwide by 2015. To lessen the burden of early deaths within childhood, interventions 
often targeted educating mothers, as they would be the primary caregivers [4]. Building on the MDGs, 
the Sustainable Developmental Goals (SDGs) have also reduced child mortality a matter of importance 
by earmarking it as concern for change. In the early 2000’s ‘more than 10 million children [died] 
annually from preventable causes’ [5]. Despite the above, by 2013 the global mortality rate for children 
under 5 years was still at a high toll of 6 million deaths, resulting from infectious diseases and neonatal 
complications [6]. In 2013, SSA contributed roughly half (49.6%, 3.113 million) of under-5 deaths 
worldwide [1]. 
 
Causes of death vary from one geological setting to another. Thus, the need for an in-depth 
understanding of child health epidemiology at a country level is pertinent [5]. The primary causes of 
death for infants result from preterm birth complications, pneumonia, birth asphyxia, diarrhoea and 
malaria [2]. Often malnutrition is an underlying aggravating factor since it makes infants exceptionally 
vulnerable to the above illnesses [2]. Ataguba, Ojo [7], indicated that over 51% of deaths in children 
below the age of 5 were caused by as pneumonia, diarrhoea, malaria and meningitis [7]. This shows 
that non –infectious diseases form part of the leading causes of death for children aged between 0 to 59 
months and as such, many have deemed these as avoidable deaths as preventative measures could have 
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been introduced to save lives. According to MDG4 in respect to child mortality reduction efforts, 
methods were to be preventative and included nutritional education programmes, promotion of 
household food security and improved access to health services as well as to basic amenities [8]. In 
recent times, 2-3 million deaths have been averted by way of paediatric vaccinations [9]. In fact, 
paediatric immunisation is regarded as one of the most important modern interventions as it has in past 
decades contributed toward substantial reductions in child deaths globally [9]. The eradication of 
smallpox and rinderpest are credited to organised immunisation efforts [10]. Immunisation has also 
contributed to the radical decline in measles, without which, the devastating effects of this disease could 
have been sorely realised as in the days of when polio, the plague and the Spanish flu wiped out 
thousands of lives. Immunisation has the added benefit of being a preventative measure, rather than a 
curative step after the disease has been contracted and spread. Delayed immunisation had resulted in 
negative after-effects when there were outbreaks of contagious diseases. The measles epidemic of the 
past decade is one such example [11]. 
 
In attempting to mitigate the prevalence of infant mortality from the disease globally, the World Health 
Organization (WHO) recommends that children should be fully immunised by age of 12 months to 
prevent major childhood related diseases [9]. According to the WHO, children are considered fully 
immunised when they have received one dose of the vaccine against tuberculosis (BCG) - which is 
given at birth or first clinical contact, three doses each of the DTP and polio vaccines – which are given 
approximately at age 6, 10 and 14 weeks and one dose of measles vaccine which is given following 9 
months [12]. 
 
The WHO estimated that by 2014, the number of children who had not received the 3rd dose of DTP 
vaccine was approximately 7.4 million in the African region. This was out of an annual birth cohort of 
32.7 million infants in Africa. Approximately one-third of these children were living in six countries; 
Ethiopia, Kenya, DR Congo, South Sudan, Nigeria and Guinea [13]. This illustrates how gains towards 




Childhood vaccination efforts have yielded returns with regards to increased life expectancy. Within 
Europe and Asia, life expectancy at birth has risen between 30 and 13 years, respectively, over a 30-
year period. However, in SSA, over the same time frame, life expectancy has only increased by about 
4 months. This is partly because of many things including the modest immunisation coverage, as by 
2015, about 19 million children remained unimmunised [9, 14]. Internationally, ‘under-five mortality 
rate has decreased by 26% from 91 deaths per 1000 live births in 1990 to 67 deaths per 1000 live births 
in 2007; while in sub-Saharan Africa the rate has fallen by only 20%, from 181 to 145 over the same 
period’ [15]. This highlights the social health gradient that is apparent between developed countries and 
the developing African world, as well as the urgent need for improved child mortality indicators with 
increased immunisation coverage within Africa being one such indicator. The social gradient reveals 
disparities in health experience within respective communities worldwide due to differing socio-
economic contributing factors [16]. Within countries, the generally observed trend is that individuals 
with a lower socioeconomic position tend to have poorer health [17]. This is a global phenomenon, seen 
in low, middle- and high-income countries and it demonstrates that health inequities exist in every 
country [18]. Poverty, relative deprivation, slow economic growth and social exclusion have a major 
impact on health and many SSA countries with a high incidence of child mortality continue to struggle 
with the above factors which are not as evident in developed countries [19]. Thus, an enhanced 
understanding of social determinants of health along with country-specific structural considerations 
help in improving child health outcomes in a contextualised manner. To this end, a focus on inequality 
in immunization is of great importance to improve child health outcomes. A more in depth 
understanding of inequalities informs, who bears a greater burden of non-full immunisation. Thereafter, 
an investigation of the role of women empowerment in full immunisation will follow to also aid in 




Although there has been slower uptake of universal immunisation in SSA compared to the more 
developed countries, successes in child mortality reduction and immunisation coverage have also been 
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legitimately realised within the region. Kanyuka and colleagues showed that Malawi was one of the 
“few countries in sub-Saharan Africa likely to meet the MDG 4 target of reducing under-5 mortality by 
two-thirds between 1990 and 2015. The estimated mortality rate in children younger than 5 years 
declined substantially in the study period, from 247 deaths (90% CI 234–262) per 1000 livebirths in 
1990 to 71 deaths (58–83) in 2013, with an annual rate of decline of 5·4% “ [27].There is an expectation 
that other countries within the region can attain the same outcomes and also meet their SDG targets 
through accelerated efforts [20]. The Ministerial Conference on Immunisation in Africa ratified this by 
accepting the Addis Declaration, which re-emphasised the significance of vaccination and its role in 
improving the health of many within the region [21]. 
 
Immunisation studies have focused on Angola, Ethiopia, Nigeria and Congo – at times referred to as 
the 'Big 4’, as they carry the bulk of the burden of preventable disease that leads to child mortality [22]. 
This study is different, as the country of interest is Zambia.  
 
On the surface, Zambia already has a seemingly decent immunisation coverage statistic compared to 
other parts of SSA. Basic immunisation coverage for infants between 12-23 months for this country 
was 68% in 2013 [12]. Through the Expanded Programme on Immunisation, the Ministry of Health’s 
strategy of ‘reaching every district’ has shown some successes. Through these measures, Zambia has 
managed to maintain polio-free status and has eliminated maternal, neonatal tetanus since 2005 [23]. 
Also, under-five mortality levels reduced to 72.9 deaths per 1000 live births in 2013 from 186.5 deaths 
per 1000 live births in 1967 (World Bank, 2018). The Zambian Health Ministry contributed to improved 
child mortality indicators by abolishing user fees for all maternal and child health services to facilitate 
better access and utilisation [24]. Nevertheless, a substantial number of infant deaths persist in Zambia 
as a result of preventable diseases [25]. 
 
Vaccination utilisation in Zambia is based on numerous factors which impact coverage levels. Long 
waiting times, the distance that vaccination sites are from mothers as well as caregiver communication 
have a bearing on acceptability of vaccination services. In Zambia, 20% of mothers were found to be 
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unsatisfied with vaccination services, with rural caregivers showing higher levels of satisfaction 
compared to their urban counterparts [26, 27]. Another study found that access to health services is a 
critical determinant of health outcomes with respect to immunisation in Zambia with children who lived 
in urban areas and close to health facilities being more likely to have completed all their immunisations 
[27]. 
 
Colson and colleagues (2015) attempted to establish whether there was progress towards universal 
health coverage by identifying drivers of success for maternal health services in Zambia over two 
decades [28]. Their study showed that Zambia saw notable gains in the delivery of malaria control 
interventions, BCG and measles immunisation across districts. They also found that there was a 
substantial gap between highest-performing and lowest-performing districts when it came to polio and 
pentavalent immunisation [28].  
 
Although much has been done in establishing links between immunisation coverage and SES, 
minimal research has been compelling in addressing this explicitly. Since Zambia is ranked amongst 
some of the world’s most unequal societies with a Gini coefficient of 57.10, the findings of the study 
will either validate this with its outcome or confirm otherwise (World Bank, 2018).  
 
Moreover, literature focusing on immunisation coverage often lacks in including the additional 




The primary aim of this study is to empirically assess the relationship between socio-economic status 
(SES) and immunisation coverage in Zambia and to understand the role of women empowerment in 







• To assess the relationship between women empowerment and immunisation coverage in Zambia. 
• To assess socio-economic inequality in full, partial, and immunisation intensity in Zambia. 
 
 
2. Brief literature review 
2.1 Theoretical review 
This section of the proposal provides the theoretical context in which women empowerment and 
health inequality was handled in the study. Although brief, it offers a foundation upon which the 
methodological and empirical considerations of women empowerment and health inequality are built. 
As such defining and contextualising the general understanding of these key concepts namely health 
inequality and women empowerment are addressed. 
 
 
2.1.1 Inequality in health and health care 
 
The Oxford dictionary defines equality as ‘the state of being equal, especially in status, rights, or 
opportunities. Within the health context, inequality has become an increasingly prominent 
consideration within the policy agenda, as indicators which provide average figures on health 
performance do not cater to such factors [29]. For simplicity, inequality is the ‘differences in health 
across individuals in the population’ [29]. William Farr’s nineteenth-century observations began 
much of how social health inequalities are understood [30].In addition to the above, Wagstaff 
emphasises that the variation in health can be a function of socio-economic grouping where the 
‘association between poverty and ill-health reflects causality’ [17]. This is consistent with Braveman 
[31] approach which conceptualises health inequalities as a ‘specific subset of health differences that 
are systematically linked with social disadvantage, which entails worse health outcomes among 





2.2 What is women empowerment? 
 
Empowerment can be difficult to define as its meaning has a cultural context. It carries both intrinsic 
and instrumental value. The World Bank Empowerment and Poverty Reduction defines empowerment 
in its broadest sense as ‘freedom of action and choice’ [32]. This definition incorporates the 
complexity of empowerment as it recognises that other intricacies such as a woman falling within 
another socially excluded subset of society based on SES for examples, would affect their sense of 
empowerment in practice [32]. Kabeer [33] defines women empowerment as the ‘process by which 
women increase their ability to make strategic life choices’ [33]. This definition is one that has carried 
much influence, although many others exist [34]. Women empowerment is a broad concept which has 
received at least 3 decades of robust theoretical work. In defining it a distinction is made to not 
confuse it with other concepts that also contribute to women social standing. These concepts form part 
of society’s construct of women status but are not the same as women empowerment. Examples of 
such are considerations of household and familial dynamics as suggested by Malhotra and Ruth 
Schuler [35]. Further, agency – the freedom to make choices and actions, is a core part of the concept 
of empowerment [33]. The ability to access resources, agency and the realisation of choice exercise 
are accepted as factors which affect the empowerment process [33, 36, 37]. These considerations 
often determine how women empowerment is measured. 
 
In cases where autonomy and the above definition of women empowerment intersect, the two 
concepts may be deemed synonyms. Dyson [38] and Basu [39] explained Autonomy as the ability to 
make decisions through control over information and resources, and it includes the ability to act upon 
those decisions, this is consistent with the above constructs of what constitutes women empowerment 






2.3 Brief Empirical Review 
 
Although socioeconomic status continues to impact the health status of many individuals within the 
developed world, this brief section focuses more on the experience of low and middle-income 
countries – given that Zambia is a lower-middle-income country. 
 
2.3.1 Socioeconomic status and immunisation coverage 
 
Health outcomes have been shown to be a function of various factors in a society and one such factor 
is SES. This finding is not only established but also consistent as with the outcome found in a study 
by Evans which showed that individuals who are more financially stable tend to enjoy improved 
health in comparison to those who are less well-off [40]. The inverse care law where ‘the availability 
of good medical care tends to vary inversely with the need for it in the population served’ [41] 
reinforces the relationship between SES and health, even in Zambia [42]. 
 
This explains why health ministries of developing countries have focused on ways to make to grant 
subsidised basic health services in an attempt towards achieving universal health coverage and 
mitigating issues of acceptability due to affordability [43]. Empirical studies have shown, however, 
that despite interventions by health parties in some countries, widening trends in inequities, in 
particular, healthcare utilisation may still persist due to other structural factors [44, 45]. This empirical 
evidence validates findings from many OECD countries [46]. 
 
The above pattern is not only true for health outcomes in general but also to those which pertain 
specifically to the maternal and child health. Even with subsidised immunisation policy in many 
developing countries, poor immunisation coverage persists in some areas for other reasons which are 
SES related. In Nigeria and Kenya, communities which have lower SES have poorer immunisation 
levels [7, 47]. Empirical studies have shown that children residing in slums or rural parts of Kenya 
and other SSA countries are often underserviced with regards to immunisation coverage. Thus 
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preventing accessibility, resulting in low coverage and increased infant mortality [47]. Another paper 
further showed how in Zimbabwe regardless of the location of residence, socioeconomic disparities in 
maternal health care were mostly pro-rich and had widened between 1994 and 2011 [48]. 
 
In a study where 46 low-middle income countries were used to identify factors associated with 
socioeconomic inequalities in full immunisation coverage against the four core vaccine-preventable 
diseases, it was found that child vaccination was in favour of the rich with exceptions of Gambia, 
Namibia and Kyrgyz Republic where children who belonged to higher SES were less likely to have 
received all four core vaccines against preventable diseases [49]. In fact, a cross country study which 
included 22 countries, focusing specifically on urban slums found that the urban poor are neglected 
and due to lower SES tend to not access adequate vaccination coverage and as such experience higher 
under-five mortality rates [50]. This observed research further confirms that SES does impact 
immunisation coverage within developing countries. 
 
2.3.2 Relationship between woman empowerment and immunisation coverage 
 
Empirical studies have shown the positive relationship that exists between women empowerment and 
child health, in particular, immunisation [51]. In fact, the sense of empowerment can have a positive 
effect on decisions that women make, especially with regards to choices which directly impact their 
health status within their households [52]. 
 
Women are often the primary caregivers for their children and can influence their children’s health 
directly [53]. As such the international development community through the values espoused in the 
MDGs have launched initiatives focused towards alleviating the constraints faced by women in 
developing countries [9]. 
 
Varkey, Mbbs [54], after assessing the relationship between women's empowerment and health in 75 
countries using the gender empowerment measure (GEM) (a composite index measuring gender 
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inequality in economic participation and decision making), found that the GEM indicator was 
significantly associated with infant mortality, amongst other significant associations. 
Singh, Bloom [55] showed that women from Nigeria who felt that wife-beating is not acceptable, 
which forms part of the women empowerment indicator- especially in an African context 
(patriarchal), are more likely to have a fully immunised child [55]. Thus one finds that where 
women’s social status is low, this would result in poor immunisation coverage outcomes [56]. This 
relationship is consistent across many studies in countries such as Thailand, India, Malaysia, Malawi, 
Philippines and Ethiopia [9, 56-58].  
 
3. Methods 
3.1 Data sources 
Data sets were derived from the Demographic and Health Surveys(DHS) for this study, which are 
nationally representative household surveys that provide data for a wide range of monitoring and 
evaluation indicators of health in developing countries [12]. 
 
Data sets were derived from the Demographic and Health Surveys (DHS), Zambia (2013-2014). This 
is the most recent DHS dataset available for the country. This data set is designed to incorporate 
information regarding children from 0 to 59 months and for men and women aged 15- 49 years old. 
There were 16411 women participants who formed part of the Zambian Demographic Health Survey 
(ZDHS). 
 
Zambia remains one of the few SSA countries which fared well in its attempt to reach the 80% 
immunisation coverage goal by 2015. However, they are yet to reach the goal of universal coverage. It 
has a keen focus on maternal and child health and has thus prioritised immunisation in their basic 
health services. This paper complements existing research regarding Zambia’s child mortality 
situation [20, 59, 60] by assessing women empowerment and intensity of immunisation. For this 
reason, results from the study could prove useful for policy formulation and for informing the Health 




3.2 Zambia Data 
 
The 2013-14 Zambia DHS [12] was conducted between August 2013 and April 2014 by the Central 
Statistical Office (CSO) of Zambia in collaboration with the University Teaching Hospital (UTH)-
Virology Laboratory, the Tropical Diseases Research Centre (TDRC), and the Department of 
Population Studies at the University of Zambia (UNZA) [12]. 
 
The sampling frame used for the 2013-14 ZDHS is the frame of the Zambia Population and Housing 
Census (ZPHC), updated in Zambia in 2010, and provided by the Central Statistical Office (CSO). An 
Enumeration Area (EA) is a geographic area that covers an average of 130 households or 600 people. 
The sampling frame contains information about the EA location, type of residence (urban or rural), 
and the estimated number of residential households [12]. 
 
Administratively, Zambia is divided into 10 provinces. The 2013-14 ZDHS sample was stratified and 
selected in two stages. Each province was stratified into urban and rural areas; therefore, the 10 
provinces were stratified into 20 sampling strata. Samples of EAs were selected independently in each 
stratum in two stages. Implicit stratification and proportional allocation were achieved at each of the 
lower administrative levels by sorting the sampling frame within each sampling stratum before sample 
selection, according to administrative units in different levels, and by using a probability proportional 
to size selection at the first stage of sampling [12]. 
 
Information on vaccination coverage was collected both from the child’s health card and the direct 
report from the mother. In instances where the cards were available, the interviewer copied the 
immunisation details directly on the questionnaire. When there was no immunisation card or if a 
vaccine had not been recorded on the card as being administered, the respondent was asked to recall 




When referring to full immunisation within the study, the child must have at least all the following 
vaccines/doses at age 12 months [12]. 
One dose of BCG Vaccine, which protects against tuberculosis 
Three doses of DPT, which protects against diphtheria, pertussis (whooping cough) and tetanus 
Three doses of polio vaccine 
One dose of measles vaccine 
 
 
3.3 Analysis plan 
The Stata 14.2 (StataCorp, Texas) software was used to carry out data cleaning, data exploration and 
analysis. 
 
3.4 Study variables 
The two main study variables are women empowerment and immunisation. The way that they are to 
be assessed is discussed below. 
 
 
3.4.1 Women empowerment 
 
Empowerment was assessed among women aged between 15 and 49 years old. Theoretically, in 
attempting to explain women empowerment two sets of indicators have been proposed for use from 
the survey- namely women’s participation in household decision making as well as women’s attitude 
towards beating [12]. These indicators are summarised into two respective indices. 
 
The first index shows the number of decisions a woman participates within her household either 
jointly with her husband (or partner) or alone. This index reflects the degree of decision-
making/control that a woman can exercise in issues which pertain to her life or her empowerment 





There are four factors which are linked to decision making according to the survey which are listed 
before. 
Decision making regarding: 
a) Making large household purchases 
b) Making day-to-day household purchases 
c) Health care for herself 
d) Visits to family and friend 
 
The second index indicates the number of reasons for which a woman deems it justified for her 
husband or partner to beat his wife. If we were to assign a 1 for each time a woman responds in the 
affirmative (agreeing that a beating is acceptable) and 0 for no, then in general, a lower score for this 
index shows a higher status of women in the society or the household as per how the DHS scores the 
response for this question. The survey does not only pose the question regarding attitudes towards 
wife-beating to married women but all participants of the survey so there is not an exclusion of some 
respondents due to marital status. 
 
There are five reasons listed which allow for wife-beating to be acceptable according to the survey. 
These are listed below: 
a) If she goes out without telling him? 
b) If she neglects the children? 
c) If she argues with him? 
d) If she refuses to have sex with him? 
e) If she burns the food? 
In the study to address this question, we  assigned scores as per the table below. 
The women empowerment variable in the study is generated from the components from the 




Table A 1 Composition of Women Empowerment Variable 
Beating 
1 if beating is unacceptable at all 




Making large household purchases 
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Making day-to-day household purchases 
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Health care for herself 
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Visits to family and friend, if the woman has  
1 if the woman makes the decision jointly or 
alone. 




The study will enter the women empowerment variables individually in the regressions as each indicator 
is assumed to measure of empowerment/disempowerment. Other approaches such as counting the 
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number of empowerment/disempowerments per mother was considered. The proposed approach, 
including the counting, is important as it does not predetermine which of the above factors prove to be 
the most significant determinant. Further, it allows for isolating the effects of these respective factors 
in trying to understand which of them most influence women empowerment for women included in this 
study within the Zambian context. 
 
3.4.2 Assessing the relationship between woman empowerment and immunisation 
 
The study used multiple logistic regression models with immunisation coverage as the outcome variable 
and the explanatory variables included women empowerment variables, among other explanatory 
variables such as mother’s age, mother’s education, land ownership, employment status, place of 







Immunisation was divided into four categories with 3 of these being mutually exclusive. 
Fully immunised denoting children (12 to 59 months) who have received all 8 immunisations as per 
WHO guideline regarding basic immunisation doses. 
Partially immunised refers to all children (12 to 59 months) who have received at least 1 but less than 
8 vaccines. 
Never immunised refers to children (12 to 59 months) who received no vaccines. 
Immunisation intensity measures the proportion of the total doses of vaccines that children (12 to 59 
months) have received. Children that received no dose were scored zero (0) while children that received 
all doses were scored one (1). 
The last category is of interest, as it shows how many children, although not fully immunised, have 




3.4.4 Socio-economic status 
 
When using the DHS, some researchers have created a wealth index as a proxy for SES. It is based on 
household data where factors regarding household assets and amenities [61]. Since the DHS does not 
include data on income and consumption, index of socio-economic status already generated as part of 
the ZDHS was a proxy for wealth. Some of the variables included in the wealth index include the source 
of drinking water, type of toilet, sharing of toilet facilities, cooking fuel, household services and 
possessions, such as electricity, TV, radio, types of vehicles, agricultural land size owned, bank account, 
mobile phone [61]. 
 
3.4.5 Assessing socio-economic inequality in full, partial and intensity of immunisation 
 
Concentration curves (CC) are used as a means to assess whether socioeconomic inequality exists in 
particular health variables. However, they are limited in that they do not provide a measure of the 
magnitude of inequality that can be used for comparison over a range of factors. The concentration 
index (CI) is defined in reference to the concentration curve as twice the area between the concentration 
curve and the line of equality (the 45-degree line) [62]. For this reason, concentration indices were 
obtained, to show the extent of socio-economic related inequalities in immunisation coverage in 
Zambia. The concentration index is defined in reference to the concentration curve as twice the area 
between the concentration curve and the line of equality (the 45-degree line) [62]. The index is bounded 
between -1 and 1. When the index is -1, this means that only the neediest child within the population 
has received all the immunisations. At a value of +1, the most well-off child within the population has 
received all the immunisations. 
 
van Doorslaer, Wagstaff [63] deemed concentration indices as a consistent measure of inequality, as 
they fulfil three important requirements, namely; i) The ability to reflect the socioeconomic dimension 
to inequalities in health, ii) They reflect the experiences of the entire population, and iii) They are 




Since the focus is inequality within the health context, it is important to note that factors such as age 
and gender can often have an impact by way of association - on health and SES. Failing to account for 
them, could lead to overestimation of the extent of the socioeconomic inequalities in health- thus 
standardisation is a method used to control for this effect [63]. 
 
To account for age-sex variations, an indirectly standardised concentration index is obtained by running 





) = 𝛼2 + 𝛽2 𝑟𝑖 + ∑ 𝛿𝑗𝑗 𝜒𝑗𝑖 +  𝑖, 
 
The estimate which this equation produces is interpreted as the indirectly standardised concentration 
index, where 𝜒𝑗𝑖 are the confounding variables - age and sex, 𝜎𝑟
2 is the variance of the rank (r) and ε is 
the stochastic error term [64, 65]. The concentration index, therefore, measures the extent of inequalities 
in health (ill-health) that are systematically associated with socioeconomic status [62]. 
 
In applying the above to this study, the concertation index will assist when assessing inequality in full, 
partial and no immunisation coverage as well as in the intensity of immunisation coverage. 
 
4. Ethics 
The study uses data which are freely available within the public domain. Permission for the use of the 
datasets has been formally obtained from the Demographic Health Survey. Thus, there should not be 
ethics related issues from the use of the data. However, ethics approval was attained from the University 
of Cape Town’s Human Research Ethics Committee. 
 
 
5. Stakeholders, reporting and implementation 
The findings of this paper will be published in an appropriate journal, once reviewed following 





There are no additional financial costs incurred by the author in writing this paper. The use of the data 
collected is at no cost to the researcher, neither is the use of the software. The most intensive resource 
to accomplish the completion of the study is time. Below is a timeline sheet, laying out the anticipated 
period it will take to complete the study from start to end- an approximation of 6 months in total, 





7. Timeline sheet 
Table A 2 
Task Duration 
Concept Note 2 weeks 
Plan for objectives 1 weeks 
Data Cleaning for DHS 2 weeks 
Protocol 4 weeks 
First draft of literature Review 6 weeks 
Revision of Protocol 1 week 
Analysis 3 weeks 
Journal Manuscript 2 weeks 
Policy Brief 1 week 
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1. Theoretical review 
1.1 Theoretical explanation of health inequalities  
1.1.1 Background 
 
Health inequalities are disparities that exist between groups of individuals Deaton [66]. When the health 
status found within a population is unequal as a result of an individuals’ position within a societal class, 
these differences are known as socioeconomic health inequalities and thereby confirm the existence of 
a social gradient [19]. An understanding of the causes of inequalities is imperative for any meaningful 
health reform [67]. Academics have documented the differences in the health of groups of people, 
occupying different positions in society since the mid-nineteenth century [68] and there have been more 
definitive theories, which have contributed towards the debate markedly.  
 
The Black Report is accepted as one of the first authoritative contributions to health inequalities 
discussions [Black 69]. This report was initially recorded to explain the phenomenon of health 
inequalities within Britain. However, it has since been applied more broadly to other contexts. It 
suggested four possible explanations for social class differences namely: artefact, natural or social 
selection, materialist and cultural/behavioural differences [Black 69]. This section of the literature 
review focuses on the concepts which the report introduced and outlined. Also, other commonly 
accepted theories which stemmed from this body of work, but form part of the social, political, 
psychological, economic sciences were noted in respect to their contribution towards explaining health 






1.1.2 Theories of health inequality  
Artefact theory 
The artefact theory is the initial justification provided by the Black Report to explain health inequality 
using the relationship between health and social class [Black 69]. This theory places prominence on the 
‘artificial’ nature between health and social class as variables which are correlated [70]. It argues that 
since health and social class are deemed artefacts of measurement, the perceived relationship between 
these two factors, resulting in socioeconomic inequality may not be ‘real’ due to measurement error 
[71-75]. 
 
The Black Report found this theory to be relatively inconsequential in its ability to consistently explain 
the variation found in health inequality as a function of social class [Black 69]. However, in contrast, 
Bloor et al. concluded that the role of the artefact explanations in mortality differentials was larger, 
more pervasive, and more complex than Black and his colleagues supposed [71]. Macintyre found it 
inconsistent to dismiss the relation that respective indicators of the social class had on health outcomes 
(morbidity and mortality) due to inequality [76]. Various studies confirm that a social gradient exists 
within health universally, which is consistent with findings where a strong relationship between 
socioeconomic status (SES) and health is noted, irrespective of how SES is measured [77, 78]. 
 
Natural and social selection  
 
This theory in its approach reduces the importance of social class in explaining inequality and assigns 
a greater degree of causal significance to health itself [76]. This interpretation suggests that there is a 
real relationship between class and morbidity, which is governed by health. This is contrary to the 
traditional direction of causality (Macintyre, 1997; Blane, 1985). It is interesting to note that the use of 
the word natural to explain this theory results in the following conclusions. Firstly, in reference to its 
biological meaning and subsequently in reference to morally neutrality, it appears that this theory may 
have an effect of ‘explaining away observed inequalities in health by occupational class as being nothing 
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meriting social concern or collective intervention’ (Macintyre, 1997, p727). There are two propositions 
to consider (and distinguish) within the context of this theory, namely social selection and social 
causation. 
 
According to the social selection approach, an individual’s health can result in their upwardly or 
downward social mobility [70]. This ideology has a long history, which was initially established by 
research undertaken in Britain and the US from the 1950s to the 1960s [79-81]. The social selection 
theory suggests that an individual’s social class is a function of their health status [Black 69]. According 
to this hypothesis, sickness (especially of a long term nature) may result in downward social mobility 
[79]. This is because illness (possibly, excluding light illnesses) would naturally disadvantage an 
individual from being active in employment and as such this state of health, would impact negatively 
on the individual financial standing and class [70]. The inverse would be true where those who are in 
good health would be able to achieve favourable positions in society [82]. Health is thus delegated as a 
cause of social class standing [83]. Searle [84] in his attempt to relate Darwinian and Eugenists theories 
of natural selection to health postulated that a process of ‘social sifting’ based on natural endowments 
left the working class inferior, on average, to their social betters in respect to health [76, 84]. In more 
contemporary times, the converse has been deemed equally true where the healthiest member of each 
social group may be absorbed into higher groups [78]. 
 
The ‘social causation’ hypothesis claims that individuals in more socially advantageous positions can 
overcome the effects of poor health more readily, than their counterparts in lower socio-economic 
standings due to resource access and support by virtue of their social class [78, 82]. With this in mind, 
Kröger, Pakpahan [82] argue that the social gradient in health is therefore created by differences in 
resources, support, knowledge, behaviour or other factors that are socially stratified [82,p951]. 
 
These two approaches have respective proponents for varying reasons although the selection theory has 
enjoyed much prominence due to evidence found in its support through empirical studies [76, 82]. What 
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remains to be established is the extent to which social selection contributes towards the social gradient 
[76, 78]. 
 
Cultural-behavioural theory  
 
The cultural-behavioural theory argues that the social distribution of ill health is linked to variations in 
health behaviours such as smoking, alcohol consumption and other risky behaviours, as a function of a 
group of individuals’ attitudes towards their health [78]. These behavioural health choices are seen as a 
continuous consequence of low socio-economic standing and as such, are often linked with social 
disadvantage [85]. Although the authors of the Black Report did not accept cultural factors as a 
sufficient explanation for health inequalities, other academics have tried to highlight that they are a 
function of the culture of poverty practised within a group of individuals which hold a low socio-
economic status, versus ‘reckless or irresponsible behaviour or incautious lifestyles’ as other authors 
would suggest [Black 69, 78, 86]. The culture of poverty as proposed by Lewis, notes that “there are 
certain persistent patterned associations of traits [which can be found] among families with the lowest 
income level and the least education” thus health choices are considered a function of ‘cultural 
construct’ rather than independent choices [75, 87]. In contrast, Raphael argues that health inequalities 





This theory emphasises the role that socio-structural and economic forces have on the distribution of 
health [Black 69]. Health is the dependent variable with social class and health having causal influences 
on health [70]. According to the authors of the Black Report, these factors ultimately influenced the 
working and living conditions of the population and as such, became material causes of health [78]. It 
was found that poor health could be explained by material deprivation as well as structural inequality 
where relative and absolute deprivation, had a significant impact on health outcomes [78]. Material 
deprivation is explained as a consequence of income distribution [76]. The theory accounts for the 
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relation between socioeconomic position and access to socio-economic resources and advocates that 
variation in the distribution of power, income and material wealth are the central causes of health 
inequalities [89]. The Black Report suggested that the structural theory provided the best explanation 
as to the fundamental causes of health inequalities [Black 69]. This finding is not only established but 
also consistent with the fact that individuals who are more financially stable tend to enjoy improved 
health in comparison to those who are less well-off [40]. Structural factors can negatively impact health 
and result in phenomena such as the inverse care law being realised, where ‘the availability of good 
medical care tends to vary inversely with the need for it in the population served’- this reinforces the 
issue of health inequalities due to class and SES [41]. Although widely accepted, the 
materialist/structural theory has been challenged as it fails to account for the gap of socio-economic 
inequalities in health within countries where the material circumstances and standard of living have 




The psychosocial theory builds on certain elements of the structural theory with a focus on the softer 
issues of how socio-economic inequalities can impact an individual’s health by way of emotional and 
biological health [75, 85]. This theory argues that there are direct health effects from the negative 
emotions which an individual experiences due to their perceived social standing [75, 90]. Psychosocial 
processes link environmental stressors to physical and mental health [91]. It is postulated that 
psychological stress is generated by society’s inequality structures which invariably mostly impacts 
those of a lower class [90]. It has been shown that a relationship exists between ill-health as a result of 
psychological reactions. This relationship can either be direct or indirect [92]. Direct effects describe 
how psychological stress can affect disease development, where indirect effects refer to damaging 
health behaviours that stress can cause (smoking, excessive alcohol consumption, accident-prone 
behaviour) [90]. The emerging perspective is a striking attempt to deal with health inequalities as it 
seems to solve some of the difficulties that other perspectives have had in accounting for existing 





Political economy theory  
 
The political economy theory derives some of its perspective from the materialist and psychosocial 
approaches, which contribute towards explaining health inequalities. This theory attempts to elucidate 
the effects of the interplay that exists between economic and political factors, and their impact on 
population morbidity and mortality [75]. This approach is concerned with how variables such as 
unemployment, Gross Domestic Product (GDP), labour markets and other social determinants affect 
health as well as how they contribute towards inequalities [Black 69, 75]. This theory acknowledges 
that politics can be instrumental in effecting societal imbalances within population health and that they 
can further exacerbate existing conditions which were created by economic structural forces [75, 93]. 
Ataguba and Alaba [93] use South Africa as a case study to show that health disparities can result from 
a political system (i.e. Apartheid), which concentrate economic power within the hands of the minority 
through the unction of historical public policy and as such, these policies negatively impact on the 
uneven distribution of the social determinants of health within the country [93]. In response to the 
aforementioned, it is proposed that a coherent intersectoral approach which accounts for the 
interrelatedness of factors should be adopted in addressing health disparities [93]. 
 
 
Life-course perspective  
 
The life course perspective attempts to validate the link that exists between adult health and early life 
experiences. This approach is prominent in epidemiology [94]. It was introduced to counterbalance the 
overemphasis that epidemiology was placing on the impact of biological programming in utero and 
adult lifestyle approaches to chronic disease [95]. It systematically directs attention to the role of 
context, showing how biological factors from early childhood can extend its impact on health in the 
future [94,p163]. This approach also seeks to understand the beginnings of socially determined 
pathways of health, which can later impact adult life thus providing further insight into how health 
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inequalities can be generated for individuals [96]. This theory finds relevancy as it shows that health is 
a lifelong development for individuals [96]. The life-course approach contributes towards providing 
information about the differential loss of human potential across distinct population groups in respect 
to health, and more generally, reflect whether resources and investments are equitably distributed in 
societies due to the outcome of population health groups [97]. 
 
Although this theory is widely accepted, it does present limitations such as operationalisation [98]. The 
issue is that, although the conceptual understanding is logically consistent, it is difficult to isolate 
various health events as they are not necessarily mutually exclusive and thus one cannot wholly attribute 
them to having a causal link to later adult health in a way that this approach speculates [98]. 
Nevertheless, respective disciplines such as psychology, sociology, demography, anthropology and 
even biologists continue to keenly endorse this approach as it does have a place in explaining biological, 
behavioural, and psychosocial processes that operate across an individual's life course, or across 




Literature explaining the theoretical approaches that frame the understanding of health inequalities have 
to a large extent, contributed, not only to the health domain but to other disciplines. Since the Black 
Report, many historical continuities regarding health inequalities have been formed and understood. In 
brief, this section has considered various theories in trying to account for health disparities within 
population groups. These include the artefact, material, behavioural, psychosocial, life-course, selection 
and political economy approaches. 
 
The materialist or structural approach seems to be the most preferred explanation for health inequality 
although debates continue regarding the matter [69, 75, 88]. It is important to appreciate the benefits 
that these theories contribute towards a better understanding of health inequalities and how to best tackle 
them. McCartney states that ‘theories focusing primarily on behaviour and culture can provide some 
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insights around the mechanisms through which such inequalities are generated, but they cannot provide 
sufficient explanation as to their principal causes’ [89]. Therefore, it is important to distinguish between 
underlying causes and mechanisms which impact health, as this informs actions for addressing 
injustices [89]. Further, social context and its importance with regards to how it can impact concrete 
hypotheses in inequality reduction would need to be considered [76]. 
 
This study draws from the materialist as well as the behavioural approaches. In combining these 
approaches, socio-economic inequalities are better explained as they touch on different areas of 
importance with regards to how health inequalities can be explained [85, 99]. 
 
2. Methodological review  
Following the recognition of health inequalities and theories which attempted to explain their causes, a 
great deal of literature has been generated to precisely measure inequalities. At first, crude methods 
were used in measuring health disparities, but with time, more sophisticated means have been employed 
[62]. Within health economics, Wagstaff and van Doorslaer critically appraise measures of inequality 
within the early 1990s. Not only did they explain the respective rationales that accompany the differing 
methods used by academics, they also recommend which methods would be most appropriate in 
explaining and capturing the variation in health inequalities experienced within and between 
populations. 
 
After Wagstaff and van Doorslaer, other scholars have recommended alternative methods to measure 
socioeconomic inequalities. Varying factors must be considered in relation to the objective of the study 
to best determine the most appropriate tool of measurement [73]. Murray, Gakidou [100] postulated 
that there are convincing reasons to measure health inequalities on a social group level versus the 
average outcome based on the population. In fact, they hypothesised that a shift towards measuring 
health inequalities across individuals would prove profitable in challenging the advantages and 




In this section, the most commonly used measures of inequality were explored—from the basic 
approaches such as the range to the more advanced methods such as Gini coefficient, the Lorenz curve, 
the index of dissimilarity, the slope index of inequality and the concentration index. Their advantages, 
as well as their limitations, also form part of this review. The template established by Wagstaff and 




2.1 Overview of common measures of health inequalities  
The range 
 
The range is one of the simplest methods used for measuring inequalities. It compares the health 
experiences of the top tier (e.g., socio-economic tier) of the population to the bottom tier using the 
extreme points on either end of the spectrum. Although it is a quick tool to gauge the overview of the 
disparity in inequality, it is flawed as it fails to explain the experience of the intermediate groups [62]. 
It does not take into account the sizes of the groups being compared or the relative difference due to 
context. This makes it difficult to generalise findings as outcomes could be ambiguous [101]. Further, 
since it is concerned with extreme values, it could miss the extent to which inequalities within the 




Lorenz curve and Gini coefficient  
 
The Lorenz curve and Gini coefficient are inter-individual indicators of health inequality [102]. The 
Lorenz curve plots the cumulative proportions of the population as a function of their ranked health 
status. The relationship between the individual with the poorest health and that of the one who is the 
healthiest within a population is depicted visually by the use of cumulative health distribution. When 
the health of that population is equally distributed, the Lorenz curve will coincide with the diagonal line 
(i.e. the line of equality) otherwise, it lies beneath the diagonal [62]. The farther the Lorenz curve lies 
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from the diagonal line indicates a greater extent of inequality. Unlike the range, the Lorenz curve 
manages to incorporate the experience of all individuals within the population rather than only of those 
who are represented in the extreme ends of the social classes [62]. The Lorenz curve is inadequate in 




Figure B. 1 Lorenz Curves for health or ill health of the population 
 
 
The Gini coefficient is a numerical expression of the Lorenz curve and is defined as twice the area 
between the Lorenz curve and the diagonal [62]. It is a univariate measure of inequality, which is used 
to express inequality within a population. In health, the Gini co-efficient explains how much more 
health, the healthiest individuals enjoy compared to unhealthiest individuals within the same population 
[103]. It ranges from 0 to 1 (i.e. from complete equality to when all the health is concentrated in the 
hands of one person) [102]. This measure is limited as it cannot be used to account for the sources of 






A pseudo-Gini coefficient and pseudo-Lorenz curve  
 
This method builds on some of the definitive features of the Lorenz curve using grouped data instead 
of individual-level data [62]. It plots the cumulative proportions of the population grouped by social 
class and ranked by their mean health status (from the group with lowest mean health status to the group 
with the highest mean health status) against the cumulative proportion of health [102]. Le Grand and 
Rabn in 1986 originally proposed it. In the same way, the pseudo-Gini-coefficient is also twice the area 
between the pseudo-Lorenz curve and the diagonal. Like its original counterpart, it is also restricted in 
explaining to the socio-economic dimension of inequalities in health [62]. 
 
The index of dissimilarity (ID)  
 
The index of dissimilarity is another technique that has been used in measuring inequality. It can be 
explained as the sum of the absolute difference of share of total population health and share of 
population for each group divided by two [102]. It is useful as it can account for population size when 
it comes to comparisons. A situation of perfect equality in this context is reached where everyone’s 
share of health is the same as the population share [63]. The limitation of this technique is that it is 
unable to account for socio-economic variations in ill health. 
 
The Slope Index of Inequality (SII) and the Relative Index of Inequality (RII)  
 
The Slope Index of Inequality is the slope of the regression line of the “mean health status for each 
group against the relative rank of socioeconomic status (not health status) beginning with the most 
disadvantaged. It assumes a linear relationship between the two properties. Both properties are weighted 
by the square root of the group size. RII is SII “divided by the mean health status for the entire 
population” [102]. The key benefits of the SII and RII is that they satisfy all three minimum 
requirements of a good inequality index, which reflect the socioeconomic dimension of inequalities in 
health; i.e., the fact that inequalities are systematically related to socioeconomic status; (ii) reflects the 
38 
 
experiences of the entire population; i.e., use the information available on all population subgroups and 
(iii) be sensitive to the changes in the distribution and size of population across socioeconomic groups” 
[62,p548]. These methods also present disadvantages. The SII Approach can only be applied to 
socioeconomic variables which are ordered according to hierarchy. Further, the index can be biased 
should the regression estimate show deviations from linearity (Regidor, 2004). 
 
 
Concentration curve and index 
 
Concentration curves (CC) are used to assess whether socioeconomic inequality exists in health 
variables. However, they are limited in that they do not provide a measure of the magnitude of inequality 
that can be used for comparison over a range of factors. The concentration index (CI) is defined in 
reference to the concentration curve as twice the area between the concentration curve and the line of 
equality (the 45-degree line or the diagonal) [62]. The index is bounded between -1 and 1. When the 
index assumes a value of -1, the neediest individual within the population has all the populations’ health. 
At a value of +1, the population’s health is concentrated in the hands of the most well-off individual 
within the population. 
 
van Doorslaer, Wagstaff [63] deem concentration indices as a consistent measure of inequality, as they 
also fulfil three important requirements, namely: i) The ability to reflect the socioeconomic dimension 
to inequalities in health, ii) they reflect the experiences of the entire population, and iii) they are 
sensitive to changes in the distribution of the population across socioeconomic groups. 
 
2.2 Standardisation of the concentration Index  
Since the focus is on inequality within the health context, it is important to note that factors such as age 
and gender can often have an impact, by way of association, on health and income. Failing to account 
for them could lead to mis-estimation of the extent of the socioeconomic inequalities in health. Thus 




This standardisation could be direct or indirect. Direct standardisation entails using grouped data and 
applying the age-sex average of health (illness rates) for those respective groups to the age-sex structure 
of the population of each socio-economic group [64]. This method does bare some disadvantage. Its use 
of grouped data has an impact on the numerical values of the concentration index (CI) (where C+ or C- 
refers to the positive and negative concentrations indices, respectively) due to the number of socio-
economic groups applied. Thus, concentration indices that are produced by this method tend to display 
a greater reliance on the number of selected socioeconomic status (SES) groups [64, 104]. 
 
The indirect standardisation method offers an alternative approach whereby individual-level data are 
used instead to solve for confounding factors. The method proceeds to replace an individual’s health 
(or ill-health status) by the average health that someone of that age and sex would experience as per the 
population in question [62-64]. This method is deemed to have more precision and as such is the more 
favoured approach [46]. 
 
2.3 Correction of the concentration index 
 
Thus far, the concentration index has been argued to be one of the superior indicators of the inequality 
of health in relation to the socioeconomic position of individuals. However, it also does have some 
limitations which have been highlighted by many academics in recent years [105]. One consideration 
is the fact that the bounds of the concentration index may depend upon the mean of the health variable 
and hence make a comparison of populations with different mean health levels problematic where the 
outcome variable is binary or categorical [105, 106]. Other limitations according to Erreygers (2009) 
include the fact that ‘different rankings are obtained if inequalities in ill health rather than inequalities 
in health are considered, and that the value of the index is to a large extent arbitrary if the health variable 
is of a qualitative nature’ [107, p2]. 
 
In attempting to provide solutions to the above shortcomings, Wagstaff (2005) and Erreygers (2009a) 
suggest respective normalisation techniques. Wagstaff’s method of normalisation aims to correct the 
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bounds issue by dividing the health concertation index (𝐶(ℎ)) by subtracting the upper bound from 1, 
which in theory results in a normalised health concentration index equal to 𝐶(ℎ) ⁄ (1 − 𝜇ℎ ) [106]
1.This 
method ensures that a uniform range between (-1;1) always exists by way of stretching the index [106]. 
The generalised health concentration index, which is derived by multiplying the health concentration 
index by the average health level is sensitive to the scale or unit of the health variable, which then makes 
it an absolute measure of inequality rather than a relative one [108, 109]. 
 
Erreygers offers his normalised technique (E) using the axiomatic approach as one that would satisfy 
all the properties that a corrected concentration index should encompass. These four properties are 
namely [110]—transfer, level independence, cardinal invariance and mirror. This is in direct reference 
to the Wagstaff’s corrected index and the standard concertation index. Like its counterparts, the 
corrected concertation index forms part of the family of rank-dependent measures [110]. 
 
Despite the ongoing debate, other scholars have noted that minimal variation exists between the 
standard concentration index and the normalised index proposed by Wagstaff and that the ordering of 
inequality has been shown to remain the same for both measures [104]. Moreover, Ataguba, Akazili 
[104] found that Erreygers’ index could be obtained by simply scaling Wagstaff’s normalised index if 
a binary health variable is used.  
  
 
1 Here, 𝜇 denotes the mean of a binary variable y whose distribution by some measure of socioeconomic 




3. Empirical review 
3.1 The objective of the review 
This section focuses on reviewing literature that covers the topics of socioeconomic inequalities in 
immunisation and maternal health. Since this study has a two-pronged focus, the literature on women 
empowerment and maternal health and immunisation was also reviewed. In investigating existing 
empirical studies regrading both areas of emphasis, key information regarding study design, 
country/countries, target population, objectives, the measure of SES, analytical methods used for 
inequality assessment, variable of interest used, and critical summary of the key findings were obtained. 
Empirical studies reflecting a variety of contexts and settings were used with a special emphasis on low 
and middle income (or developing) countries since this study will use Zambia as a case study. The main 
objective of the literature review is to establish consistencies in existing research as well as isolate areas 
for further research. 
 
3.2 Socioeconomic inequalities in health  
3.2.1 Search strategy, inclusion and exclusion criteria 
 
A search for studies written regarding the topic was conducted where various key terms were included 
to obtain a body of potential empirical studies. The search was run on the following databases: Google 
Scholar, PubMed, Springer, Lancet and Web of Science. Keywords and terms for the search were 
“socioeconomic inequalities and maternal health”, “socioeconomic inequalities and immunisation”, 
“disparities in immunisation” and “socioeconomic health inequality”. These phrases were amended to 
include the following suffixes “developing countries”, “low-middle-income countries”. Reference lists 
from studies provided an alternative basis for additional literature searches and inclusion. Literature 
from developing countries was included in the review since the study’s subject, explores immunisation 
coverage within Zambia although this topic is not an area of material concern in developed countries. 
 
Studies were included if they were published within the past two decades as they proved more current. 
It is important to note that some of these studies had integrated within the data sets that spanned from 
the 1990s. The primary determinant of inclusion was if a paper mainly centred on socioeconomic 
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inequality and immunisation or maternal health. It was difficult to find studies from the developed 
countries, which focused on immunisation specifically since immunisation is nearly universal and child 
mortality within that context is relatively less evident as is developed countries. 
 
3.2.2 Studies from developing countries 
 
A relatively large body of empirical studies exists for developing countries with regards to inequalities 
being made manifest in maternal health and immunisation since much of the child mortality burden of 
disease falls within this region of the world [1]. These studies are more recent with the first of the ones 
included in this section being published in 2004 and the others spanning until 2018. This section 
includes 11 studies, eight of which are from sub-Saharan Africa (one cross–country study 
compromising 22 countries), two from Asia and one more from South America (Brazil). 
  
Many of these studies used the Demographic and Health Survey (DHS) to measure child health 
inequalities and maternal health. Five studies focused on immunisation and inequality whereas one 
looked at self-reported illness and inequality, and five used respective factors to serves as proxies for 





Table B. 1 Empirical Studies of socioeconomic inequalities in health in developing countries 
Study 
Authors 
Type of Study 
& 
Country of study 













(The sample sizes 
were 297,729 for 
1970, 527,927 for 
1980, and 406,976 
for 1991-a total of 
1,232,632 
observations.) 
To examine the effects 





five mortality for the 
state of Sao Paulo, 
Brazil, over a 21- year 
period during which 
much of the transition 






was based on the 
presence of 
electricity in the 
household; 




the number of 
bedrooms and 





Index of child mortality  
 
 
There was a substantial 
reduction in under-five 
mortality over the study 
period which was due to 
improved 
socioeconomic changes 
within the demographic. 
The study found that 
those who were worst 
impacted by child 
mortality were families 
with low SES. 
 
(1) There was a decline 
in inequality in under-
five mortality by 
household wealth but a 
substantial increase by 
mother’s education.  
 
(2) Improvements in 
infrastructure and 
economic development 
were associated with 






Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
inequality in under-five 
mortality. 
 
(3) Mother’s education 




five mortality even as 
levels of education for 
women increased and 




















Highlighting of the 
implications of urban 
population growth and 
access to health and 
social services on 
progress in achieving 
MDG 4. 















The study suggested that 
rapid urban growth can 
cripple the rate of child 
mortality reduction, 
especially as safe 
drinking water is not 
readily available. Thus, 
the government ought to 
improve the living 
conditions of the 
impoverished urban in 
order to realise a 







Type of Study 
& 
Country of study 












Two or more DHS 
surveys carried out 
between the 1990s 





(1) The findings of this 
study recommend that 
there should be attention 
given to the poor urban 
population with policy 
ensuring that resources 
are allocated adequately 
to them too.  
 
(2) Paper establishes the 
inter-relationships 
between trends in urban 
under-five mortality, 
urban population 
growth, and trends in 
access to safe drinking 
water and in vaccination 
coverage. 
 
(3) The study found that 
countries which showed 
the least improvement in 
child mortality were 
those which had an 
urban population which 
was growing at a rapid 
rate.  
 
(4) Countries, where the 





Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
access to improved 
water for drinking, had a 
greater chance of 









Health Surveys of 
1992, 2000 and 
2004 
To assess trends in 
inequities in selected 
indicators of health 
status and health 
service utilisation in 
Malawi. 
Asset Index with 





index and curves 
Infant mortality rate  
 




(represented by stunting 
– low height-for-age 
and underweight) 
 
Prevalence of diarrhoea 
and acute respiratory 
infections (ARI) 
 
Total fertility rate  
 
Low body mass index 
(BMI in women, which 






The study found that 
inequities existed where 
those who experienced 
the burden of disease 
with regards to Health 
indicators tended to 
receive the least 
attention or 
interventions for these 




of certain diseases. 
 
(1) It was found that 
inequality within 
Malawi in reference to 
healthcare and health 
was pervasive and pro-
rich despite policy 







Type of Study 
& 
Country of study 











(2) In some cases, the 
pro-rich widening trend 
is found in inequities, in 
particular, healthcare 
utilisation for proven 
cost-effective 
interventions 
       
(Lauridsen, 
2011) 
India To use a concentration 
index to quantify the 
socioeconomic 
distribution of child 










Asset Index with 












(pertussis), and tetanus 
(DPT); poliomyelitis 
(polio); and measles 














The study offered 
findings that were 
original in terms of child 
health care in India and 
immunisation in 
establishing the role of 
SES on these outcomes. 
 
(1) “Poor household 
economic status, 
mother's illiteracy, per 
capita state domestic 
product and proportion 
of illiterate at the state 
level is systematically 
related to 97% of 
predictable 
socioeconomic 
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& 
Country of study 









sex of the child 
(male/female),  
 
Birth order (birth order 








at the national level.” 
 
(2) Of these 
determinants, mother's 
illiteracy proves to have 
the most significant 
impact as a determinant 














months who were 
expected to have 




To determine the 
extent of full and up to 
date (UTD) 
vaccination coverage 
among children aged 
between 12-23 months 
living in the slums 
Nairobi, and to 
identify risk factors 
associated with 
incomplete 
vaccination in these 
resource-deprived 






















vaccination at birth; 
three doses 
of polio vaccine at 1, 2 
and 3 months 
of age; three doses of 
DPT vaccine at 
1, 2 and 3 months of 
age; and measles 
vaccine at 9 months of 
age. 
 
sex of child 
 
Maternal education  
 
The study suggests that 
children rising in slums 
are most neglected and 
as such underserved 
with regards to 
vaccination and service 
delivery. 
 
(1) “Measles coverage 
was substantially lower 
than that for the other 
vaccines when 
determined using only 
vaccination cards or in 
addition to maternal 
recall. Up to date (UTD) 





Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
Maternal age at index 
child's birth  
 
Parity (1, 2, and 3+) 
 




Antenatal care (no 
ANC, seen by a doctor, 
seen by a nurse),  
 
Birth weight (less than 
2.5 kg, 2.5 kg or 
greater), 
 
Postnatal care (no 
postnatal, postnatal 
care)  
vaccinations at 12 
months was 41.3% and 
51.8% with and without 
the birth dose of OPV, 
respectively. 
 (2) Full vaccination 
coverage (57.5%) was 
higher than up-to-date 
coverage (51.8%) at 12 
months overall, and in 
both slum settlements, 
using data from cards. 
Multivariate analysis 
showed that household 
assets and expenditure, 
ethnicity, place of 
delivery, mother's level 
of education, age and 
parity were all 
predictors of full 
vaccination among 
children living in the 
slums.” 
(Zere, 2012) Ghana 
 
DHS,2008 
To examine the equity 
dimension of child 






(Derived from the 
household 
ownership of 
assets such as 
television, car etc. 












Perinatal mortality rate 
(Includes pregnancy 
The study suggests that 
the child and maternal 
health outcomes, which 
were employed show 
substantial inequities as 






Type of Study 
& 
Country of study 









such as flooring 
material and 
source of drinking 
water.) 
losses of at least seven 
months gestation 
(stillbirths) and deaths 
among live births that 
occurred within the first 




age of under-five 
children below minus 
two standard deviations 





for-age of under-five 
children below minus 
two standard deviations 










(1) “No statistically 
significant inequities are 
observed in infant and 
under-five mortality, 
perinatal mortality, 
wasting and acute 





five children, anaemia in 
children and women, 
childhood diarrhoea and 
underweight in women 
(BMI < 18.5) show 
inequities that are to the 
disadvantage of the 
poorest.” 
 
(3) “Overweight (BMI 
25-29.9) and obesity 
(BMI ≥ 30) among 
women reveals that 
there are inequities in 
favour of the poorest.” 
 
(4) “Treatment of 
diarrhoea in children, 





Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
Diarrhoea in children. 
 
Anaemia in women age 
15-49 years. 
 
Nutritional status of 
women age 15-49 years 
(Defined using Body 
Mass Index (BMI). A 
BMI of < 18.5 was 
regarded as thin, 18.5-
24.9 normal, 25-29.9 






vaccines among children 
and sleeping under ITN 
(children and pregnant 











dataset of children 
aged between 12 
and 59 months) 








(a) Fully immunised 
children (i.e. 
children aged 12–59 
months that received all 
of the following 12 
vaccines2—measles, 
BCG, DPT1-3, OPV0-
3, yellow fever, MMR 
and vitamin A) 
(1) Factors such as 
mother’s literacy, region 








(2) Children from richer 





Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
b) Partially immunised 
children (i.e. those that 
received at least one but 
not all of the ‘vaccines’)  
(c) Never immunised 
(i.e. those that have 










urban areas, and from 
richer geo-political 
zones in Nigeria are 
more likely to be fully 
immunised compared 
with their counterparts. 
 
(3) In Nigeria, 
inequality in full 
immunisation coverage 
is to the advantage of 
the rich while inequality 
in partial or no 
immunisation coverage 
suggests that poor 
children generally are 
either partially 




Nepal To compare 
immunisation 
coverage and equity 
distribution of 
coverage between 
2001 and 2014 in 
Nepal. 
 






of scores based on 
families’ 
ownership 








=BCG vaccination at 
birth; three doses 
of polio vaccine at 1, 2 
and 3 months 
of age; three doses of 
DPT vaccine at 
1, 2 and 3 months of 
age; and measles 
vaccine at 9 months of 
age. 
(1) From 2001 to 2014, 
the proportion of 
children who received 
all vaccines at the age of 
12 months increased 
from 68.8%. 
 
(2) The poorest wealth 
quintile showed the 






Type of Study 
& 
Country of study 





Variables of interest Findings, explanations 
and conclusions 
of durable assets, 
housing 
characteristics 
and access to 
services.) 
from 58% to 77.9%, 
while the wealthiest 
quintile only improved 
from 84.8% to 86.0%. 
 
3) The improvement in 
immunisation coverage 
between 2001 and 2014 
in Nepal can mainly be 












DHS 1994, 1999, 
2005/06 and 
2010/11 
To quantify and 
explain the observed 
differences in prenatal 




















Binary indicators used 
for maternal health care 
utilisation; 
 
 (1) The receipt of four 





assistance for the most 
recent pregnancy. 
 




disparities in maternal 
health care use are 
mostly pro-rich and 
have widened over time 
regardless of the 
location of residence. 
 
(2) Inequalities in 
wealth and education are 
amongst the top drivers 
of the observed 






Type of Study 
& 
Country of study 





















Data collection is 
done 2010 and 
2015. 




inequalities in full 
immunisation 






(three doses), polio 
(three doses) and 
measles vaccines)  
Wealth index 













(1) Pro-rich distribution 
of child vaccination in 
most low/middle-
income countries 
remains an important 
public health policy 
concern.  
 
(2) Gambia Namibia and 
the Kyrgyz Republic 
were the only countries 
where children who 
belong to a higher 
socioeconomic status 
group were less likely to 
receive all the four core 






3.3 Characteristics of reviewed studies from developing countries  
 
3.3.1 Study design: Most of the literature reviewed (eight of the eleven studies) used longitudinal 
data, although time frames varied between studies. Some studies used various rounds of the 
Demographic and Health Survey (DHS), and one used the Core Welfare Indicator Survey. Three 
studies observing inequality in child and maternal health in Nepal, India and Ghana were cross-
sectional. Although most of the studies were representative at the national level, one study controlled 
for observations in three towns within Nairobi, Kenya instead of the entire country [47]. Where 
immunisation coverage was the outcome of interest, the sample of children ranged from those aged 
12-23 months,12-59 month, to those aged 10–59 months. 
 
Health indicators/outcomes: The review aimed to focus on immunisation coverage and the 
impact of income inequalities thereon. When immunisation was an outcome of interest, it was usually 
categorised based on either the WHO vaccination norms taking into account the particular vaccination 
in question. Infants were regarded as fully immunised when they had received BCG vaccination at 
birth; three doses of polio vaccine at 1, 2 and 3 months of age; three doses of DPT vaccine at 1, 2 and 
3 months of age; and measles vaccine at 9 months of age [47, 111, 112]. 
 
In other cases, maternal health outcomes were used to indicate health status. One study used the index 
of child mortality (under five) [113] as a proxy for child health whereas other authors used multiple 
factors including child mortality such birth weight, mothers’ health indicators as well as utilisation of 
health services to assist in investigating inequities that were rooted in SES (Makate, 2017; Zere, 
2012).  
 
Measurement diarrhoea of SES: Ten studies used wealth, household or asset indexes as a proxy 
for SES. The Principal Component Analysis was used to construct these respective indices. One 




Measurement of health inequality: Seven of the eleven studies used the concentration index to 
measure inequality. Two studies used the concentration index, followed by a decomposition analysis 
[112, 114]. Another used both a Gini coefficient and a concentration index as a measure of inequality 
[115]. Other methods used although less popular where the slope index of inequality (SII) and 
Relative index of inequality (RII) in the study undertaken [111, 116] along with Multivariate Analysis 
via regressions and correlation methods. 
 
3.3.2 Findings of the review 
 
The findings of these eleven studies proved consistent with those established in the developed 
countries in connection with income-related inequalities and health. The difference is in the outcome 
variable under scrutiny. For studies assessing immunisation, SES inequalities were found to have a 
significant impact on immunisation coverage. In most cases, the findings showed the extent to which 
children resident in slums or lower SES groups were underserved with vaccinations [47]. In Nigeria, 
children from richer households and even richer geopolitical areas were more likely to be fully 
immunised [112]. In Zimbabwe, regardless of residence, socioeconomic disparities in maternal health 
care were mostly pro-rich and had widened from 1994 to 2011 [114]. Factors such as mother’s 
education and SES had a bearing on inequality experienced in light of child immunisation within 
Nigeria and Kenya [47, 112]. Lauridsen and Pradhan [117] found by way of decomposing the 
concentration index that lower SES and mother’s illiteracy are systematically related to 97% of 
predictable socioeconomic inequalities in full immunisation coverage at the national level. 
 
In a study where 46 low/middle-income countries were used to identify factors associated with 
socioeconomic inequalities in full immunisation coverage against the four core vaccine-preventable 
diseases, it was found that child vaccination was in favour of the rich with exceptions in Gambia, 
Namibia and Kyrgyz Republic where children who belonged to higher SES were less likely to have 
received all four core vaccines against preventable diseases [115]. In fact, a cross country study which 
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included 22 countries, focusing specifically on urban slums found that the urban poor is neglected, 
and due to lower SES, tend to not access adequate vaccination and as such experience higher under-
five mortality rates [45]. This study showed that in cases where there is an ever-growing urban 
population without improved living conditions, worsening trends with regards to child mortality can 
be expected, which would impact negatively on child mortality reduction [45]. 
 
Inequalities persist even in other child health indicators such as stunting, underweight in under-five 
children, anaemia in children and women, childhood diarrhoea and underweight in women (BMI < 
18.5) where these indicators demonstrate inequities that are to the disadvantage of the poorest in 
Ghana [116]. However, there was no wealth-related gradient for treatment of diarrhoea in children, 
receiving all basic vaccines among children and sleeping under insecticide-treated bed nets (ITN) 
(children and pregnant women) which are all preventive method of child mortality [116]. In contrast, 
one study showed that through focused government interventions, immunisation coverage improved 
in Nepal, with the poorest wealth quintile showing the greatest improvement compared to the 
wealthiest quintile for immunisation coverage measured from 2001 to 2004 [111]. Further, using 
Brazil as a case study, it was shown that there was a decline in under-five child mortality over 21 
years. This decline was caused by household wealth increases where mothers who had improved 
education were then able to earn more [113]. This demonstrated how improvements in infrastructure 
and economic development could positively impact on child mortality [113]. 
 
3.4 Woman empowerment and immunisation 
3.4.1 Search strategy, inclusion and exclusion criteria – woman empowerment and 
immunisation 
 
A search for literature published pertaining to women empowerment and immunisation was run where 
respective key terms, phrases and words were used to collect viable studies of consideration for this 
section of the literature review. The search was run on the following databases: Google Scholar, 
PubMed, Springer, Lancet and Web of Science. Keywords and terms for the search was “women 
empowerment and maternal health”, “women autonomy and immunisation”, “women decision 
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making” and “women empowerment and child vaccination”. These phrases were amended to include 
the following suffixes “developing countries”, “low-middle-income countries” and Reference lists 
from studies found were also used as an alternative basis for additional literature searches. Mostly 
studies from developing countries were included in the review, although there are some cross-country 
studies. 
 
Studies were included which were published from 1979 until 2018. The primary determinant of 
inclusion was if they focused on women empowerment and factors that not only affect a mother’s 
health but the health of her baby too (special emphasis on immunisation). 
 




In total, 16 studies from developing countries were reviewed. Empirical studies have shown the 
positive relationship that exists between women empowerment and child health care, in particular, 
immunisation [51]. In fact, this sense of empowerment can have a positive effect on decisions that 
women make, especially with regards to choices which will directly impact their health status within 
their households [52]. 
 
In this section, the relationship between women empowerment and child health (immunisation) is 
established with a critical emphasis on developing countries. The reason for this is two-pronged. 
Firstly, literature regarding women empowerment and immunisation within developed countries is 
scarce. Further, although women empowerment is esteemed within the developing world, it is often 
perceived through a different lens compared to developing countries due to cultural nuances [9, 55]. 
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Table B. 2  Empirical studies: women empowerment in child health, immunisation and self-reported health 
Study Type of Study 
& 
Countries/Year 
















To gauge whether 
education has an impact 
on child mortality 





















Child mortality  
 
(1) It was concluded that 
women’s education in Nigeria 
can produce profound changes 
in family structure and 
relationships, which in turn may 






Mali, Uganda, and 
Zimbabwe in sub-
Saharan Africa; 
Egypt, India, and 
Nepal in Asia; and 
Haiti, Colombia, 
Nicaragua, and 





To examine the impact 
of 
women’s ability to make 




nutritional status, and 

































60 months have 
received 
(includes three 
doses of polio 
three rounds of 
DPT, and BCG 
 
(1) The impact of women’s 
empowerment on health 
outcomes differs by the type of 
outcome, and the effect is 
greater for height-for-age than 
for either child mortality or 
vaccination status. 
(2) In Nepal and India, women’s 
decision-making authority 
improves height-for-age and 
reduces child mortality, even 






Study Type of Study 
& 
Countries/Year 























dying between 13 
and 60 months of 
age for children 
born 60-120 
months before the 
survey. 
 
(3) More than three-fourths of 
the effect of women’s decision-
making is concentrated at the 
community level; the 
coefficients for individual 
effects are relatively small. 
 
(Bloom, 2017) Varanasi, India 
 
To investigate 
dimensions of women’s 
autonomy and their 
relationship to maternal 






































(1) After controlling for age, 
education, household structure, 
and other factors, women with 
closer ties to natal kin were 
more likely to have greater 
autonomy in each of these three 
areas.  
 
(2) Women with greater freedom 
of movement obtained higher 
levels of antenatal care and were 





Study Type of Study 
& 
Countries/Year 






Findings and explanations (and 
conclusions) 
 
(3) The influence of women's 
autonomy on the use of health 
care appears to be as important 
as other known determinants 
























































blood vs affinal 
relatives, and 
living with 













(1) Women's autonomy, as 
measured by the extent of a 
woman's freedom of movement 
was found to be a major 
determinant of maternal health 




Study Type of Study 
& 
Countries/Year 


























Data collected in 
1993-1994. 
 
(1) Aim of the paper was 
to ascertain whether 
Muslim women are more 
oppressed than non-
Muslims in various 
dimensions of personal 
autonomy. 
 
(2) To gauge whether 
there a consistent 
mortality disadvantage 
among the 15 Muslim 
communities compared 
to non-Muslim ones. 
 
(3) To find whether there 
is an association, both 
across and within 
settings, between 
religious differences in 
infant and child 









































(1) The study found limited 
evidence in favour of the idea 
that higher Muslim than non-
Muslim infant and child 
mortality is related to lower 
autonomy among Muslim 
women. 
 
(2) Mortality among infants and 
children was often higher in 
Muslim communities, 
particularly in parts of Thailand, 
the Philippines, and Malaysia. 
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Study Type of Study 
& 
Countries/Year 


















To determine whether 
there is a link between 
women’s autonomy and 
the utilisation of 
maternal and child health 
care in these countries, 
and if so, how such 
relationships depend on 
socio-economic factors 
including educational 
attainment of women 
and husbands/partners, 
women’s current work 














































as measured by 









(1) Both women’s autonomy and 
socioeconomic indicators should 
be analysed in order to derive a 
complete understanding of the 
determinants of maternal and 
child health-care utilisation. 
(2) Socio-economic factors have 
a significant influence on 
women’s autonomy, with 
women’s current employment 
and the rural-urban residence 
being the most important 










in three northern 
 
To examine the 
determinants of the 
uptake of the full dose of 
diphtheria-pertussis-
















(1) The most significant 
predictors of the uptake of DPT3 
include child's place of birth, 
presence of an immunisation 
card, mother's ideation, mother's 
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Study Type of Study 
& 
Countries/Year 





















decision-making power and 











To assess the 






























































(1) Women empowerment is 
associated with several key 
health indicators at a national 
level.  
 
(2) When GDP was not 
considered, GEM had a 
statistically significant 
association with all health 
indicator variables except for the 
proportion of 1-year-olds 












is a function 
  
Contraceptive use 
Antenatal care  
 
(1) The odds of having a skilled 
attendant at delivery for women 
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Study Type of Study 
& 
Countries/Year 

















empowerment status and 
maternal health service 

























in the poorest wealth quintile are 
94% lower than that for women 
in the highest wealth quintile 
and almost 5 times higher for 
women with complete primary 
education relative to those less 
educated. 
 
(2) The likelihood of using 
modern contraception and 
attending four or more antenatal 
care visits are 2.01 and 2.89 
times, respectively, higher for 
women with complete primary 
education than for those less 
educated. Women with the 
highest empowerment score are 
between 1.31 and 1.82 times 
more likely than those with a 
null empowerment score to use 
modern contraception, attend 
four or more antenatal care visits 










To examine the 
simultaneous 
























(1) This study reinforces the 
importance of education and 
income as important 





Study Type of Study 
& 
Countries/Year 










and child health care 
utilisation and to 





indicators on the 
utilisation of 
maternal and child health 
care. 
 














































(2) Residing in an urban area 
enhances the likelihood of using 
maternity services. 
 
(3) Birth order has a significant 
and consistently negative 
relationship with women’s 
health-seeking behaviour. 
 
(4) However, the husband’s 
occupational status does not 
have a relation with health care 
utilisation. 
 
(5) Women’s autonomy 
indicators in some cases, 
influence the utilisation of 
maternal and child health care, 
but healthcare seeking 
behaviours are more strongly 





Study Type of Study 
& 
Countries/Year 










































Study Type of Study 
& 
Countries/Year 









































To examine the 
influence of household 
decision making on 
women’s uptake of 
































(1) It was found that women’s 
decision-making power has a 
significant positive correlation 
with maternal health services 
uptake and that influential 
males’ decision-making power 
has the opposite effect, after 
controlling for socioeconomic 





Study Type of Study 
& 
Countries/Year 
















To gauge whether 
measures of gender 
equality, autonomy and 
individual attitudes 
towards gender norms, 
are associated with a 
child being fully 




























variable is binary 










(1) Household decision-making 
and attitudes towards wife-
beating were significantly 
associated with a child being 
fully immunised after 
controlling for socioeconomic 
variables. 
(2) Ethnicity, wealth and 
education were also significant 
factors. 
 







To examine the 
influences of 
demographic factors and 
women's autonomy on 




























doses each of 
DPT-HepB-Hib 
vaccine, polio 





(1) Completion of basic 
vaccination series is very low in 
the study area.  
 
(2) Association between 
women's decision-making 





Study Type of Study 
& 
Countries/Year 














































To examine whether 
measures of gender 
equality are associated 
with maternal and child 






































(1) Found protective 
associations between gender 
equality measures and the 
outcomes studied. 
(2) Found that gender equality is 
a potential strategy to improve 




Study Type of Study 
& 
Countries/Year 



















between 1982 and 
2012 were used. 
 




This paper aims to offer 
a contextualised 
understanding and 
explanation of how 
gender affects access to 
vaccination in childhood 











































Key words were 























(1) The study found that 
women's low social status 
manifests on every level, as a 
barrier to accessing 
vaccinations. 
 
(2) Indirectly, women's lower 
status made them vulnerable to 
blame and shame in case of 
childhood illness, partly 
reinforcing access problems, but 
partly increasing women's 
motivation to use every means 
to keep their children healthy. 
 
(3) In settings where gender 
discrimination exists most 
strongly, increasing availability 
and information may not be 





Study Type of Study 
& 
Countries/Year 

















(Ebot, 2015)  
Ethiopia 
 
To find if a relationship 





















It ranged from 
0 to 4: a low 
























were used to 



























(1) Women’s socioeconomic 
status and household autonomy 
were found to be significantly 
associated with children’s 
immunisation status. 
 
(2) Overall, the implications of 
this study align with those of the 
Millennium Development Goal 
#3: 
 
(3) Study provides important 
insight into one of the many 
ways that empowering women 






Study Type of Study 
& 
Countries/Year 















age in years, 
polygamous 
marriage, age at 
first marriage, 
child’s age, child 
sex, number of 
children under 5 
years of 













Most studies included, in this section of the review had a representative sample as they often focused 
on national statistics provided by the DHS and in some cases, they focused on more than one country. 
Two studies especially focused on regions within countries [58, 118]. All studies were cross-sectional 
although in some cases, data were collected over a period of five to twelve months [119, 120]. All 
studies found that women empowerment had a significant positive impact on maternal and child 
health outcomes. The earliest qualitative study was published in 1979 by Caldwell – at that time 
women empowerment was understood to be a function of education. In more recent times the concept 
of women empowerment has evolved to include aspects of autonomy and decision making. In that 
study, Caldwell attempted to gauge whether a mother’s education (level) had an impact on child 
mortality decline in Nigeria by use of a survey based on population. 
 
Following Caldwell’s observation, other authors have subsequently examined the impact that 
women’s decision making has on their children’s health outcomes especially in line with child 
mortality [54], health care utilisation [57] and immunisation coverage [58, 121]. 
 
A systematic review by Merten and his colleagues, covering 25 qualitative studies conducted between 
1982 and 2012, with 18 of these published after 2000 explain how gender affected access to child 
vaccination within the context of middle- and low-income countries. A total of six cross-country 
studies were incorporated into the review. One included 31 developing countries [122], another was 
composed of 75 countries [54], while Ghuman [120] focused on four countries in his study. Desai and 








All studies were specifically concerned with reductions in child mortality, and thus the health 
outcomes varied as respective factors were assigned as proxies for maternal child health. Women 
empowerment and its impact on maternal health were most closely observed. In most cases, women 
empowerment was represented as a function of responses regarding decision making within the 
household. These decisions were of whether women formed part of decisions concerning large 
household purchases, day-to-day household purchases, and health care for themselves, and visits to 
family and friend. In other studies, additional consideration of ‘acceptability of wife-beating’ was 
incorporated to create the woman empowerment variable. 
 
At least four studies used child vaccination/immunisation as the main health outcome. In these 
studies, often, the impact of women empowerment on child immunisation or vaccination was 
examined. In other studies, immunisation was used as an indicator of child health along with other 
factors. Child mortality and health care utilisation were also health outcomes of interest in some 
studies. 
 
Measurement of women empowerment 
 
Initially, education was accepted as an indicator of women empowerment in the past. It was 
understood that through education, women were able to make more informed decisions not only 
regarding their own health but also that of their children [51, 52]. In the past few decades, a more 
evolved understanding of what constitutes women empowerment within the developing world context 
(especially Africa) has been consistently applied in various studies. In many cases, the measurement 
of women empowerment is via an index that is constructed from responses from questions asked to 
women via a survey [61]. These questions touch on two main aspects. Firstly, the extent to which a 
woman makes decisions either jointly or with a husband/partner for her household. The second 
paradigm accounts for attitudes toward wife beating and its acceptability (if at all) based on respective 
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reasons provided within the survey for its cause. At least ten of the studies defined women 
empowerment as a function of responses regarding a woman’s decision-making power in line with 
household purchases, day-to-day household purchases, her health care, and visits to family and friend 
[9, 56, 58]. In at least seven studies, an additional element of a woman’s attitude towards violence 
also formed part of women empowerment [55]. Three studies also included an additional 
consideration of mobility when measuring women empowerment within the maternal-child health 
context [57]. 
 
Measurement of immunisation 
 
Immunisation was defined in a range of varied methods for the empirical studies which were included 
in the review. In ten of the sixteen studies featured in this section, immunisation status was used as a 
proxy for maternal health or child mortality reduction. The most crucial point to establish when 
dealing with immunisation was the immunisation (or vaccination) status of the child in question. In 
most cases, the authors explicitly stated what would constitute full immunisation. Wado, Afework 
[58] considered a child fully vaccinated when at the age 12-24 months, the child had received (BCG), 
three doses each of DPT-HepB-Hib vaccine, polio vaccines, and a measles vaccination (Desai et al, 
2000). Bloom (2001) used a child who had received diphtheria-pertussis-tetanus vaccines (DPT3) to 
serve as a proxy for a fully immunised child. Immunisation was often treated as a binary variable—a 
child was either fully immunised or not. 
 
3.5 Collating findings from reviewed studies and establishing opportunities for 
further study 
General findings tended to confirm a positive relationship between women empowerment and child 
health outcomes [9]. In general after assessing the relationship between women's empowerment and 
health in 75 countries by use of the gender empowerment measure (GEM) (a composite index 
measuring gender inequality in economic participation and decision making), Varkey, Mbbs [54] 
found that the GEM indicator was significantly associated most strongly with infant mortality, 
amongst other significant associations. Interestingly, after accounting for the Gross Domestic Product 
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(GDP) of countries, GEM had statistically significant associations with health indicators such as low 
birth weight, maternal mortality and infant mortality except for the proportion of 1-year-olds 
immunised against measles [54]. Other cross-country studies observed that the impact of women’s 
empowerment on health outcomes differs by the type of outcome [121]. In Nepal and India, women’s 
decision-making authority had a positive impact on child mortality reduction, after the study 
controlled for education and wealth [121] 
 
In another cross-country study comprising 31 developing countries, it was learnt that income and 
education, which are at the core of shaping women empowerment, had a significant impact on health 
outcomes realised for women. This cross-country study aimed to examine the relationship between 
women’s economic, educational and empowerment status in connection to its impact on her maternal 
health service utilisation within developing countries. Educated women who had completed their 
primary education had improved health utilisation outcomes versus their less-educated counterparts 
[123]. In more recent general studies, Merten, Hilber [123] found that women who had a low social 
status manifested as having a barrier to accessing vaccinations on every level. The study aimed to 
contextualise the understanding of gender effects on childhood vaccination with low- and middle-
income countries using a systematic review compromising 25 countries. They observed that in 
settings where gender discrimination existed most strongly, providing information and simply 
increasing the availability of immunisation would not translate into improved immunisation coverage 
for those under immunised due to the impact of the lack of women empowerment [56]. 
 
Moving towards papers focusing on the Asian region, findings of included studies were consistent 
with those of the cross-country studies. In India, Bloom, Wypij [57] investigated the dimensions of 
women autonomy and its relationship with maternal health care utilisation, which is an important 
consideration in child mortality reduction [57]. After controlling for various factors, it was found that 
women with greater freedom of mobility were more likely to have a safe delivery due to increased 
probability of improved antenatal care and that together with education, women’s autonomy is an 
important determinant of health care usage [57]. Further, Bloom, Wypij [57] and colleagues also 
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noted that freedom of mobility for women within Northern India was a key determinant of maternal 
health care utilisation among the poor to middle-income households. In attempting to examine the 
simultaneous effects of women’s socio-economic, demographic and decision-making status on 
maternal and child health care utilisation within India, Mahapatro [124] found that the place of 
residence, especially urban residency impacts the likelihood of a woman using maternity services. The 
study further found that education accompanied by income remain significant determinants of 
maternity services utilisation amongst mothers. Hou and Ma [125] focusing on Pakistan instead, also 
noticed that women’s decision-making power had a substantial positive correlation with maternal 
health services uptake. 
 
Studies in sub-Saharan Africa also showed that there was a positive relationship between women 
empowerment and maternal health outcomes. In general, Singh, Bloom [55] examined whether 
measures of gender equality were associated with maternal and child health outcomes in Africa using 
8 African countries. They found that there existed protective associations between gender equality 
measures and the outcomes studied examples of which were immunisation status, maternal health 
outcomes and the treatment of acute respiratory infection for infants. 
 
In Ethiopia and Eritrea, Woldemicael and Tenkorang [126] showed that there is a need to derive an 
improved understanding of the factors which impact maternal and child health outcomes. These 
studies found that factors which most affected woman autonomy were socioeconomic determinants 
such as women’s current employment and rural-urban residence. Further, in Ethiopia, Wado found 
that there is an association between women's decision-making autonomy and vaccination [58]. Most 
recently, Ebot [9] study to assess whether a relationship exists between women autonomy and 
immunisation found that women’s socioeconomic status and household autonomy were significantly 
associated with children’s immunisation status. This further reinforces the role of women’s decision 




In Nigeria, building on Caldwell’s initial findings which showed that a positive relationship exists 
between maternal health and education, other studies using women empowerment were also able to 
find significant associations between women empowerment and a child’s immunisation status [118]. 
For this study, the uptake of DPT3 (being fully immunised) was significantly influenced by a 
woman’s household decision-making power [118]. Singh, Haney [127] found similar outcomes with 
their study when they noted that there was a substantial association between a child being fully 
immunised, after controlling for socioeconomic factors, and their mothers’ attitude towards wife-
beating and household decision making. This finding was the result of a study that aimed to gauge 
whether measures of gender equality, autonomy and individual attitudes towards gender norms are 
associated with a child being fully immunised in Nigeria [127]. 
 
In light of the findings of this review, a gap remains unexplored. Immunisation studies in SSA have 
mostly focused on Angola, Ethiopia, Nigeria and Congo but not Zambia. Although much has been done 
in establishing links between immunisation coverage and socioeconomic status (SES), minimal research 
has been compelling in addressing this explicitly. Moreover, literature focusing on immunisation 
coverage often does not include the additional consideration of women empowerment to the debate. 
Thus, an enhanced understanding of the social determinants of health along with country-specific 
structural considerations and women empowerment could help in improving child health outcomes in 
a more contextualised manner in Zambia. Lastly, policy interventions will stem from findings that are 
established from the study. This is due to the growing evidence that will further support the effects that 
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Women empowerment and socio-economic inequality in immunisation coverage: a case study  






Basic immunisation coverage for children between 12-23 months in Zambia was 68% in 2013. 
Nevertheless, a substantial number of child deaths persist as a result of preventable disease. This study  
assesses the relationship between women empowerment and immunisation coverage in Zambia. It 
investigates socio-economic inequality in full, partial, and immunisation intensity. To understand the 
role of women empowerment in immunisation coverage in the country, two sets of indicators have been 
proposed for use from the survey- namely women’s participation in household decision making as well 
as women’s attitude towards beating. Thus, the findings can support improved immunisation coverage, 




The study uses the 2013-14 Zambia Demographic and Health Surveys (ZDHS), which are nationally 
representative household surveys [12]. These datasets incorporates information regarding children from 
0 to 59 months and for men and women aged 15- 49 years old. The two main study variables are women 
empowerment and immunisation. Immunisation is divided into three categories namely, full, partial and 
no immunisation. Concentration indices are used to assess inequality in full, partial and no 
immunisation coverage as well as in the intensity of immunisation coverage. Briefly, a positive 
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concentration index means that immunisation coverage is pro-rich as richer children are more likely to 




The main finding of this study was that socioeconomic status has a significant impact on the 
immunisation coverage of a child. For children who were fully immunised, immunisation was found to 
be pro-rich (concentration index = 0.046). The distribution of partially immunised children 
(concentration index = -0.114) and not immunised children (concentration index = -0.138) is pro-poor. 
This confirmed that poorer women were more likely to have a partially immunised/not immunised 
children compared to a child whose mother is richer. Immunisation intensity had a pro-rich outcome 
(concentration index = 0.153). In addition, the study confirmed the importance of household decision 




This study has shown that close attention to factors such as women empowerment and a mother’s 
education can support improved immunisation coverage, especially for those who are the poorest in 















Child mortality is a health concern that affects many countries, with the sub-Saharan African (SSA) and 
the Middle Eastern regions being most acutely impacted [1]. Studies show that there has been a marked 
decline in under-five mortality. However, deaths remain high at a toll of 5.6 million in 2016 [128]. The 
causes of under-five deaths vary from one geographic setting to another. Thus, the need for an in-depth 
understanding of child health epidemiology at a country level is pertinent [69]. 
 
The World Health Organization (WHO) cited preterm birth complications, pneumonia, birth asphyxia, 
diarrhoea and malaria as the prominent reasons for child deaths in many countries. Non–infectious 
diseases are the leading cause of the death of children under the age of 5 years in 2016 [128]. 
 
To mitigate the prevalence of major childhood related diseases and infant mortality, the WHO has 
adopted a strategy which encourages full immunisation of children by the age of 12 months. Paediatric 
immunisation is regarded as one of the most important modern interventions as it has in past decades 
contributed toward substantial reductions in child deaths globally where 2-3 million deaths were averted 
in recent times [9]. 
 
Immunisation studies in SSA have mostly focused on Angola, Ethiopia, Nigeria and Congo but not 
Zambia. The Zambian Health Ministry contributed to improved child mortality indicators by abolishing 
user fees for all maternal and child health services to facilitate better access and service utilisation [24]. 
Nevertheless, a substantial number of infant deaths persist in Zambia as a result of preventable diseases 
[25]. Vaccination in Zambia is based on numerous factors which impact coverage levels. Long waiting 
times, the distance that vaccination sites are from mothers as well as how health workers communicate 
with parents (and caregivers) have a bearing on acceptability of vaccination services [60, 129]. 
Socioeconomic status has also been reported as an additional consideration which impacts child health 




The social gradient (i.e. a situation where socioeconomic status is positively related to good child health 
indicators) is not only evident in Zambia but also in other parts of the globe, where disparities in health 
are experienced due to differing contributing factors including socioeconomic status [16]. Low-, 
middle- and high-income countries have demonstrated the existence of the social gradient [17]. Poverty, 
relative deprivation, slow economic growth and social exclusion have a major impact on health and 
many SSA countries with a high incidence of child mortality continue to struggle with the above factors 
which are not as evident in developed countries [19]. 
 
Although much has been done in establishing links between immunisation coverage and socioeconomic 
status (SES), minimal research has been compelling in addressing this explicitly. Moreover, literature 
focusing on immunisation coverage often does not include the additional consideration of women 
empowerment to the debate. Thus, an enhanced understanding of the social determinants of health along 
with country-specific structural considerations and women empowerment could help in improving child 
health outcomes in a more contextualised manner in Zambia. 
 
Empirical studies have shown the positive relationship that exists between women empowerment and 
child health, in particular, immunisation [51]. In fact, the sense of empowerment can have a positive 
effect on decisions that women make, especially with regards to choices which directly impact their 
health status within their households [52]. 
 
Women are often the primary caregivers for their children and can influence their children’s health 
directly [53]. As such the international development community through the values espoused in the 
MDGs have launched initiatives focused towards alleviating the constraints faced by women in 






The primary aim of this study is to empirically assess the relationship between SES and immunisation 
coverage in Zambia and to understand the role of women empowerment in immunisation coverage in 
the country. An enhanced understanding of the impact of the interaction of these factors on 
immunisation aids in improving immunisation coverage in Zambia. 
 
Methods 
Setting of study 
 
The country of interest for this paper is Zambia, a country which shares borders with Malawi (which 
has made significant progress in achieving the MDGs). Zambia already has a seemingly decent 
immunisation coverage statistic compared to other parts of SSA. Basic immunisation coverage for 
infants aged between 12-23 months for this country was 68% in 2013 [12]. Through the Expanded 
Programme on Immunisation, the Ministry of Health’s strategy of ‘reaching every district’ has shown 
some successes. Through these measures, Zambia has managed to maintain a polio-free status and has 
eliminated maternal and neonatal tetanus since 2005 [18]. It has also managed to reduce under-five 





Data sets were derived from the Demographic and Health Surveys (DHS), which are nationally 
representative household surveys that provide data for a wide range of monitoring and evaluation 
indicators of health in developing countries. Information on vaccination coverage was sourced for the 
study outcomes, from the most recent DHS for Zambia (2013-2014). This data set is designed to 
incorporate information regarding children from 0 to 59 months and for men and women aged 15- 49 
years old. The Zambia Demographic Health Survey (ZDHS) contains data on 16,411 women and 
13,457 children under the age of 5 years [12]. Only women with children who were aged 12 to 59 
months formed part of the final sample. The sample size was 9542 respectively for both groups.   
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Measuring women empowerment 
 
The two main study variables are women empowerment and immunisation. Women empowerment is a 
function of a woman’s participation in household decision making as well as a woman’s perception of 
beating [12]. In the study, these two components which explain women empowerment were defined 
separately. There was a variable which showed women who were deemed physically empowered should 
the respondent agree that beatings were unacceptable in all circumstances. The second variable also 
demonstrated the degree to which a woman is deemed empowered due to the respondent participating 
in all household decisions alone or with their partner.  
 
There are four factors linked to decision making, according to the DHS. These are decisions in making 
large household purchases, making day-to-day household purchases, whether a woman can make 
decisions regarding her own health as well as decisions regarding her movement in visiting friends and 
family. The survey cites five reasons where respondents may consider women beating acceptable. 
Reasons for beating include neglect of the children, burning of food, arguing with one’s partner, refusal 
of sex as well as if a woman goes out without telling her partner. 
In the study to address this question, we assign scores as per the table below. 
The women empowerment variable in the study was generated from the components from the above 2 
indices as follows: 
Table A 3 Composition of Women Empowerment Variable 
Beating 
1 if beating is unacceptable at all 




Making large household purchases 
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Making day-to-day household purchases 
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1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Health care for herself 
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
Visits to family and friend, if the woman has  
1 if the woman makes the decision jointly or 
alone. 
0 if otherwise 
 
 
Measuring immunisation coverage 
 
Immunisation uptake is divided into four categories with three of these being mutually exclusive. The 
mutually exclusive variables include (1) fully immunised denoting children (aged 12 to 59 months) who 
have received all 8 immunisations as per the WHO guideline regarding basic immunisation doses, (2) 
partially immunised denoting all children (aged 12 to 59 months) who have received at least 1 but less 
than 8 vaccines, and (3) never immunised as children (aged 12 to 59 months) who received no vaccines. 
The fourth category, immunisation intensity, measures the proportion of the total doses of vaccines that 
children (aged 12 to 59 months) have received. When referring to full immunisation within the study, 
the child must have all the following vaccines/doses at age 12 months: one dose of BCG vaccine which 
protects against tuberculosis, three doses of DPT, which protects against diphtheria, pertussis 




Measuring socioeconomic status 
 
The ZDHS does not include data on income and consumption. However, it does generate an index of 
socioeconomic status which stands as a proxy for wealth. Some of the variables included in the wealth 
index include the source of drinking water, type of toilet, sharing of toilet facilities, cooking fuel, 
household services and possessions, such as electricity, TV, radio, types of vehicles, agricultural land 
size owned, bank account, mobile phone [61]. This measure of SES contained directly in the DHS has 
been used by researchers as it adjusts for urban and rural differences in asset ownership among other 
things, which forms part of the reason why this study used this measure. The wealth index forms part 
of the basis of how the quintiles are derived. The continuous wealth index computes the concentration 




Measuring socioeconomic related health inequality: concentration index 
 
Concentration curves (CC) are used as a means to assess whether socioeconomic inequality exists in 
particular health variables. However, they are limited in that they do not provide a measure of magnitude 
of inequality that can be used for comparison over a range of factors. The concentration index (CI) is 
defined in reference to the concentration curve as twice the area between the concentration curve and 
the line of equality (the 45-degree line)[62]. 
 
Therefore, a concentration index was used to show the extent of socioeconomic inequality in 
immunisation coverage in Zambia. The concentration index shows the extent to which the poor, relative 
to the rich, have less realised or more realised immunisation coverage. 
 
To account for age-sex variations, an indirectly standardised concentration index is obtained by running 









The estimate, β, is interpreted as the indirectly standardised concentration index, where 𝑋𝑗𝑖 are the 
confounding variables - age and sex, 𝜎𝑟
2 is the variance of the rank (r) and ε is the stochastic error term, 
The variable ℎ𝑖 is the immunisation coverage variable (i.e. full immunisation, partial immunisation, no 
immunisation and immunisation intensity),  𝜇𝑖 is its mean, 𝛿𝑗 is the coefficient of the age or sex variable 
and 𝛼2  is the constant [64, 65].  
 
Should the estimate of a concertation index take a positive value, then the outcome is said to be ‘pro-
rich’, since the concentration curve lies above the line of equality- indicating a disproportionate 
concentration of the immunisation variable among the poor. When the concentration index value is 
negative it is ‘pro-poor’ since the concentration curve lies below the line of equality [131, 132]. 
 
Measuring variables  
Table 1- Summary description of key variables 













Children aged at least 12 months who received all 8 
immunisations (one dose of BCG vaccine, three doses of DPT, 
three doses of the polio vaccine and one dose of measles 
vaccine) as per WHO  
 
Partially immunised Children aged at least 12 months who received between 1 and 8 
immunisations as per WHO. 
 
Not immunised Children aged at least 12 months who have not received any 




Immunisation_intensity The proportion of the 8 immunisations that a child aged at least 
12 months had received as per WHO. A child that received all 8 
immunisations scores 1 while a child that received no 

















    
B_arguing Dummy variable, where “no” to beating for arguing = 1 and zero 
otherwise  
 
Note: “no” to beating corresponds to being empowered. 
 
Beat_child_neglect Dummy variable, where “no” to beating for child neglect = 1 
and zero otherwise.  
 





Dummy variable, where “no” to beating for movement without 
permission = 1 and zero otherwise.  
 
Note: “no” ” to beating for movement without permission 
corresponds to being empowered. 
Beat_burnt_food Dummy variable, where “no” to beating for burning food = 1 
and zero otherwise.  
 




Beat_sex_refusal Dummy variable, where “no” to beating for refusing sex = 1 and 
zero otherwise.  
 
Note: “no” to refusing sex corresponds to being empowered. 
D_self_health  Dummy variable, where “yes” to the woman making decision 
jointly or alone towards self-health = 1 and zero otherwise.  
 
Note: “yes” to the woman makes decision jointly or alone 




















Dummy variable, where “yes” to the woman making decision 
jointly or alone towards large household purchases = 1 and zero 
otherwise.  
 
Note: “yes” to the woman makes decision jointly or alone 
corresponds to being empowered. 
D_daily_purchase  Dummy variable, where “yes” is for the woman making decision 
jointly or alone with regards to daily purchases = 1 and zero 
otherwise.  
 
Note: “yes” to the woman makes decision jointly or alone 
corresponds to being empowered. 
D_family_visits Dummy variable, where “yes” is for the woman makes decision 





Note: “yes” to the woman makes decision jointly or alone 
corresponds to being empowered. 
 
 Wealth Quintiles This is a composite measure of a household’s living standard, 
demarcated in 5 quintiles where through ranking one can note 
another quintiles standard of living relative to the others. This 
was obtained directly from the DHS. 
 
 HHsize  The number of members in a household. 
 
 urban_dweller  Dummy variable. Living in an urban area = 1 while living in a 
rural area =0 
 
 Employed  Dummy variable: employed = 1 while not employed = 0  
 
 Edu Categorical variable where education is categorised into 4 levels. 
 
a) No formal education 
b) Completed primary education 
c) Completed secondary education 
d) Completed tertiary education 
 
 Agecat Categorical variable where age is cut into 4 intervals. 
 
a) Women aged between 15 to 19 years  
b) Women aged between 20 to 29 years 
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c) Women aged between 30 to 39 years 
d) Women aged between 40 to 49 years 
 
 Wom_Emp_Physical This is a binary variable where, 
 
1 = woman is physically empowered  
0 = woman is not empowered  
 
To be classified as empowered, a respondent must have a score 
of 5 since they would have found beating unacceptable in all 
circumstances. 
 
Otherwise, she is not considered physically empowered. 
 
i.e. Wom_Emp_Physical = 0 if a woman is not empowered  
 
 Wom_Emp_Mind This is a discrete variable where, 
 
1 = woman is mentally empowered  
0 = woman is not mentally empowered 
 
The respondent is only deemed mentally empowered if they 
obtain a score 4 (they make all decisions alone or with partner in 
all instances). 
 




   
 
Results 
As shown in Table 2, a significant number of children are fully immunised (72.1%), with only 2.9% 
reported as not immunised. The average age of the mothers who formed part of the study was 25 years, 
with the majority of these women only having completed primary school (56.8%). Over half of the 
women are employed (56.7%). It is interesting to note that a considerable portion of women do not 
support beating in general and a majority were generally involved in household decision making. On 
the surface, the outcomes for these two factors suggest that women empowerment is prominent. 
However, in the strictest sense, women empowerment with regards to beating and decision making 





Table 2-Descriptive statistics   
Variable Name  Mean Standard 
Deviation  
Min Max Number of 
Observations 
Fully immunised 0.721 0.448  0 1 9542 
Partially immunised 0.250 0.433 0 1 9542 
Not immunised 0.029 0.166 0 1 9542 
Immunisation intensity 
 
0.913 0.203 0 1 9542 
Household size 6.626 2.653 2 23 9542 
Urban dweller 0.337  0.473 0 1 9542 
Employed 0.567 0.496 0 1 9514 
105 
 
Variable Name  Mean Standard 
Deviation  
Min Max Number of 
Observations 
Education (for mothers; in years) 
 
Education of mother (categories) 
0- “None” 






































Age of mothers (in years) 
 
Age of mothers (categories) 
1 -"15 to 19 years"  
2 -"20 to 29 years" 
3 - "30 to 39 years"  









































































Variable Name  Mean Standard 
Deviation  
Min Max Number of 
Observations 















Assessing socioeconomic inequality in immunisation coverage in Zambia 
 
Table 3 shows the concentration indices for the four categories describing immunisation coverage. The 
concentration indices for all four categories were statistically significant at the 5% level. For children 
who were fully immunised, we see that immunisation is pro-rich (concentration index = 0.046) as a 
mother from a wealthier household is more likely to have a fully immunised child compared to a child 
whose mother is from a poorer household. Partially immunised children (concentration index = -0.114) 
and not immunised children (concentration index = -0.138) are more likely to come from poorer 
households. This confirms that a woman from a poorer household is more likely to have a partially 
immunised/not immunised child compared to a child whose mother is from rich household. 
Immunisation intensity had a pro-rich outcome (concentration index = 0.153). The table reports figures 
for both the unstandardised and indirectly standardised concentration indices. For fully and partially 
immunised children, the index had similar outcomes for standardised and unstandardised immunisation 
indicators. Immunisation intensity results for these figures were also similar in range. For children who 
were not immunised, once indirect standardisation was applied to account for age-sex variations, the 




Table 3- Concentration indices  
Variable Unstandardised 

































Note: *, **, and *** denote statistical significance at the 10%, 5% and 1%, respectively; standard 
errors in parenthesis  
 
Assessing the relationship between woman empowerment and immunisation coverage 
 
Table 4- Logistic model assessing the relationship between woman empowerment and immunisation 
coverage 
Fully immunised Coefficient Standard error 
Wom_Emp_Physical -0.023  0.0564  
Wom_Emp_Mind 0.149*** 0.0562  
Wealth index 0.165***  0.030  
Household size -0.019* 0.011 
Urban dweller -0.044  0.083  
Employed  -0.140** 0.056  
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Age categories  
(15 to 20yrs) 
20 to 29yrs 
30 to 39yrs 



























___cons 0.207 0.163 







Note: *, **, and *** denote statistical significance at the 10%, 5% and 1%, respectively  
Pseudo R2=0.0205 , Prov>chi2 = 0.0000, Wald chi2 (15) = 144.43 
 
This section presents the results from the analysis to explain the relationship between women 
empowerment and a child’s immunisation coverage status. It is hypothesised that women empowerment 
is an important factor in a child being fully immunised. The results in Table 4 show that there is a 
negative relationship between a woman being physically empowered and her child being fully 
immunised. This means that should a woman find beatings completely unacceptable (i.e. being 
physically empowered) her child is less likely to be fully immunised. However, this was not statistically 
significant at conventional levels (p-value>0.1). In contrast, decision making was found to be a 
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statistically significant (p-value<0.01) contributing factor towards a child’s full immunisation status. 
This confirms that a child is more likely to be fully immunised when their mother participates in making 
all decisions at home (i.e. she is empowered). 
 
The results also demonstrated the effect of wealth on full immunisation coverage, since women with a 
higher wealth (p-value<0.01) status were more likely to have fully immunised children. This was found 
to be statistically significant. Expectedly, women’s employment status (p-value <0.05) was also 
positively associated with being fully immunisation. It is also worth noting that the size of the household 
also had a negative marginal impact (p-value <0.1) on the child being fully immunised. Further, 
education of the mother vitally contributes towards the increased likelihood of a child being fully 
immunised—a child with an educated mother, at a primary, secondary or tertiary level, is more likely 




The main finding of this study was that socioeconomic status has a significant impact on the 
immunisation coverage of a child. This proved true whether the child was fully, partially or not 
immunised. The findings confirmed that for fully immunised children, immunisation coverage was pro-
rich. Further, it was found that a poor woman is more likely to have a partially immunised/not 
immunised child compared to a child whose mother is rich. The findings of this study are consistent 
with those from other developing countries in connection with income-related inequalities in health in 
Kenya, Nigeria and Zimbabwe [7, 47, 93, 114]. The results point to the need for strategies that the 
Zambia Health Ministry would need to focus on in closing the inequality gap in immunisation coverage. 
This improves immunisation uptake rates, especially among the poor. A study done in Nepal by Ashish 
showed that through focused government interventions, immunisation coverage improved in Nepal, 
with the poorest wealth quintile showing the greatest improvement compared to the wealthiest quintile 




Another outcome of the paper was the importance of household decision making. This was shown to 
be another significant determinant of full immunisation. This proves that to a degree, being empowered 
as a mother, especially with regards to participation in all household decisions can improve the chances 
of a child being fully immunised. This conclusion was one which was previously confirmed in other 
studies by Ebot with a positive relationship between women empowerment and child health outcomes 
in the case of immunisation coverage [9]. A mother’s educational level was also found to be a vital 
contributing factor towards the increased likelihood of full immunisation. This was initially reported by 
Caldwell and then subsequent authors who examined the impact that women’s decision making has on 
their children’s health outcomes especially in line with child mortality (Varkey et al, 2010), health care 
utilisation [119] and immunisation coverage [58, 121]. 
 
This study provided an alternative understanding of women empowerment. This is due to the fact that 
empowerment was a function of both a woman’s attitude towards wife-beating (physical empowerment) 
and decision making (mental empowerment). For both variables, a woman was only deemed 
empowered if she was completely against wife-beating or participated in all household decision making, 
respectively. This was useful as it highlighted the impact that a fully empowered woman can have as 
an agent that influences her child’s immunisation coverage status. 
 
Not many studies have undertaken to focus both on women empowerment as well as socioeconomic 
status when viewing their impact on full immunisation coverage. Nevertheless, the findings which 
confirmed the impact of SES on full immunisation coverage were consistent with existing studies which 
also showed full immunisation as being pro-rich [112]. Factors such as mother’s education and SES 
had a bearing on inequality experienced in light of child immunisation as was the case in other studies 
in Nigeria and Kenya [47, 112]. 
 
The use of the DHS data sets is a strength that allows for comparative studies to be done for Zambia in 
years to come for cross-country analysis. However, limitations to be noted are as a result of the use 
indicators constructed to explain women empowerment; there could have been a bias introduced during 
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their construction as they do not allow for the respective factors that contribute towards women beating 
as well as decision making to be assessed in isolation, in their respective rights. 
 
Nevertheless, the findings of this paper confirm the importance of women empowerment on child health 
outcomes, including child immunisation. This empowerment is not confined to the household but 
speaks to education too. Women who had attained higher education levels compared to those who had 
no schooling background were also shown to have children who are more likely to be fully immunised. 
In attempting to find alternative avenues to encourage increased take-up of free immunisation, the 
government should provide educational programmes to mothers of infants to encourage women 
empowerment. 
 
Further, with regards to government interventions, they would need to be positioned towards those who 
fall within the lower wealth quintiles- as full immunisation was confirmed to be pro-rich. In attempting 
to improve immunisation coverage, the government would need to work towards removing perceived 
and existing barriers to immunisation access since affordability is not a material factor due to the 
Zambian government providing free immunisation at public clinics. As per other studies, improvements 
in infrastructure and economic development could positively impact on child mortality and 
immunisation coverage [113]. 
 
Although the Zambian government has shown strong leadership and commitment towards addressing 
maternal, neonatal and childhood (MNCH) interventions, the fact that the immunisation coverage is in 
favour of the rich means more work to tackle barriers for those who are poorer needs to take place [133]. 
Attending to issues of accessibility such as, providing transportation and ensuring improved availability 
of needed medication would do much to encourage greater adoption amongst the poorer in society 
[133]. Strategies that would boost the economy to allow for women to participate as active economic 
contributors would have a two-pronged result in that it would first foster empowerment as well as reduce 
reliance on external financing through a growing economy [133]. This would ensure that efforts towards 
focusing on MNCH interventions can be sustained. 
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Further to address acceptability, the distance of immunisation services for mothers who situated in peri-
urban areas can be reduced as it could potentially improve coverage for women who are not based in 





An enhanced understanding of the social determinants of health along with country-specific structural 
considerations help in improving child health outcomes. This study has shown that close attention to 
factors such as women empowerment and a mother’s education can support improved immunisation 
coverage, especially for those who are the poorest in Zambia. This paper further highlighted the 
importance of SES as it impacts on immunisation. Tackling inequalities would contribute significantly 
to increased immunisation coverage and reduce child mortality. Apart from government concentrating 
on reducing factors of acceptability and access, it is essential to investigate the causal factors that are 
fundamental to the observed socioeconomic inequality in immunisation coverage in Zambia. 
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Addressing universal immunisation coverage in Zambia: The role of the 
government in improving immunisation coverage and reducing disparities 
between the poor and the rich 
 
Introduction 
Child mortality is a health concern that affects many 
countries, with the sub-Saharan African (SSA) and 
the Middle Eastern regions being most acutely 
impacted. Studies show that there has been a 
marked decline in under-five mortality. The causes 
of death vary from one area to another, requiring an 
in-depth understanding of child health epidemiology 
at a country level. 
The World Health Organization (WHO) adopted a 
strategy to encourage full immunisation of children 
by the age of 12 months to mitigate the prevalence 
of major childhood related diseases and infant 
mortality. Paediatric immunisation is one of the most 
important modern interventions as it has in past 
decades contributed toward substantial reductions 
in child deaths globally where 2-3 million deaths 
were averted in recent times. 
 The Zambian Health Ministry contributed to 
improved child mortality indicators by abolishing 
user fees for all maternal and child health services 
to facilitate better access and utilisation.  
Nevertheless, a substantial number of preventable 
infant deaths persist in Zambia.  
Socioeconomic status (SES) has also been 
reported as an additional consideration, which 
impacts child health indicators in Zambia. This 
phenomenon where people who are less 
advantaged in terms of socioeconomic position 
have worse health than those who are more 
advantaged, is not only evident in Zambia but 
also in other parts of the globe. 
Low, middle- and high-income countries have 
demonstrated the existence of health inequities.
KEY MESSAGES 
• In general, a child’s 
immunisation coverage is 
significantly impacted by their 
mother’s socioeconomic status. 
 
• Children with poorer mothers are 
more likely to not be immunised 
or partially immunised, since 
most children who are fully 
immunised have richer mothers. 
 
• Women who are more educated 
tend to participate more in 
household decision making, 
which was found to impact 
positively on their children’s 
immunisation status. 
 
• Acceptability factors, such as the 
distance to immunisation 
services adversely impact poorer 
mothers. 
 
• Empowered women are more 
able to give their children 
adequate immunisation 
coverage in Zambia. 
 
• There is a need to improve 
immunisation coverage 
especially for those who are the 





The study assessed the 
relationship between women 
empowerment and 
immunisation coverage in 
Zambia. It also investigated 
disparities in immunisation 
coverage of children, 
considering the number of 
vaccinations that they received -
while linking them to how 
wealthy a household is. 
Immunisation uptake was 
divided into four categories with 
three of these being mutually 
exclusive. The mutually 
exclusive variables include (1) 
fully immunised denoting 
children (aged 12 to 59 months) 
who have received all 8 
immunisations as per the WHO 
guideline regarding basic 
immunisation doses, (2) partially 
immunised denoting all children 
(aged 12 to 59 months) who 
have received at least one but 
less than eight vaccines, and (3) 
never immunised as children 
(aged 12 to 59 months) who 
received no vaccines. The fourth 
category, immunisation 
intensity, measures the 
proportion of the total doses of 
vaccines that children (aged 12 
to 59 months) have received.  
To be considered fully 
immunised, a child must have 
the following vaccines/doses at 
age 12 months: one dose of 
BCG vaccine which protects 
against tuberculosis, three 
doses of DPT, which protects 
against diphtheria, pertussis 
(whooping cough) and tetanus, 
three doses of polio vaccine and 
one dose of measles vaccine 
(CSO, 2015). 
The 2013 Zambia Demographic 
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Figure D. 1 Immunisation Coverage status in 
Zambia ,2013 




Is there evidence to suggest that immunisation coverage is unequal as a result of 
income levels? 
 
Immunisation coverage was shown to favour children with richer mothers.  
There is evidence that points towards unequal immunisation coverage by income levels.  
The extent of the disparity by five wealth categories (or quintiles) of the mothers is depicted in D3. By 
looking at the graphs it is evident that immunisation cover is disproportionate within the poorer individuals 
of Zambia. About 23% of children that have received all the required immunisation come from the richest 
households compared to about 18% from the poorest households. More than 25% of children who have 



















Figure D. 3 Disparities in immunisation coverage by wealth category 
 
Of all the children who received full immunisation before their first birthday, a majority of those had 











































































WEALTH QUINTILES FROM LOWEST (Q1) TO HIGHEST (Q5)
IMMUNISATION COVERAGE INEQUALITY




A wealthier woman is more likely to have a fully immunised child compared to a child whose mother is 
poorer. Partially immunised children and not immunised children are more likely to come from poorer 
households. This confirms that a poor woman is more likely to have a partially immunised/not immunised 
child compared to a child whose mother is rich. The number of immunisations that a child receives is 
disproportionate between the rich and poor in Zambia—children from poorer homes receive fewer 
immunisations compared to those from richer homes. 
 
Evidently, a woman’s employment status was also positively related to her child receiving all the required 
immunisation. Further, education of the mother vitally contributes towards the increased likelihood of a 
child being fully immunised—a child with an educated mother, at a primary, secondary or tertiary level, 






Government intervention is needed, especially for the children of the poor and uneducated in Zambia, as 
children with richer mothers tend to receive all the required immunisation services than children whose 
mothers are comparatively poorer. These findings have significant policy implications for policymakers in 
Zambia. 
• To improve immunisation coverage, the government should work towards removing perceived 
and existing barriers to accessing immunisation services beyond just the direct cost of 
immunisation as the Zambian government already provides free immunisation.  
• Addressing issues of accessibility such as, providing transportation and ensuring improved 
availability of needed vaccine doses would do much to encourage higher uptake amongst the 
poor. 
• Strategies towards educating mothers, especially those in rural areas could potentially have 
positive effects as this would enhance their sense of empowerment and encourage them to 
pursue further education, as necessary. This intervention would have a two-pronged result, in that 
it would first foster empowerment as well as reduce reliance on male partners in decision making 
that directly impacts on the mother and the child’s health. 
• It is essential to sustain efforts towards improving maternal and neonatal child health, including 
the provision of key childhood interventions. Further, there is a potential to improve immunisation 
services by bringing vaccination services closer to women and their children. Examples could 
include providing immunisation services directly to households in remote areas. 
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minimum to avoid degradation of quality. 
If you have any questions or are experiencing a problem with figures, please contact the customer service 
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funded by the U.S. Agency for International Development (USAID). The project is implemented 
by ICF International in Calverton, Maryland, in partnership with the Johns Hopkins Bloomberg 
School of Public Health/Center for Communication Programs, the Program for Appropriate 
Technology in Health (PATH), Futures Institute, Camris International, and Blue Raster.  
The main objectives of the MEASURE DHS program are to: 1) provide improved information 
through appropriate data collection, analysis, and evaluation; 2) improve coordination and 
partnerships in data collection at the international and country levels; 3) increase host-country 
institutionalization of data collection capacity; 4) improve data collection and analysis tools and 
methodologies; and 5) improve the dissemination and utilization of data.  
For information about the Demographic and Health Surveys (DHS) program, write to DHS, ICF 
International, 11785 Beltsville Drive, Suite 300, Calverton, MD 20705, U.S.A. (Telephone: 301-
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5 November 2012 
DEMOGRAPHIC AND HEALTH SURVEYS 
MODEL HOUSEHOLD QUESTIONNAIRE 
[NAME OF COUNTRY] 




 CLUSTER NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 HOUSEHOLD NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
   
   
 
INTERVIEWER VISITS 











 NEXT VISIT: DATE 
TIME   
 





2 NO HOUSEHOLD MEMBER AT HOME OR NO COMPETENT RESPONDENT 
AT HOME AT TIME OF VISIT 
3 ENTIRE HOUSEHOLD ABSENT FOR EXTENDED PERIOD OF TIME 
4 POSTPONED 
5 REFUSED 
6 DWELLING VACANT OR ADDRESS NOT A DWELLING 
7 DWELLING DESTROYED 
























Note: Questions with blue highlighting in the question number column are HIV related questions that may be 
deleted in some circumstances (see footnotes). Questions with pink highlighting in the question number 








INTRODUCTION AND CONSENT 
Hello.  My name is _______________________________________. I am working with (NAME OF  
ORGANIZATION).  We are conducting a survey about health all over (NAME OF COUNTRY). The information we 
collect will help the government to plan health services. Your household was selected for the survey. I would like 
to ask you some questions about your household. The questions usually take about 15 to 20 minutes. All of the 
answers you give will be confidential and will not be shared with anyone other than members of our survey team. 
You don't have to be in the survey, but we hope you will agree to answer the questions since your views are 
important. If I ask you any question you don't want to answer, just let me know and I will go on to the next question 
or you can stop the interview at any time.  
In case you need more information about the survey, you may contact the person listed on this card.  
GIVE CARD WITH CONTACT INFORMATION 
Do you have any questions? 
May I begin the interview now? 
SIGNATURE OF INTERVIEWER: DATE: 
RESPONDENT AGREES TO BE INTERVIEWED . . . RESPONDENT DOES NOT 





 IF AGE 0-17 YEARS IF AGE 5 YEARS 
OR OLDER 
IF AGE 5-24 YEARS IF AGE 0-
4 YEARS 
03 = SON OR DAUGHTER 10 = 
ADOPTED/FOSTER/ 
04 = SON-IN-LAW OR  STEPCHILD 
DAUGHTER-IN-LAW 11 = NOT RELATED 
05 = GRANDCHILD 
06 = PARENT 
07 = PARENT-IN-LAW 













 12 13 14 15 16 17 18 19 20 







usually live in 
this  
household or 



















usually live in 
this  
household or 


















What is the 





What is the 
highest grade 
(NAME)  














school year, what 





Does (NAME)  
have a birth 
certificate? 
IF NO, PROBE: 
Has (NAME)'s 
birth ever been 
registered with the 
civil authority? 
1 = HAS  
CERTIFICATE 
2 = REGISTERED 







2  8 




2  8 
GO TO 16  
Y N 
 1 2 
NEXT 
LINE 
 LEVEL GRADE 
 
 Y N 
 1 2 
NEXT LINE 




2  8 
GO TO 14  
1 
2  8 
GO TO 16  




 1 2 
NEXT LINE   
03 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  




 1 2 
NEXT LINE   
04 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
05 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
06 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
07 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
08 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
09 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
10 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
CODES FOR Qs. 17 AND 19: EDUCATION 
LEVEL GRADE 
1 = PRIMARY 00 = LESS THAN 1 YEAR COMPLETED 
2 = SECONDARY (USE '00'  FOR Q. 17 ONLY.  
3 = HIGHER THIS CODE IS NOT ALLOWED  
6 = PRE-PRIMARY FOR Q. 19) 




 IF AGE 0-17 YEARS IF AGE 5 YEARS 
OR OLDER 














 12 13 14 15 16 17 18 19 20 







usually live in 
this  
household or 



















usually live in 
this  
household or 


















What is the 





What is the 
highest grade 
(NAME)  














school year, what 





Does (NAME)  
have a birth 
certificate? 
IF NO, PROBE: 
Has (NAME)'s 
birth ever been 
registered with the 
civil authority? 
1 = HAS  
CERTIFICATE 
2 = REGISTERED 
3 = NEITHER8 = 
DON'T  
KNOW 
 Y N DK  Y N DK   Y N  LEVEL GRADE Y N  LEVEL GRADE  
11 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
12 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
13 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
14 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
15 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
16 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
17 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
18 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
19 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
20 1 
2  8 
GO TO 14  
1 
2  8 
GO TO 16  





NEXT LINE   
CODES FOR Qs. 17 AND 19: EDUCATION 
 
LEVEL GRADE 
1 = PRIMARY 00 = LESS THAN 1 YEAR COMPLETED 
2 = SECONDARY  (USE '00'  FOR Q. 17 ONLY.  
3 = HIGHER THIS CODE IS NOT ALLOWED  
6 = PRE-PRIMARY FOR Q. 19) 




NO. QUESTIONS AND FILTERS SKIP 
101 1 DAILY. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 WEEKLY. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . . . . .  3 MONTHLY 
. . . . . . . . . . . . . . . . 4 LESS THAN MONTHLY 
5 NEVER . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
102 PIPED WATER 
. . . . . . . . . . . . 11 PIPED INTO DWELLING 
105 PIPED TO YARD/PLOT . . . . . . . . . . . . . . 12 
PUBLIC TAP/STANDPIPE . . . . . . . . . . . . 13 
. . . . . . . . . . . . 21 TUBE WELL OR BOREHOLE 
DUG WELL 
PROTECTED WELL . . . . . . . . . . . . . . . . 31 
. . . . . . . . . . . . . . 32 UNPROTECTED WELL 
WATER FROM SPRING 
PROTECTED SPRING . . . . . . . . . . . . . . 41 
. . . . . . . . . . . . 42 UNPROTECTED SPRING 
105 . . . . . . . . . . . . . . . . . . . . . . . . 51 RAINWATER 
TANKER TRUCK . . . . . . . . . . . . . . . . . . . . 61 
CART WITH SMALL TANK . . . . . . . . . . . . 71 
SURFACE WATER (RIVER/DAM/ 
LAKE/POND/STREAM/CANAL/ 
IRRIGATION CHANNEL) . . . . . . . . . . . . 81 
BOTTLED WATER . . . . . . . . . . . . . . . . . . . . 91 
OTHER 96 
( SPECIFY ) 
103 IN OWN DWELLING . . . . . . . . . . . . . . . . . . 1 
. . . . . . . . . . . . . . . . 2 105 IN OWN YARD/PLOT 
ELSEWHERE . . . . . . . . . . . . . . . . . . . . . . 3 
HOUSEHOLD CHARACTERISTICS 
CODING CATEGORIES 
How often does anyone smoke inside your house? 
Would you say daily, weekly, monthly, less than monthly, or  
never? 
What is the main source of drinking water for members of your  
household? 
Where is that water source located? 
104 
MINUTES . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . 998 DON'T KNOW 
105 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
. . . . . . . . . . . . . . . . . . . . . . 8 DON'T KNOW 107 
106 BOIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A 
. . . . . . . . . . . . B ADD BLEACH/CHLORINE 
C . . . . . . . . .  STRAIN THROUGH A CLOTH 
USE WATER FILTER (CERAMIC/ 
SAND/COMPOSITE/ETC.) . . . . . . . . . . . . D 
RECORD ALL MENTIONED. . . . . . . . . . . . . . . . . E SOLAR DISINFECTION 
. . . . . . . . . . . . F LET IT STAND AND SETTLE 
X OTHER 
( SPECIFY ) 
DON'T KNOW . . . . . . . . . . . . . . . . . . . . . . Z 
How long does it take to go there, get water, and come back? 
Do you do anything to the water to make it safer to drink? 




NO. QUESTIONS AND FILTERS SKIP CODING CATEGORIES 
 
107 FLUSH OR POUR FLUSH TOILET 
FLUSH TO PIPED SEWER  
SYSTEM . . . . . . . . . . . . . . . . . . . . . . 11 
FLUSH TO SEPTIC TANK . . . . . . . . . . . . 12 
. . . . . . . . . . . . 13 FLUSH TO PIT LATRINE 
FLUSH TO SOMEWHERE ELSE. . . . . . . 14 
. . . . . . . 15 FLUSH, DON'T KNOW WHERE 
PIT LATRINE 
VENTILATED IMPROVED 
PIT LATRINE . . . . . . . . . . . . . . . . . . . . 21 
. . . . . . . . . . . . 22 PIT LATRINE WITH SLAB 
PIT LATRINE WITHOUT SLAB/ 
OPEN PIT . . . . . . . . . . . . . . . . . . . . . . 23 
COMPOSTING TOILET . . . . . . . . . . . . . . . . 31 
. . . . . . . . . . . . . . . . . . . . 41 BUCKET TOILET 
HANGING TOILET/HANGING 
LATRINE. . . . . . . . . . . . . . . . . . . . . . . . . . 51 
NO FACILITY/BUSH/FIELD . . . . . . . . . . . . 61 110 
96 OTHER 
) SPECIFY ( 
108 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 110 
109 NO. OF HOUSEHOLDS 
. . . . . . . . .  IF LESS THAN 10 
 OR MORE HOUSEHOLDS 10 . . . . . . .  95 
98 DON'T KNOW . . . . . . . . . . . . . . . . . . . .  
110 
YES NO 
ELECTRICITY. . . . . . . . . . . . . .  1 2 
RADIO. . . . . . . . . . . . . . . . . . . .  1 2 
0 
Does your household have:  (4) 
Electricity? 
A radio? 
How many households use this toilet facility? 
What kind of toilet facility do members of your  household  
usually use?  (3) 
Do you share this toilet facility with other households? 
. . . . . . . . . . . . . .  1 2 TELEVISION 
MOBILE TELEPHONE 1 2 . . . . .  
NON-MOBILE TELEPHONE. . .  1 2 
REFRIGERATOR 1 2 . . . . . . . . .  
4.] [ ADD ADDITIONAL ITEMS. SEE FOOTNOTE  
111 ELECTRICITY. . . . . . . . . . . . . . . . . . . . . . . . 01 
LPG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 02 
NATURAL GAS . . . . . . . . . . . . . . . . . . . . . . 03 
BIOGAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 04 
. . . . . . . . . . . . . . . . . . . . . . . . 05 KEROSENE 
. . . . . . . . . . . . . . . . . . . . . . 06 COAL, LIGNITE 
. . . . . . . . . . . . . . . . . . . . . . . . 07 CHARCOAL 
WOOD . . . . . . . . . . . . . . . . . . . . . . . . . . . . 08 
. . . . . . . . . . . . . . 09 STRAW/SHRUBS/GRASS 
AGRICULTURAL CROP . . . . . . . . . . . . . . . . 10 
ANIMAL DUNG . . . . . . . . . . . . . . . . . . . . . . 11 
NO FOOD COOKED  
IN HOUSEHOLD. . . . . . . . . . . . . . . . . . . . 95 114 
OTHER 96 
( SPECIFY ) 
A non-mobile telephone? 
A refrigerator? 
What type of fuel does your household mainly use for cooking? 
A television? 
A mobile telephone? 
 
HH-10 
NO. QUESTIONS AND FILTERS SKIP CODING CATEGORIES 
 
112 IN THE HOUSE . . . . . . . . . . . . . . . . . . . . . . 1 
. . . . . . . . . . . . 2 IN A SEPARATE BUILDING 
. . . . . . . . . . . . . . . . . . . . . . . . 3 OUTDOORS 
6 OTHER 
) SPECIFY ( 
113 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
114 MAIN MATERIAL OF THE FLOOR.  (3) NATURAL FLOOR 
. . . . . . . . . . . . . . . . . . . . 11 EARTH/SAND 
RECORD OBSERVATION. DUNG. . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 
RUDIMENTARY FLOOR 
. . . . . . . . . . . . . . . . . . 21 WOOD PLANKS 
. . . . . . . . . . . . . . . . . . 22 PALM/BAMBOO 
FINISHED FLOOR 
PARQUET OR POLISHED 
. . . . . . . . . . . . . . . . . . . . . . . . 31 WOOD 
VINYL OR ASPHALT STRIPS . . . . . . . 32 
CERAMIC TILES . . . . . . . . . . . . . . . . . . 33 
. . . . . . . . . . . . . . . . . . . . . . . . 34 CEMENT 
CARPET. . . . . . . . . . . . . . . . . . . . . . . . . . 35 
OTHER 96 
( SPECIFY ) 
115 MAIN MATERIAL OF THE ROOF.  (3) NATURAL ROOFING 
NO ROOF . . . . . . . . . . . . . . . . . . . . . . . . 11 
RECORD OBSERVATION. . . . . . . . . . . . . . . . . 12 THATCH/PALM LEAF 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 SOD 
RUDIMENTARY ROOFING 
RUSTIC MAT . . . . . . . . . . . . . . . . . . . . . . 21 
PALM/BAMBOO . . . . . . . . . . . . . . . . . . . . 22 
WOOD PLANKS . . . . . . . . . . . . . . . . . . . . 23 
Do you have a separate room which is used as a kitchen? 
Is the cooking usually done in the house, in a separate  
building, or outdoors? 
114 
CARDBOARD . . . . . . . . . . . . . . . . . . . . 24 
FINISHED ROOFING 
METAL . . . . . . . . . . . . . . . . . . . . . . . . . . 31 
WOOD . . . . . . . . . . . . . . . . . . . . . . . . . . 32 
. . . . . . . . . 33 CALAMINE/CEMENT FIBER 
CERAMIC TILES. . . . . . . . . . . . . . . . . . . . 34 
CEMENT. . . . . . . . . . . . . . . . . . . . . . . . . . 35 
ROOFING SHINGLES. . . . . . . . . . . . . . . . 36 
OTHER 96 
( SPECIFY ) 
 
HH-11 
NO. QUESTIONS AND FILTERS SKIP CODING CATEGORIES 
 
116 MAIN MATERIAL OF THE EXTERIOR WALLS.  (3) NATURAL WALLS 
NO WALLS. . . . . . . . . . . . . . . . . . . . . . . . 11 
RECORD OBSERVATION. CANE/PALM/TRUNKS . . . . . . . . . . . . . . 12 
DIRT . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 
RUDIMENTARY WALLS 
. . . . . . . . . . . . . . . . 21 BAMBOO WITH MUD 
. . . . . . . . . . . . . . . . 22 STONE WITH MUD 
. . . . . . . . . . . . . . 23 UNCOVERED ADOBE 
. . . . . . . . . . . . . . . . . . . . . . 24 PLYWOOD 
CARDBOARD . . . . . . . . . . . . . . . . . . . . 25 
. . . . . . . . . . . . . . . . . . 26 REUSED WOOD 
FINISHED WALLS 
. . . . . . . . . . . . . . . . . . . . . . . . 31 CEMENT 
. . . . . . . . . 32 STONE WITH LIME/CEMENT 
. . . . . . . . . . . . . . . . . . . . . . . . . . 33 BRICKS 
CEMENT BLOCKS . . . . . . . . . . . . . . . . . . 34 
. . . . . . . . . . . . . . . . 35 COVERED ADOBE 
. . . . . . . . . 36 WOOD PLANKS/SHINGLES 
OTHER 96 
SPECIFY ) ( 
117 
ROOMS . . . . . . . . . . . . . . . . . . . . . .  
118 
YES NO 
1 WATCH . . . . . . . . . . . . . . . . . .  2 
2 BICYCLE. . . . . . . . . . . . . . . . . .  1 
MOTORCYCLE/SCOOTER 1 2 . . .  
ANIMAL-DRAWN CART 1 . . . . .  2 
1 2 CAR/TRUCK . . . . . . . . . . . . . .  
2 1 BOAT WITH MOTOR . . . . . . .  
119 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
How many rooms in this household are used for sleeping? 
Does any member of this household own: 
A watch? 
A bicycle? 
A motorcycle or motor scooter? 
An animal-drawn cart? 
A car or truck? 
A boat with a motor? 
Does any member of this household own any agricultural land? 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 121 
120 
HECTARES. . . . . . . . . . . .  . 
IF 95 OR MORE, CIRCLE '950'. 95 OR MORE HECTARES . . . . . . . . . . . . 950 
DON'T KNOW . . . . . . . . . . . . . . . . . . . . 998 
121 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  123 2 NO 
Does this household own any livestock, herds, other farm  
animals, or poultry? 




NO. QUESTIONS AND FILTERS SKIP CODING CATEGORIES 
 
122 
IF NONE, ENTER '00'. 
IF 95 OR MORE, ENTER '95'. 
IF UNKNOWN, ENTER '98'. 
CATTLE . . . . . . . . . . . . . . . . . . . . . .  
COWS/BULLS . . . . . . . . . . . . . . . .  
HORSES/DONKEYS/MULES . . . . .  
GOATS . . . . . . . . . . . . . . . . . . . . . .  
SHEEP . . . . . . . . . . . . . . . . . . . . . .  
CHICKENS. . . . . . . . . . . . . . . . . . . .  
123 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
124 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(6) 2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . 8 DON'T KNOW 126 
125 GOVERNMENT WORKER/PROGRAM. . . . . A 
(6) PRIVATE COMPANY . . . . . . . . . . . . . . . . B 
NONGOVERNMENTAL  
ORGANIZATION (NGO) . . . . . . . . . . . . . . C 
X OTHER 
) SPECIFY ( 
. . . . . . . . . . . . . . . . . . . . . . Z DON'T KNOW 
How many of the following animals does this household own?  
(5) 
Cattle? 
Milk cows or bulls? 




At any time in the past 12 months, has anyone come into your  
dwelling to spray the interior walls against mosquitoes? 
Who sprayed the dwelling? 
Does any member of this household have a bank account? 
126 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(7) 137 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
127 
(7) NUMBER OF NETS. . . . . . . . . . . . . . . . . .  
IF 7 OR MORE NETS, RECORD '7'. 
Does   your   household   have   any   mosquito   nets   that   can   be   used   
while sleeping? 











Who slept under this mosquito net 
last night? 
RECORD THE PERSON'S NAME 




















































  GO BACK TO 128 FOR 
 NEXT NET; OR, IF NO  
MORE NETS,  GO TO 
137. 
 GO BACK TO 128 FOR  
NEXT NET; OR, IF NO 
 MORE NETS,  
GO TO 137. 
 GO TO 128 IN FIRST  
COLUMN OF A NEW 
 QUESTIONNAIRE;  
OR, IF NO MORE 
 NETS, GO TO 137. 
137 Please show me where members of your household most often 
wash their hands.  OBSERVED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NOT OBSERVED, 
 NOT IN DWELLING/YARD/PLOT . . . . . . . . . . . . . . . . 2 
NOT OBSERVED, 
 NO PERMISSION TO SEE . . . . . . . . . . . . . . . . . . . . . . 3 
NOT OBSERVED, OTHER REASON . . . . . . . . . . . . . . . . 4 
(SKIP TO 140) 
138 
OBSERVATION ONLY: 
OBSERVE PRESENCE OF WATER AT THE PLACE 
FOR HANDWASHING. 
 WATER IS AVAILABLE . . . . . . . . . . . . . . . . . . . . . . . . 1 
 WATER IS NOT AVAILABLE . . . . . . . . . . . . . . . . . . . . . . 2 
139 OBSERVATION ONLY: SOAP OR DETERGENT 
 (BAR, LIQUID, POWDER, PASTE) . . . . . . . . . . . . . . A 
 OBSERVE PRESENCE OF SOAP, DETERGENT, OR   ASH, MUD, SAND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B 
 OTHER CLEANSING AGENT. NONE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C 
140 ASK RESPONDENT FOR A TEASPOONFUL OF  IODINE PRESENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 COOKING SALT. NO IODINE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
 TEST SALT FOR IODINE. (8)  NO SALT IN HOUSEHOLD . . . . . . . . . . . . . . . . . . . . . . 3 
 SALT NOT TESTED 6 
(SPECIFY REASON) 
WEIGHT, HEIGHT AND HEMOGLOBIN MEASUREMENT FOR CHILDREN AGE 0-5 
201 CHECK COLUMN 11 IN HOUSEHOLD SCHEDULE. RECORD THE LINE NUMBER AND NAME FOR ALL ELIGIBLE CHILDREN 0-5 
YEARS  IN QUESTION 202.  IF MORE THAN SIX CHILDREN, USE ADDITIONAL QUESTIONNAIRE(S).  
  CHILD 1 CHILD 2 CHILD 3 
202 LINE NUMBER FROM COLUMN 
11 
LINE 
NUMBER . . . 
. . .  
LINE 
NUMBER . . . 
. . .  
LINE 
NUMBER . . . 
. . .  
 
HH-15 
 NAME FROM COLUMN 2 NAME NAME NAME 
203 IF MOTHER INTERVIEWED, 
COPY MONTH AND YEAR OF 
BIRTH  
FROM BIRTH HISTORY AND 
ASK  
DAY; IF MOTHER NOT 
INTERVIEWED, ASK:  
What is (NAME)'s birth date? 
   
DAY . . . . . . . . . .  
MONTH . . . . . .  
   
DAY . . . . . . . . . .  
MONTH . . . . . .  
   
DAY . . . . . . . . . .  
MONTH . . . . . .  
   
      
YEAR 
    
YEAR 
    
YEAR  
   
204 CHECK 203: 
CHILD BORN IN JANUARY 
2005 (9) OR  LATER? 
YES . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . 2 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,  
  GO TO 214) 
YES . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . 2 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,   
GO TO 214) 
YES . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . 2 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,   
GO TO 214) 





















 . . 
ER . . . . 
. . . 9994 
 . . . . . . 
9995  . . . . . 
. 9996 
NOT PRESENT . . . 9994 
REFUSED . . . . . . . . 9995 
OTHER . . . . . . . . . . 
9996 
 PRESENT . . . 9994 
USED . . . . . . . 
. 9995 ER . . . . . . . 
. . . 9996 
206 HEIGHT IN CENTIMETERS 
CM. 
OTHER 












REFUSED . . . . . . . . 9995 
. . . . . . . . . . 
9996 
. . . 
9994 
NOT PRESENT . . . 9994 
REFUSED . . . . . . . . 9995 
OTHER . . . . . . . . . . 
9996 
NOT PRESENT . . . 9994 
REFUSED . . . . . . . . 9995 
. . . . . . . . . . 9996 
207 MEASURED LYING DOWN OR 
STANDING UP? 
LYING DOWN . . . . . . . . 1 
STANDING UP . . . . . . . . 2 NOT 
MEASURED . . . . . . 3 
LYING DOWN . . . . . . . . 1 
STANDING UP . . . . . . . . 2 
NOT MEASURED . . . . . . 3 
LYING DOWN . . . . . . . . 1 
STANDING UP . . . . . . . . 2 NOT 
MEASURED . . . . . . 3 
208 CHECK 203: 
IS CHILD AGE 0-5 MONTHS, 
I.E., 
WAS CHILD BORN IN MONTH 
OF  
INTERVIEW OR FIVE 
PREVIOUS MONTHS? 
0-5 MONTHS . . . . . . . . 1 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,  
  GO TO 214) 
0-5 MONTHS . . . . . . . . 1 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,  
  GO TO 214) 
0-5 MONTHS . . . . . . . . 1 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,  
  GO TO 214) 
  OLDER . . . . . . . . . . . . 2 OLDER . . . . . . . . . . . . 2 OLDER . . . . . . . . . . . . 2 
209 LINE NUMBER OF PARENT/ 
OTHER ADULT RESPONSIBLE  
FOR THE CHILD (FROM 
COLUMN 1 OF HOUSEHOLD 
SCHEDULE). 
RECORD '00' IF NOT LISTED. 
LINE 
NUMBER . . . 
. . .  
LINE 
NUMBER . . . 
. . .  
LINE 
NUMBER . . . 
. . .  
210 ASK CONSENT FOR ANEMIA  
TEST FROM 
PARENT/OTHER ADULT 
IDENTIFIED IN 209 AS 
RESPONSIBLE FOR 
CHILD. 
As part of this survey, we are asking people all over the country to take an anemia test. Anemia is a 
serious health problem that usually results from poor nutrition, infection, or chronic disease. This 
survey will assist the government to develop programs to prevent and treat anemia. 
We ask that all children born in 2005 (9) or later take part in anemia testing in this survey and give a 
few drops of blood from a finger or heel. The equipment used to take the blood is clean and 
completely safe. It has never been used before and will be thrown away after each test. 
The blood will be tested for anemia immediately, and the result will be told to you right away. The 
result will be  kept strictly confidential and will not be shared with anyone other than members of our 
survey team. 
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide.  
Will you allow (NAME OF CHILD) to participate in the anemia test?   
211 CIRCLE THE APPROPRIATE 
CODE AND SIGN YOUR NAME. 
GRANTED . . . . . . . . . . 1 
 
REFUSED . . . . . . . . . . 2 
GRANTED . . . . . . . . . . 1 
 
REFUSED . . . . . . . . . . 2 
GRANTED . . . . . . . . . . 1 
 
REFUSED . . . . . . . . . . 2 
212 RECORD HEMOGLOBIN LEVEL  
HERE AND IN THE ANEMIA 
PAMPHLET (11). G/DL  
NOT PRESENT . . . . . . 
994 REFUSED . . . . . . 
. . . .9 95 OTHER . . . . . . 
. . . . . .9 96 
G/DL  
NOT PRESENT . . . . 
. . 994 REFUSED . . . . 
. . . . . .9 95 OTHER . . . . 
. . . . . . . .9 96 
G/DL  
NOT PRESENT . . . . . 9. 94 
REFUSED . . . . . . . . . . 995 
OTHER . . . . . . . . . . . . 996 
213 GO BACK TO 203 IN NEXT COLUMN OF THIS QUESTIONNAIRE OR IN THE FIRST COLUMN OF THE NEXT PAGE; IF NO MORE 
CHILDREN, GO TO 214. 
 
  CHILD 4 CHILD 5 CHILD 6 





202 LINE NUMBER FROM 
COLUMN 11 
LINE 
NUMBER . . . 
. .  
LINE 
NUMBER . . . 
. .  
LINE 
NUMBER . . . 
. .  
 NAME FROM COLUMN 2 NAME NAME NAME 
203 IF MOTHER INTERVIEWED, 
COPY MONTH AND YEAR OF 
BIRTH  
FROM BIRTH HISTORY AND 
ASK DAY; IF MOTHER NOT 
INTERVIEWED, ASK:  
What is (NAME)'s birth date? 
   
DAY . . . . . . . . .  
 MONTH . . . . .  
   
DAY . . . . . . . . .  
 MONTH . . . . .  
   
DAY . . . . . . . . .  
 MONTH . . . . .  
   
      
YEAR 
    
YEAR 
    
YEAR  
   
204 CHECK 203: 
CHILD BORN IN JANUARY 
2005 (9) OR  LATER? 
YES . . . . . . . . . . . . . . . . 1 NO
 . . . . . . . . . . . . . . . . 2 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,   GO 
TO 214) 
YES . . . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . . . 2 
  (GO TO 203 FOR NEXT 
  CHILD OR, IF NO  
  MORE CHILDREN,   
GO TO 214) 
YES . . . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . . . 2 
  (GO TO 203 IN 
FIRST   COLUMN 
OF NEW  
  QUESTIONNAIRE; OR, 
  IF NO MORE CHILDREN, 
  GO TO 214) 






  .    
KG.  









 . . 
ER . . . . 
. . . . . 9994 
 . . . . . 9995  
. . . . . 9996 
NOT PRESENT 
REFUSED . . 
OTHER . . . . 
. . . . . 9994 
 . . . . . 9995  




 . . 
ER . . . . 
. . . . . 
9994 
 . . . . . 
9995  . . . . 
. 9996 




   
. 














   
.  
 
NOT PRESENT . . 
 D . . . . . .  




 NOT PRESENT . . 
 REFUSED . . . . . .  




NOT PRESENT . . . 9994 
 D . . . . . . . 9995 
. . . . . . . . . 9996 
207 MEASURED LYING DOWN OR 
STANDING UP? 
LYING DOWN . . . . . . .  1 
STANDING UP . . . . . . .  2 NOT 
MEASURED . . . . .  3 
LYING DOWN . . . . . . .  1 
STANDING UP . . . . . . .  2 
NOT MEASURED . . . . .  3 
 LYING DOWN . . . . . . .  1 
STANDING UP . . . . . . .  2 NOT 
MEASURED . . . . .  3 
208 CHECK 203: 
IS CHILD AGE 0-5 MONTHS, 
I.E., 
WAS CHILD BORN IN MONTH 
OF  
INTERVIEW OR FIVE 
PREVIOUS MONTHS? 
 0-5 MONTHS . . . . . . .  1 
  (GO TO 203 FOR NEXT   
CHILD OR, IF NO  
  MORE CHILDREN,   GO 
TO 214) 
 0-5 MONTHS . . . . . . .  1 
  (GO TO 203 FOR NEXT   
CHILD OR, IF NO  
  MORE CHILDREN,   
GO TO 214) 
 0-5 MONTHS . . . . . . .  1 
  (GO TO 203 IN 
FIRST   COLUMN 
OF NEW  
  QUESTIONNAIRE; OR, 
  IF NO MORE CHILDREN, 
  GO TO 214) 
   OLDER . . . . . . . . . . .  2  OLDER . . . . . . . . . . .  2  OLDER . . . . . . . . . . .  2 
209 LINE NUMBER OF PARENT/ 
OTHER ADULT RESPONSIBLE  
FOR THE CHILD (FROM 
COLUMN 1 OF HOUSEHOLD 
SCHEDULE). 
RECORD '00' IF NOT LISTED. 
LINE 
NUMBER . . . 
. .  
LINE 
NUMBER . . . 
. .  
LINE 
NUMBER . . . 
. .  
210 ASK CONSENT FOR ANEMIA  
TEST FROM PARENT/OTHER 
ADULT IDENTIFIED IN 209 AS 
RESPONSIBLE FOR CHILD. 
As part of this survey, we are asking people all over the country to take an anemia test. Anemia is a 
serious health problem that usually results from poor nutrition, infection, or chronic disease. This survey 
will assist the government to develop programs to prevent and treat anemia. 
We ask that all children born in 2005 (9) or later take part in anemia testing in this survey and give a few 
drops of blood from a finger or heel. The equipment used to take the blood is clean and completely safe. 
It has never been used before and will be thrown away after each test. 
The blood will be tested for anemia immediately, and the result told to you right away. The result will be 
kept strictly confidential and will not be shared with anyone other than members of our survey team. 
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide.  
Will you allow (NAME OF CHILD) to participate in the anemia test?   
211 CIRCLE THE APPROPRIATE 
CODE AND SIGN YOUR 
NAME. 
 GRANTED . . . . . . . . .  1 
 
 REFUSED . . . . . . . . .  2 
 GRANTED . . . . . . . . .  1 
 
 REFUSED . . . . . . . . .  2 
 GRANTED . . . . . . . . .  1 
 
 REFUSED . . . . . . . . .  2 
212 RECORD HEMOGLOBIN 
LEVEL HERE AND IN THE 







. . . . . . . 994 








. . . . . . . 994 










. . . . . . 
996 
 T 
. . . . . . . . . . . 
996 
 T. . . . . . . 994 
. . . . . . . . . 995 
. . . . . . . . . . . 
996 
213 GO BACK TO 203 IN NEXT COLUMN OF THIS QUESTIONNAIRE OR IN THE FIRST COLUMN OF AN ADDITIONAL 
QUESTIONNAIRE; IF NO MORE CHILDREN, GO TO 214. 
WEIGHT, HEIGHT, HEMOGLOBIN MEASUREMENT AND HIV TESTING FOR WOMEN AGE 15-49 
( SIGN ) ( SIGN ) ( SIGN ) 
 
HH-17 
214 CHECK COLUMN 9 IN HOUSEHOLD SCHEDULE. RECORD THE LINE NUMBER AND NAME FOR ALL ELIGIBLE WOMEN IN 215. 
IF THERE ARE MORE THAN THREE WOMEN, USE ADDITIONAL QUESTIONNAIRE(S). 
  WOMAN 1 WOMAN 2 WOMAN 3 
215 LINE NUMBER 




NUMBER . . . . . . . . . . . .  
NAME 
   LINE 
NUMBER . . . . . . . . . . . .  
NAME 
   LINE 
NUMBER . . . . . . . . . . . .  
NAME 
  






NOT PRESENT . . . . . . . . . .  99994 
KG.  
NOT PRESENT . . . . . . . . . .  99994 
KG.  
NOT PRESENT . . . . . . . . . .  99994 
  REFUSED . . . . . . . . . . . . . .  99995 REFUSED . . . . . . . . . . . . . .  99995 REFUSED . . . . . . . . . . . . . .  99995 
  OTHER . . . . . . . . . . . . . . . .  99996 OTHER . . . . . . . . . . . . . . . .  99996 OTHER . . . . . . . . . . . . . . . .  99996 
217 HEIGHT  
IN CENTIMETERS 
CM. .  
   
CM. .  
   
CM. .  
   
  NOT PRESENT . . . . . . . . . . . . 9994 NOT PRESENT . . . . . . . . . . . . 9994 NOT PRESENT . . . . . . . . . . . . 9994 
  REFUSED . . . . . . . . . . . . . . . . 9995 REFUSED . . . . . . . . . . . . . . . . 9995 REFUSED . . . . . . . . . . . . . . . . 9995 
  OTHER . . . . . . . . . . . . . . . . . . . 9996 OTHER . . . . . . . . . . . . . . . . . . . 9996 OTHER . . . . . . . . . . . . . . . . . . . 9996 
218 AGE: CHECK  15-17 YEARS . . . . . . . . . . . . . . . .  1 15-17 YEARS . . . . . . . . . . . . . . . .  1 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 COLUMN 7. 18-49 YEARS . . . . . . . . . . . . . . . .  2 18-49 YEARS . . . . . . . . . . . . . . . .  2 18-49 YEARS . . . . . . . . . . . . . . . .  2 
  (GO TO 223)  (GO TO 223)  (GO TO 223)  
219 MARITAL STATUS: CODE 4 (NEVER IN UNION) . . . . . . 1 CODE 4 (NEVER IN UNION) . . . . . . 1 CODE 4 (NEVER IN UNION) . . . . . . 1 
  CHECK COLUMN 8. OTHER  . . . . . . . . . . . . . . . . . . . . . 2 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
  (GO TO 223)  (GO TO 223)  (GO TO 223)  
220 RECORD LINE 






IF NOT LISTED. 
LINE NUMBER OF 
PARENT OR OTHER 
RESPONSIBLE ADULT 
  
LINE NUMBER OF 
PARENT OR OTHER 
RESPONSIBLE ADULT 
  









IDENTIFIED IN 220 
AS RESPONSIBLE 
FOR  
NEVER IN UNION 
WOMEN AGE 15-17. 
As part of this survey, we are asking people all over the country to take an anemia test.  Anemia is a serious health problem that 
usually results from poor nutrition, infection, or chronic disease.  This survey will assist the government to develop programs to prevent 
and treat anemia. 
For the anemia testing, we will need a few drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe.  It has never been used before and will be thrown away after each test. 
The blood will be tested for anemia immediately, and the result will be told to you and (NAME OF ADOLESCENT) right away. The 
result will be kept strictly confidential and will not be shared with anyone other than members of our survey team. 
Do you have any questions? 
You can say yes to the test for (NAME OF ADOLESCENT), or you can say no. It is up to you to decide.  
Will you allow (NAME OF ADOLESCENT) to take the anemia test? 





GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 228) 
GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 228) 
GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 228) 
 
  WOMAN 1 WOMAN 2 WOMAN 3 
 NAME FROM 
COLUMN 2 
NAME NAME NAME 
. . . 
 
HH-18 





As part of this survey, we are asking people all over the country to take an anemia test. Anemia is a serious health problem that usually 
results from poor nutrition, infection, or chronic disease. This survey will assist the government to develop programs to prevent and 
treat anemia. 
For the anemia testing, we will need a few drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe. It has never been used before and will be thrown away after each test. The blood will be tested for anemia immediately, and the 
result will be told to you right away. The result will be kept strictly confidential and will not be shared with anyone other than members 
of our survey team. 
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide.  
Will you take the anemia test? 






GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
(IF REFUSED, GO TO 226) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 226) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 





226 IN WOMAN'S 
QUESTIONNAIRE 
OR ASK: 
Are you pregnant? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . 
. . 2 DK . . . . . . . . . . . . . . . . . . . . . . . . . 
. . 8 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
 DK . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . 
. . 2 DK . . . . . . . . . . . . . . . . . . . . . . . . . 





 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 230)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 230)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 




CHECK COLUMN 8. 
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 230)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 230)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 230)  





IDENTIFIED IN 220 
AS RESPONSIBLE 
FOR  
NEVER IN UNION 
WOMEN AGE 15-17. 
very serious illness. The HIV test is being done to see how big the AIDS problem is in (COUNTRY). 
For the HIV test, we need a few (more) drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe. It has never been used before and will be thrown away after each test. No names will be attached so we will not be able to tell you 
the test results. No one else will be able to know (NAME OF ADOLESCENT)'s test results either. If (NAME OF ADOLESCENT) wants 
to know her HIV status, I can provide a list of [nearby] facilities offering counseling and testing for HIV.  I will also give her a voucher for 
free services that can be used at any of these facilities. 
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide.  








 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 239) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 239) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 239) 
 
  WOMAN 1 WOMAN 2 WOMAN 3 
 NAME FROM 
COLUMN 2 
NAME NAME NAME 










As part of the survey we also are asking people all over the country to take an HIV test. HIV is the virus that causes AIDS. AIDS is a 
very serious illness. The HIV test is being done to see how big the AIDS problem is in (COUNTRY). 
For the HIV test, we need a few (more) drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe. It has never been used before and will be thrown away after each test. No names will be attached so we will not be able to tell you 
the test results. No one else will be able to know your test results either. If you want to know whether you have HIV, I can provide you 
with a list of [nearby] facilities offering counseling and testing for HIV.  I will also give you a voucher for free services for you (and for 
your partner if you want) that you can use at any of these facilities.  
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide. 











GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
   
(IF REFUSED, GO TO 239) 
 
GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
   
(IF REFUSED, GO TO 239) 
 
GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
   





 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 236)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 236)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 




CHECK COLUMN 8. 
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 236)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 236)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 









IDENTIFIED IN 220 
AS RESPONSIBLE 
FOR  
NEVER IN UNION 
WOMEN AGE 15-17. 
We ask you to allow [SURVEY IMPLEMENTING ORGANIZATION/MINISTRY OF HEALTH] to store part of the blood sample at the 
laboratory for additional tests or research. We are not certain about what additional tests might be done. 
The blood sample will not have any name or other data attached that could identify ( NAME OF ADOLESCENT). You do not have to 
agree. If you do not want the blood sample stored for additional testing (NAME OF ADOLESCENT) can still participate in the HIV 








 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 238) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 238) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 








We ask you to allow [SURVEY IMPLEMENTING ORGANIZATION/MINISTRY OF HEALTH] to store part of the blood sample at the 
laboratory for additional tests or research. We are not certain about what additional tests might be done. 
The blood sample will not have any name or other data attached that could identify you. You do not have to agree. If you do not want 
the blood sample stored for additional testing, you can still participate in the HIV testing in this survey. Will you allow us to keep the 
blood sample stored for additional testing? 
 
  WOMAN 1 WOMAN 2 WOMAN 3 
 NAME FROM 
COLUMN 2 
NAME NAME NAME 
RESPONDENT REFUSED . . . . . . 2 RESPONDENT REFUSED . . . . . . 2 RESPONDENT REFUSED . . . . . . 2 
 
HH-20 
237 CIRCLE THE  GRANTED . . . . . . . . . . . . . . . . . . . 1   GRANTED . . . . . . . . . . . . . . . . . . . 1   GRANTED . . . . . . . . . . . . . . . . . . . 1  
(12) APPROPRIATE  RESPONDENT REFUSED . . . . . . 2   RESPONDENT REFUSED . . . . . . 2   RESPONDENT REFUSED . . . . . . 2  









  (IF GRANTED, GO TO 239) (IF GRANTED, GO TO 239) (IF GRANTED, GO TO 239) 
238 ADDITIONAL 
TESTS 
CHECK 235 AND 237: CHECK 235 AND 237: CHECK 235 AND 237: 
(12)  IF CONSENT HAS NOT BEEN GRANTED IF CONSENT HAS NOT BEEN GRANTED IF CONSENT HAS NOT BEEN GRANTED 
  WRITE "NO ADDITIONAL WRITE "NO ADDITIONAL WRITE "NO ADDITIONAL 
  TEST" ON THE FILTER PAPER. TEST" ON THE FILTER PAPER. TEST" ON THE FILTER PAPER. 
239 
(12) 
PREPARE EQUIPMENT AND SUPPLIES ONLY FOR THE TEST(S) FOR WHICH CONSENT HAS BEEN OBTAINED AND PROCEED WITH THE TEST(S).  
240 RECORD 
HEMOGLOBIN 




   
 G/DL . . . . . . . . . .  
NOT PRESENT 
  .   
 G/DL . . . . . . . . . .  




 G/DL . . . . . . . . . .  
NOT PRESENT 
  .   
. . . . . . . . . . . 
.  994 994 
. . . . . . . . . . . 
.  994 
 (11).  REFUSED . . . . . . . . . . . . . . . .  995  REFUSED . . . . . . . . . . . . . . . .  995  REFUSED . . . . . . . . . . . . . . . .  995 
   OTHER . . . . . . . . . . . . . . . . . . . 996  OTHER . . . . . . . . . . . . . . . . . . . 996  OTHER . . . . . . . . . . . . . . . . . . . 996 
241 BAR CODE LABEL    




PUT THE 1ST BAR CODE LABEL 
HERE. 
 
NOT PRESENT . . . . . . . . . .  99994   NOT PRESENT . . . . . . . . . .  99994 
   REFUSED . . . . . . . . . . . . . .  99995  REFUSED . . . . . . . . . . . . . .  99995  REFUSED . . . . . . . . . . . . . .  99995 
   OTHER . . . . . . . . . . . . . . . .  99996  OTHER . . . . . . . . . . . . . . . .  99996  OTHER . . . . . . . . . . . . . . . .  99996 
  PUT THE 2ND BAR CODE LABEL PUT THE 2ND BAR CODE LABEL PUT THE 2ND BAR CODE LABEL 
  ON THE RESPONDENT'S ON THE RESPONDENT'S ON THE RESPONDENT'S 
  FILTER PAPER AND THE 3RD FILTER PAPER AND THE 3RD FILTER PAPER AND THE 3RD 
  ON THE TRANSMITTAL FORM. ON THE TRANSMITTAL FORM. ON THE TRANSMITTAL FORM. 
242 GO BACK TO 216 IN NEXT COLUMN OF THIS QUESTIONNAIRE OR IN THE FIRST COLUMN OF AN ADDITIONAL QUESTIONNAIRE; IF NO MORE 
WOMEN, GO TO 243. 
WEIGHT, HEIGHT, HEMOGLOBIN MEASUREMENT AND HIV TESTING FOR MEN AGE 15-49 
243 CHECK COLUMN 10 IN HOUSEHOLD SCHEDULE. RECORD THE LINE NUMBER AND NAME FOR ALL ELIGIBLE MEN IN 244. 
IF THERE ARE MORE THAN THREE MEN, USE ADDITIONAL QUESTIONNAIRE(S). 
  MAN 1 MAN 2 MAN 3 
244 LINE NUMBER 




NUMBER . . . . . . . . . . . .  
NAME 
   LINE 
NUMBER . . . . . . . . . . . .  
NAME 
   LINE 
NUMBER . . . . . . . . . . . .  
NAME 
  






NOT PRESENT . . . . . . . . . .  99994 
KG.  
NOT PRESENT . . . . . . . . . .  99994 
KG.  
NOT PRESENT . . . . . . . . . .  99994 
  REFUSED . . . . . . . . . . . . . .  99995 REFUSED . . . . . . . . . . . . . .  99995 REFUSED . . . . . . . . . . . . . .  99995 
  OTHER . . . . . . . . . . . . . . . .  99996 OTHER . . . . . . . . . . . . . . . .  99996 OTHER . . . . . . . . . . . . . . . .  99996 
246 HEIGHT  
IN CENTIMETERS 
CM. . . . . . . . . .  
   
CM. . . . . . . . . .  
   
CM. . . . . . . .  
   
  NOT PRESENT . . . . . . . . . . . . 9994 NOT PRESENT . . . . . . . . . . . . 9994 NOT PRESENT . . . . . . . . . . . . 9994 
  REFUSED . . . . . . . . . . . . . . . . 9995 REFUSED . . . . . . . . . . . . . . . . 9995 REFUSED . . . . . . . . . . . . . . . . 9995 
  OTHER . . . . . . . . . . . . . . . . . . . 9996 OTHER . . . . . . . . . . . . . . . . . . . 9996 OTHER . . . . . . . . . . . . . . . . . . . 9996 
247 AGE: CHECK  15-17 YEARS . . . . . . . . . . . . . . . .  1 15-17 YEARS . . . . . . . . . . . . . . . .  1 15-17 YEARS . . . . . . . . . . . . . . . .  1 
PUT THE 1ST BAR CODE LABEL  
HERE. 
PUT THE 1ST BAR CODE LABEL  
HERE. 
NOT PRESENT . . . . . . . . . .  99994 
. . . 
 
HH-21 
 COLUMN 7. 18-49 YEARS . . . . . . . . . . . . . . . .  2 18-49 YEARS . . . . . . . . . . . . . . . .  2 18-49 YEARS . . . . . . . . . . . . . . . .  2 
  (GO TO 252)  (GO TO 252)  (GO TO 252)  
248 MARITAL STATUS: CODE 4 (NEVER IN UNION) . . . . . . 1 CODE 4 (NEVER IN UNION) . . . . . . 1 CODE 4 (NEVER IN UNION) . . . . . . 1 
  CHECK COLUMN 8. OTHER  . . . . . . . . . . . . . . . . . . . . . 2 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
  (GO TO 252)  (GO TO 252)  (GO TO 252)  
249 RECORD LINE 






IF NOT LISTED. 
LINE NUMBER OF 
PARENT OR OTHER 
RESPONSIBLE ADULT 
  
LINE NUMBER OF 
PARENT OR OTHER 
RESPONSIBLE ADULT 
  




250 ASK CONSENT 
FOR ANEMIA TEST  
FROM PARENT/ 
OTHER ADULT  
IDENTIFIED 
IN 249 AS 
RESPONSIBLE 
FOR  
NEVER IN UNION 
MEN AGE 15-17. 
As part of this survey, we are asking people all over the country to take an anemia test.  Anemia is a serious health problem that 
usually results from poor nutrition, infection, or chronic disease.  This survey will assist the government to develop programs to prevent 
and treat anemia. 
For the anemia testing, we will need a few drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe.  It has never been used before and will be thrown away after each test. 
The blood will be tested for anemia immediately, and the result will be told to you and (NAME OF ADOLESCENT) right away. The 
result will be kept strictly confidential and will not be shared with anyone other than members of our survey team. 
Do you have any questions? 
You can say yes to the test for (NAME OF ADOLESCENT), or you can say no. It is up to you to decide.  
Will you allow (NAME OF ADOLESCENT) to take the anemia test? 
251 CIRCLE THE  
APPROPRIATE 
CODE AND SIGN 
YOUR NAME. 
GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 256) 
GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 256) 
GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 256) 
 
  MAN 1 MAN 2 MAN 3 
 NAME FROM 
COLUMN 2 
NAME NAME NAME 
252 ASK CONSENT 
FOR ANEMIA TEST  
FROM  
RESPONDENT. 
As part of this survey, we are asking people all over the country to take an anemia test. Anemia is a serious health problem that usually 
results from poor nutrition, infection, or chronic disease. This survey will assist the government to develop programs to prevent and 
treat anemia. 
For the anemia testing, we will need a few drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe. It has never been used before and will be thrown away after each test. The blood will be tested for anemia immediately, and the 
result will be told to you right away. The result will be kept strictly confidential and will not be shared with anyone other than members 
of our survey team. 
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide.  
Will you take the anemia test? 
253 CIRCLE THE  
APPROPRIATE 
CODE AND SIGN 
YOUR NAME. 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 






 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 258)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 258)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 




CHECK COLUMN 8. 
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 258)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 258)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 











249 AS  
RESPONSIBLE 
FOR  
NEVER IN UNION   
As part of the survey we also are asking people all over the country to take an HIV test. HIV is the virus that causes AIDS. AIDS is a 
very serious illness. The HIV test is being done to see how big the AIDS problem is in (COUNTRY). 
For the HIV test, we need a few (more) drops of blood from a finger. The equipment used to take the blood is clean and completely 
safe.  It has never been used before and will be thrown away after each test. No names will be attached so we will not be able to tell 
you the test results. No one else will be able to know (NAME OF ADOLESCENT)'s test results either. If (NAME OF ADOLESCENT) 
wants to know his HIV status, I can provide him with a list of [nearby] facilities offering counseling and testing for HIV.  I will also give 
him a voucher for free services that can be used at any of these facilities. 
 MEN AGE 15-17. Do you have any questions? 
You can say yes to the test for (NAME OF ADOLESCENT), or you can say no. It is up to you to decide.  
Will you allow (NAME OF ADOLESCENT) to take the HIV test? 
257 
(12) 
CIRCLE THE  
APPROPRIATE 
CODE AND  
SIGN  
YOUR NAME. 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 267) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
.(IF REFUSED, GO TO 267) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 267) 
 
  MAN 1 MAN 2 MAN 3 
 NAME FROM 
COLUMN 2 








As part of the survey we also are asking people all over the country to take an HIV test. HIV is the virus that causes AIDS. AIDS is a 
very serious illness. The HIV test is being done to see how big the AIDS problem is in (COUNTRY). 
For the HIV test, we need a few more drops of blood from a finger. The equipment used in taking the blood is clean and completely 
safe.  It has never been used before and will be thrown away after each test. No names will be attached so we will not be able to tell 
you the test results. No one else will be able to know your test results either. If you want to know whether you have HIV, I can provide 
you with a list of [nearby] facilities offering counseling and testing for HIV.  I will also give you a voucher for free services for you (and 
for your partner if you want) that you can use at any of these facilities.  
Do you have any questions? 
You can say yes to the test, or you can say no. It is up to you to decide. 
Will you take the HIV test? 
259 
(12) 




AND ENTER YOUR 
INTERVIEWER 
NUMBER. 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
   
(IF REFUSED, GO TO 267) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
   
(IF REFUSED, GO TO 267) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
 RESPONDENT REFUSED . . . . . . 2 
(SIGN) 
   





 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 264)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 
(GO TO 264)  
 15-17 YEARS . . . . . . . . . . . . . . . .  1 
 18-49 YEARS . . . . . . . . . . . . . . . .  2 




CHECK COLUMN 8. 
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 264)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 
(GO TO 264)  
CODE 4 (NEVER IN UNION) . . . . . . 1 
 OTHER  . . . . . . . . . . . . . . . . . . . . . 2 











IDENTIFIED IN 249 
AS RESPONSIBLE 
FOR 
NEVER IN UNION  
MEN AGE 15-17. 
We ask you to allow [SURVEY IMPLEMENTING ORGANIZATION/MINISTRY OF HEALTH] to store part of the blood sample at the 
laboratory for additional tests or research. We are not certain about what additional tests might be done. 
The blood sample will not have any name or other data attached that could identify ( NAME OF ADOLESCENT). You do not have to 
agree.  If you do not want the blood sample stored for additional testing, (NAME OF ADOLESCENT) can still participate in the HIV 
testing in this survey. Will you allow us to keep the blood sample stored for additional testing? 
263 
(12) 
CIRCLE THE  
APPROPRIATE 
CODE AND  
SIGN 
YOUR NAME. 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 266) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 266) 
 GRANTED . . . . . . . . . . . . . . . . . . . 1 
PARENT/OTHER RESPONSIBLE 
  ADULT REFUSED . . . . . . . . . . . . 2 
(SIGN) 
(IF REFUSED, GO TO 266) 
 
  MAN 1 MAN 2 MAN 3 
 NAME FROM 
COLUMN 2 








We ask you to allow [SURVEY IMPLEMENTING ORGANIZATION/MINISTRY OF HEALTH] to store part of the blood sample at the 
laboratory for additional tests or research. We are not certain about what additional tests might be done. 
The blood sample will not have any name or other data attached that could identify you. You do not have to agree. If you do not want 
the blood sample stored for additional testing, you can still participate in the HIV testing in this survey. Will you allow us to keep the 
blood sample stored for additional testing?  
265 
(12) 
CIRCLE THE  
APPROPRIATE 
CODE AND SIGN 
YOUR NAME.  
GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
(IF GRANTED, GO TO 267) 
 
GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 
(IF GRANTED, GO TO 267) 
 
GRANTED. . . . . . . . . . . . . . . . . . . 1 
(SIGN) 




CHECK 263 AND 265: 
IF CONSENT HAS NOT BEEN GRANTED 
WRITE "NO ADDITIONAL 
TEST" ON THE FILTER PAPER. 
CHECK 263 AND 265: 
IF CONSENT HAS NOT BEEN GRANTED 
WRITE "NO ADDITIONAL 
TEST" ON THE FILTER PAPER. 
CHECK 263 AND 265: 
IF CONSENT HAS NOT BEEN GRANTED 
WRITE "NO ADDITIONAL 
TEST" ON THE FILTER PAPER. 
267 
(12) 
PREPARE EQUIPMENT AND SUPPLIES ONLY FOR THE TEST(S) FOR WHICH CONSENT HAS BEEN OBTAINED AND PROCEED WITH THE TEST(S).  
268 RECORD HEMO- 
GLOBIN LEVEL 
HERE AND IN  
ANEMIA PAMPHLET 
(11). 
 G/DL . . . . . . . . . . .  
NOT PRESENT . . . . . . . . . . . . 
 994 REFUSED . . . . . . 
. . . . . . . . . .  995 OTHER . . . . . . 
. . . . . . . . . . . . . 996 
  
 G/DL . . . . . . . . . . .  
 NOT PRESENT . . . . . . . . . . . .  994 
REFUSED . . . . . . . . . . . . . . . . 
 995 OTHER . . . . . . . . . . . . . . . . . 
. . 996 
  
 G/DL . . . . . . . . . . .  
 NOT PRESENT . . . . . . . . . . . .  994 
 REFUSED . . . . . . . . . . . . . . . .  995 




BAR CODE LABEL   
 
 
PUT THE 1ST BAR CODE LABEL 
HERE. 
 
PUT THE 1ST BAR CODE LABEL 
HERE. 
 
NOT PRESENT . . . . . . . . . . . . 99994 NOT PRESENT . . . . . . . . . . . . 99994  NOT PRESENT . . . . . . . . . . . . 99994 
   REFUSED . . . . . . . . . . . . . . . . 99995  REFUSED . . . . . . . . . . . . . . . . 99995  REFUSED . . . . . . . . . . . . . . . . 99995 
   OTHER . . . . . . . . . . . . . . . . . . .9 9996  OTHER . . . . . . . . . . . . . . . . . . .9 9996  OTHER . . . . . . . . . . . . . . . . . . .9 9996 
RESPONDENT REFUSED . . . . . . 2 RESPONDENT REFUSED . . . . . . 2 RESPONDENT REFUSED . . . . . . 2 




  PUT THE 2ND BAR CODE LABEL PUT THE 2ND BAR CODE LABEL PUT THE 2ND BAR CODE LABEL 
  ON THE RESPONDENT'S ON THE RESPONDENT'S ON THE RESPONDENT'S 
  FILTER PAPER AND THE 3RD FILTER PAPER AND THE 3RD FILTER PAPER AND THE 3RD 
  ON THE TRANSMITTAL FORM. ON THE TRANSMITTAL FORM. ON THE TRANSMITTAL FORM. 
270 GO BACK TO 245 IN NEXT COLUMN OF THIS QUESTIONNAIRE OR IN THE FIRST COLUMN OF AN ADDITIONAL QUESTIONNAIRE; IF NO MORE 
MEN, END INTERVIEW. 
FOOTNOTES 
(1) This section should be adapted for country-specific survey design. 
(2) In Q. 18, the year should refer to the school year that is in session at the time the survey begins.  If the survey 
begins between two school years, then the year should refer to the school year that just ended. 
(3) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 
(4) Each country should add to the list at least five items of furniture (such as a table, a chair, a sofa, a bed, an 
armoire, or a cupboard or cabinet). In addition, each country should add at least four additional household 
appliances so that the list includes at least three items that even a poor household may have, at least  three 
items that a middle income household may have, and at least three items that a high income household may 
have. Some possible additions are clock, water pump, grain grinder, fan, blender, water heater, 
generator, washing machine, microwave oven, computer, VCR or DVD player, cassette or CD player, camera, 
air conditioner or cooler, color TV, sewing machine. 
(5) Add other country-specific animals, such as oxen, water buffalo, camels, llamas, alpacas, pigs, ducks, geese, 
or elephants. 
(6) The question should be deleted in countries that do not have an organized spraying program to prevent the 
transmission of malaria. 
(7) The question should be deleted in countries that are not affected by malaria.  
(8) There are many different kinds of iodine testing kits available. The proper test kit should be selected in each 
country depending on the type of iodine additive used in the country (potassium iodate or potassium iodide).  If 
both of these additives are used in a country, then both types of test kits should be used.  
(9) Year of fieldwork is assumed to be 2010.  For fieldwork beginning in 2011 or 2012, the year should be 2006 or 
2007, respectively. 
(10) In countries where the weighing scale shows the weight to only one decimal place, retain only one box after 
the decimal point and delete the first '9' from the other three codes. 
(11) In countries where some enumeration areas are higher than 1,000 meters, altitude information should be 
collected on a separate form for each enumeration area higher than 1,000 meters so that the anemia 
estimates can be adjusted appropriately. 
(12) Questions should be omitted in countries in which HIV testing is not a component of the survey. 
 
 
[THIS PAGE IS INTENTIONALLY BLANK]  
 
W-1 
   3 Jan 2012 
DEMOGRAPHIC AND HEALTH SURVEYS 
MODEL WOMAN'S QUESTIONNAIRE 
[NAME OF COUNTRY] 




 CLUSTER NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 HOUSEHOLD NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . .  
NAME AND LINE NUMBER OF WOMAN 
   
   
  
INTERVIEWER VISITS   












 NEXT VISIT: DATE 





1 COMPLETED 4 REFUSED 
2 NOT AT HOME 5 PARTLY COMPLETED 
3 POSTPONED 6 INCAPACITATED 
 7 OTHER 
 
(SPECIFY) 
 COUNTRY-SPECIFIC INFORMATION: LANGUAGE OF QUESTIONNAIRE, LANGUAGE OF INTERVIEW, NATIVE 

















 (1) This section should be adapted for country-specific survey design. 
Note: Questions with blue highlighting in the question number column are HIV related questions that may be deleted  in 
some circumstances (see footnotes). Questions with pink highlighting in the question number column are malaria  
related questions that may be deleted in some circumstances (see footnotes). Questions with yellow highlighting  in the 
question number column are other questions that may be deleted in some circumstances (see footnotes). 








. . .  1 
SECTION 1.  RESPONDENT'S BACKGROUND 
INTRODUCTION AND CONSENT 
INFORMED CONSENT 
Hello.  My name is _______________________________________.  I am working with (NAME OF ORGANIZATION).  We are conducting a 
survey about health all over (NAME OF COUNTRY).  The information we collect will help the government  to plan health services.  Your 
household was selected for the survey.  The questions usually take about 30 to 60 minutes.  All of the answers you give will be confidential 
and will not be shared with anyone other than members of our survey team.  You don't have to be in the survey, but we hope you will agree to 
answer the questions since your views are important.  If I ask you any question you don't want to answer, just let me know and I will go on to 
the next question or you can stop the interview at any time. 
In case you need more information about the survey, you may contact the person listed on the card that has already been given to your 
household.  
Do you have any questions?  May I begin the interview now? 
SIGNATURE OF INTERVIEWER:  DATE: 
RESPONDENT AGREES TO BE INTERVIEWED RESPONDENT DOES NOT AGREE TO BE INTERVIEWED . . .  2 END 
 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
101 RECORD THE TIME. 
HOUR. . . . . . . . . . . . . . . . . . . .  
MINUTES. . . . . . . . . . . . . . . . . .  
102 
MONTH . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . 98 DON'T KNOW MONTH 
In what month and year were you born? 
YEAR. . . . . . . . . . . .  
DON'T KNOW YEAR . . . . . . . . . . . . 9998 
103 
AGE IN COMPLETED YEARS 
COMPARE AND CORRECT 102 AND/OR 103 IF INCONSISTENT. 
104 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 108 
105 PRIMARY . . . . . . . . . . . . . . . . . . . . . . 1 
SECONDARY. . . . . . . . . . . . . . . . . . . . 2 
HIGHER. . . . . . . . . . . . . . . . . . . . . . . . 3 
106 
GRADE/FORM/YEAR. . . . . . .  
IF COMPLETED LESS THAN ONE YEAR AT THAT LEVEL, 
RECORD '00'. 
CHECK 105: 107 
SECONDARY PRIMARY 
OR HIGHER 110 
How old were you at your last birthday? 
Have you ever attended school? 
What is the highest level of school you attended: primary,  
secondary, or higher? (1) 





(1) Revise according to the local education system. 
(2) Each card should have four simple sentences appropriate to the country (e.g., "Parents love their 
children.", "Farming is hard work.", "The child is reading a book.", "Children work hard at school.").  Cards 
should be  prepared for every language in which respondents are likely to be literate. 
(3) The question may be considered for deletion in countries with a very low HIV prevalence. 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
108 CANNOT READ AT ALL . . . . . . . . . . . . 1 
ABLE TO READ ONLY PARTS OF 
SHOW CARD TO RESPONDENT.  (2) SENTENCE. . . . . . . . . . . . . . . . . . . . 2 
ABLE TO READ WHOLE SENTENCE 3 
NO CARD WITH REQUIRED IF RESPONDENT CANNOT READ WHOLE SENTENCE, PROBE: 
4 LANGUAGE 
) SPECIFY LANGUAGE ( 
5 . . . . . . .  BLIND/VISUALLY IMPAIRED 
CHECK 108: 109 
CODE '1' OR '5' CODE '2', '3' 
OR '4' CIRCLED 111 
CIRCLED 
110 AT LEAST ONCE A WEEK. . . . . . . . .  1 
. . . . . . .  LESS THAN ONCE A WEEK 2 
NOT AT ALL . . . . . . . . . . . . . . . . . . . . 3 
111 AT LEAST ONCE A WEEK. . . . . . . . .  1 
LESS THAN ONCE A WEEK 2 . . . . . . .  
. . . . . . . . . . . . . . . . . . . . 3 NOT AT ALL 
112 1 AT LEAST ONCE A WEEK. . . . . . . . .  
. . . . . . .  2 LESS THAN ONCE A WEEK 
NOT AT ALL . . . . . . . . . . . . . . . . . . . . 3 
113 
114 
Do you read a newspaper or magazine at least once a week, less  
than once a week or not at all? 
Do you listen to the radio at least once a week, less than once a  
week or not at all? 
Do you watch television at least once a week, less than once a  
week or not at all? 
COUNTRY-SPECIFIC QUESTION ON RELIGION, IF  
APPROPRIATE. 
COUNTRY-SPECIFIC QUESTION ON ETHNICITY, IF  
APPROPRIATE. 
Now I would like you to read this sentence to me. 
Can you read any part of the sentence to me? 
115 
(3) NUMBER OF TIMES . . . . . . .  
NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 201 
116 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
In the last 12 months, how many times have you been away from  
home for one or more nights? 
In the last 12 months, have you been away from home for more  




SECTION 2.  REPRODUCTION 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
201 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
206 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
202 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
204 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
203 SONS AT HOME. . . . . . . . . . . .  
. . . . . .  DAUGHTERS AT HOME 
IF NONE, RECORD '00'. 
204 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
206 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
205 . . . . . . . .  SONS ELSEWHERE 
DAUGHTERS ELSEWHERE 
IF NONE, RECORD '00'. 
206 
YES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
IF NO, PROBE: 208 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 NO 
207 BOYS DEAD . . . . . . . . . . . . . .  
GIRLS DEAD . . . . . . . . . . . . . .  
Now I would like to ask about all the births you have had during your  
life. Have you ever given birth? 
Do you have any sons or daughters to whom you have given birth  
who are now living with you? 
How many sons live with you?  
And how many daughters live with you? 
Do you have any sons or daughters to whom you have given birth  
who are alive but do not live with you? 
And how many girls have died? 
How many sons are alive but do not live with you? 
And how many daughters are alive but do not live with you? 
Have you ever given birth to a boy or girl who was born alive but later  
died? 
Any baby who cried or showed signs of life but did  
not survive? 
How many boys have died? 
IF NONE, RECORD '00'. 
208 SUM ANSWERS TO 203, 205, AND 207, AND ENTER TOTAL. 
IF NONE, RECORD '00'. TOTAL BIRTHS . . . . . . . . . . . .  
CHECK 208: 209 
PROBE AND 
NO YES CORRECT 
 AS 201-208
NECESSARY. 
CHECK 208: 210 
ONE OR MORE NO BIRTHS 
BIRTHS 226 
Just to make sure that I have this right: you have had in TOTAL  













(1) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2006 
or 2007, respectively. 
238 
DAYS AGO. . . . . . . . . . . . 1 
WEEKS AGO . . . . . . . . .  2 
MONTHS AGO. . . . . . . . .  3 
( DATE, IF GIVEN ) YEARS AGO . . . . . . . . .  4 
IN MENOPAUSE/ 
. . .  994 HAS HAD HYSTERECTOMY 
BEFORE LAST BIRTH. . . . . . . . . . . . 995 
996 NEVER MENSTRUATED. . . . . . . . .  
239 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
301 DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
240 JUST BEFORE HER PERIOD 
. . . . . . . . . . . . . . . . . . . . . . 1 BEGINS 
. . . . . . . . . . . . 2 DURING HER PERIOD 
RIGHT AFTER HER 
PERIOD HAS ENDED. . . . . . . . . . . . 3 
HALFWAY BETWEEN 
TWO PERIODS . . . . . . . . . . . . . . . . 4 
OTHER 6 
( SPECIFY ) 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
_________________________ 
Is this time just before her period begins, during her period, right  
after her period has ended, or halfway between two periods? 
When did your last menstrual period start? 
From one menstrual period to the next, are there certain days when  




SECTION 3.  CONTRACEPTION 
301 
01 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 
02 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
03 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
04 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
05 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
06 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
07 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
08 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
09 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
Now I would like to talk about family planning - the various ways or methods that a couple can use to delay or avoid a pregnancy. 
Have you ever heard of (METHOD)?    (1) 
Female Sterilization . PROBE: Women can have an operation to  
avoid having any more children. 
Male Sterilization . PROBE: Men can have an operation to avoid  
having any more children. 
IUD .  PROBE: Women can have a loop or coil placed inside them  
by a doctor or a nurse. 
Implants . PROBE: Women can have one or more small rods  
placed in their upper arm by a doctor or nurse which can prevent  
pregnancy for one or more years. 
Pill . PROBE: Women can take a pill every day to avoid becoming  
pregnant.  
Condom . PROBE: Men can put a rubber sheath on their penis  
before sexual intercourse. 
Female Condom . PROBE: Women can place a sheath in their  
vagina before sexual intercourse. 
Lactational Amenorrhea Method (LAM) .  (2) 
Injectables . PROBE: Women can have an injection by a health  
provider that stops them from becoming pregnant for one or more  
months. 
10 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
11 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
12 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
13 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
________________________________ 
) ( SPECIFY 
________________________________ 
( SPECIFY ) 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
302 CHECK 226: 
NOT PREGNANT PREGNANT 
OR UNSURE 311 
303 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
311 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
Emergency Contraception . PROBE: As an emergency measure,  
within three days after they have unprotected sexual intercourse,  
women can take special pills to prevent pregnancy.  (3) 
Are you currently doing something or using any method to delay or  
avoid getting pregnant? 
Rhythm Method . PROBE: To avoid pregnancy, women do not have  
sexual intercourse on the days of the month they think they can get  
pregnant. 
Withdrawal . PROBE: Men can be careful and pull out before  
climax. 
Have you heard of any other ways or methods that women or men  




304 A . . . . . . . . .  FEMALE STERILIZATION 
307 . . . . . . . . . . . . B MALE STERILIZATION 
CIRCLE ALL MENTIONED. IUD. . . . . . . . . . . . . . . . . . . . . . . . . . . . C 
. . . . . . . . . . . . . . . . . . D INJECTABLES 308 A 
. . . . . . . . . . . . . . . . . . . . . . E IMPLANTS IF MORE THAN ONE METHOD MENTIONED, FOLLOW SKIP 
INSTRUCTION FOR HIGHEST METHOD IN LIST. PILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
CONDOM 306 . . . . . . . . . . . . . . . . . . . . . . G 
. . . . . . . . . . . . . . H FEMALE CONDOM 
. . . . . . . . . . . . . . . . . . . . I DIAPHRAGM 
. . . . . . . . . . . . . . . . . . . . J FOAM/JELLY 
LACTATIONAL AMEN. METHOD. . . . . K 
RHYTHM METHOD. . . . . . . . . . . . . . . . L 
WITHDRAWAL . . . . . . . . . . . . . . . . . . M 
OTHER MODERN METHOD . . . . . . .  X 
OTHER TRADITIONAL METHOD . . . Y 
305 BRAND A . . . . . . . . . . . . . . . . . . . . . . 01 
BRAND B . . . . . . . . . . . . . . . . . . . . . . 02 
IF DON'T KNOW THE BRAND,  . . . . . . . . . . . . . . . . . . . . . . 03 BRAND C 
ASK TO SEE THE PACKAGE. 
OTHER 
( SPECIFY ) 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 98 
306 BRAND A . . . . . . . . . . . . . . . . . . . . . . 01 
BRAND B . . . . . . . . . . . . . . . . . . . . . . 02 
IF DON'T KNOW THE BRAND, . . . . . . . . . . . . . . . . . . . . . . 03 BRAND C 
ASK TO SEE THE PACKAGE. 
OTHER 




Which method are you using?  (4) 
What is the brand name of the pills you are using? 
What is the brand name of the condoms you are using? 
96 
96 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 98 
307 PUBLIC SECTOR 
. . . . . . . . . . . . . . 11 GOVT. HOSPITAL 
. . . . . . . 12 PROBE TO IDENTIFY THE TYPE OF SOURCE.  GOVT. HEALTH CENTER 
FAMILY PLANNING CLINIC. . . . . . . 13 
. . . . . . . . . . . . . . . . 14 MOBILE CLINIC 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE OTHER PUBLIC 
16 SECTOR, WRITE THE NAME OF THE PLACE. SECTOR 
) ( SPECIFY 
( NAME OF PLACE ) PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC . . . . . 21 
PRIVATE DOCTOR'S OFFICE. . . . . 23 
. . . . . . . . . . . . . . . . 24 MOBILE CLINIC 
OTHER PRIVATE MEDICAL 
26 SECTOR 
) SPECIFY ( 
OTHER 96 
( SPECIFY ) 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 98 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
308 
308A 
In what month and year was the sterilization performed? 
Since what month and year have you been using (CURRENT 
METHOD) without stopping? 
PROBE: For how long have you been using (CURRENT METHOD) 
now without stopping? 
 MONTH . . . . . . . . . . . . . 
. . . . .  
YEAR . . . . . . . . . . . .  
   
    
 
309 
CHECK 308/308A, 215 AND 231: 
 ANY BIRTH OR PREGNANCY TERMINATION AFTER MONTH AND YESNO 
YEAR OF START OF USE OF CONTRACEPTION IN 308/308A 
GO BACK TO 308/308A, PROBE AND RECORD MONTH AND YEAR AT START OF CONTINUOUS 
USE OF CURRENT METHOD (MUST BE AFTER LAST BIRTH OR PREGNANCY TERMINATION). 
 
310 CHECK 308/308A: 
YEAR IS 2005 (6) OR LATER  YEAR IS 2004 (7) OR EARLIER  
OF INTERVIEW IN THE CALENDAR  C INTERVIEW IN THE CALENDAR AND ENTER CODE FOR METHOD 
USED IN MONTH ENTER CODE FOR METHOD USED IN MONTH OF 
 AND IN EACH MONTH BACK TO THE DATE EACH MONTH BACK TO JANUARY 2005 (6). 
STARTED USING. 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
311 
I would like to ask you some questions about the times you or your partner may have used a method to avoid getting 
pregnant during the last few years. 
USE CALENDAR TO PROBE FOR EARLIER PERIODS OF USE AND NONUSE, STARTING WITH MOST  
RECENT USE, BACK TO JANUARY 2005. (6) 
USE NAMES OF CHILDREN, DATES OF BIRTH, AND PERIODS OF PREGNANCY AS REFERENCE 
POINTS. 
IN COLUMN 1, ENTER METHOD USE CODE OR '0' FOR NONUSE IN EACH BLANK MONTH. 
ILLUSTRATIVE QUESTIONS: 
* When was the last time you used a method? Which method was that?  
* When did you start using that method? How long after the birth of (NAME)? *  How long did you 
use the method then? 
IN COLUMN 2, ENTER CODES FOR DISCONTINUATION NEXT TO THE LAST MONTH OF USE. 
NUMBER OF CODES IN COLUMN 2 MUST BE SAME AS NUMBER OF INTERRUPTIONS OF METHOD 
USE IN COLUMN 1. 
ASK WHY SHE STOPPED USING THE METHOD. IF A PREGNANCY FOLLOWED, ASK WHETHER 
SHE BECAME PREGNANT UNINTENTIONALLY WHILE USING THE METHOD OR DELIBERATELY 
STOPPED TO GET PREGNANT. 
ILLUSTRATIVE QUESTIONS: 
* Why did you stop using the (METHOD)? Did you become pregnant while using (METHOD), or did 
you stop to get pregnant, or did you stop for some other reason? 
* IF DELIBERATELY STOPPED TO BECOME PREGNANT, ASK: How many months did it take you 






NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
312 CHECK THE CALENDAR FOR USE OF ANY CONTRACEPTIVE METHOD IN ANY MONTH 
NO METHOD USED ANY METHOD USED 
314 
313 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 324 
324 314 CHECK 304: NO CODE CIRCLED . . . . . . . . . . . . . . 00 
. . . . . . . . . 01 FEMALE STERILIZATION 317 A 
. . . . . . . . . . . . 02 326 CIRCLE METHOD CODE: MALE STERILIZATION 
IUD. . . . . . . . . . . . . . . . . . . . . . . . . . . . 03 
INJECTABLES. . . . . . . . . . . . . . . . . . . . 04 IF MORE THAN ONE METHOD CODE CIRCLED IN 304, 
CIRCLE CODE FOR HIGHEST METHOD IN LIST. IMPLANTS . . . . . . . . . . . . . . . . . . . . . . 05 
PILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . 06 
. . . . . . . . . . . . . . . . . . . . . . 07 CONDOM 
FEMALE CONDOM. . . . . . . . . . . . . . . . 08 
. . . . . . . . . . . . . . . . . . . . 09 DIAPHRAGM 
FOAM/JELLY . . . . . . . . . . . . . . . . . . . . 10 
LACTATIONAL AMEN. METHOD. . . . . 11 
315 A RHYTHM METHOD. . . . . . . . . . . . . . . . 12 
WITHDRAWAL . . . . . . . . . . . . . . . . . . 13 
. . . . . . . 95 326 OTHER MODERN METHOD 
OTHER TRADITIONAL METHOD. . . . . 96 
315 PUBLIC SECTOR 
GOVT. HOSPITAL . . . . . . . . . . . . . . 11 
GOVT. HEALTH CENTER . . . . . . . 12 
FAMILY PLANNING CLINIC. . . . . . . 13 
MOBILE CLINIC . . . . . . . . . . . . . . . . 14 
. . . . . . . . . . . . . . . . 15 FIELDWORKER 
You first started using (CURRENT METHOD) in (DATE FROM  
308/308A) . Where did you get it at that time?  (5) 
Have you ever used anything or tried in any way to delay or avoid  
getting pregnant? 
OTHER PUBLIC 
SECTOR _______________ 16 
( SPECIFY ) 
315 A PRIVATE MEDICAL SECTOR 
. . . . . 21 PRIVATE HOSPITAL/CLINIC 
PHARMAC Y . . . . . . . . . . . . . . . . . . . . 22 
PRIVATE DOCTOR. . . . . . . . . . . . . . 23 
. . . . . . . . . . . . . . . . 24 MOBILE CLINIC 
FIELDWORKER . . . . . . . . . . . . . . . . 25 
OTHER PRIVATE MEDICAL 
26 SECTOR ________________ 
SPECIFY PROBE TO IDENTIFY THE TYPE OF SOURCE. ) ( 
OTHER SOURCE IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR,  
WRITE THE NAME OF THE PLACE. SHOP. . . . . . . . . . . . . . . . . . . . . . . . 31 
CHURCH. . . . . . . . . . . . . . . . . . . . . . 32 
FRIEND/RELATIVE. . . . . . . . . . . . . . 33 
( NAME OF PLACE ) 
OTHER _______________________ 96 
) ( SPECIFY 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
316 CHECK 304: IUD. . . . . . . . . . . . . . . . . . . . . . . . . . . . 03 
INJECTABLES. . . . . . . . . . . . . . . . . . . . 04 
CIRCLE METHOD CODE: . . . . . . . . . . . . . . . . . . . . . . 05 IMPLANTS 
PILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . 06 
IF MORE THAN ONE METHOD CODE CIRCLED IN 304,  CONDOM 323 . . . . . . . . . . . . . . . . . . . . . . 07 
CIRCLE CODE FOR HIGHEST METHOD IN LIST. FEMALE CONDOM. . . . . . . . . . . . . . . . 08 
320 . . . . . . . . . . . . . . . . . . . . 09 DIAPHRAGM 
. . . . . . . . . . . . . . . . . . . . 10 FOAM/JELLY 
LACTATIONAL AMEN. METHOD. . . . . 11 326 
RHYTHM METHOD. . . . . . . . . . . . . . . . 12 326 
317 
319 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
317 A 
318 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
320 NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
319 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
320 CHECK 317: 
CODE '1' CODE '1' 
CIRCLED NOT 
CIRCLED 
At  that time, were you told about side effects or problems you might  
have with the method? 
When you got sterilized, were you told about side effects or  
problems you might have with the method? 
Were you ever told by a health or family planning worker about side  
effects or problems you might have with the method? 
At that time, were you told  
about other methods of family  
Were you told what to do if you experienced side effects or  
problems? 
When you obtained (CURRENT  
METHOD FROM 314) from  
1 322 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
321 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
. . . . . . . . . 01 FEMALE STERILIZATION CHECK 304: 322 
326 . . . . . . . . . . . . 02 MALE STERILIZATION 
IUD. . . . . . . . . . . . . . . . . . . . . . . . . . . . 03 CIRCLE METHOD CODE: 
INJECTABLES. . . . . . . . . . . . . . . . . . . . 04 
IF MORE THAN ONE METHOD CODE CIRCLED IN 304, . . . . . . . . . . . . . . . . . . . . . . 05 IMPLANTS 
PILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . 06 CIRCLE CODE FOR HIGHEST METHOD IN LIST. 
. . . . . . . . . . . . . . . . . . . . . . 07 CONDOM 
FEMALE CONDOM. . . . . . . . . . . . . . . . 08 
DIAPHRAGM . . . . . . . . . . . . . . . . . . . . 09 
. . . . . . . . . . . . . . . . . . . . 10 FOAM/JELLY 
LACTATIONAL AMEN. METHOD. . . . . 11 
RHYTHM METHOD. . . . . . . . . . . . . . . . 12 
WITHDRAWAL . . . . . . . . . . . . . . . . . . 13 326 
OTHER MODERN METHOD . . . . . . . 95 
OTHER TRADITIONAL METHOD . . . 96 
Were you ever told by a health or family planning worker about other  
methods of family planning that you could use? 
p l ann i ng  th a t you cou ld use ? SOURCE (   OF   METHOD   FROM   
307 OR 315), were you told  
about other methods of family  
planning that you could use? 
 
W-15 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
323 PUBLIC SECTOR 
. . . . . . . . . . . . . . 11 GOVT. HOSPITAL 
GOVT. HEALTH CENTER PROBE TO IDENTIFY THE TYPE OF SOURCE. . . . . . . . 12 
FAMILY PLANNING CLINIC. . . . . . . 13 
. . . . . . . . . . . . . . . . 14 MOBILE CLINIC IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE 
FIELDWORKER . . . . . . . . . . . . . . . . 15 SECTOR, WRITE THE NAME OF THE PLACE. 
OTHER PUBLIC 
16 _________________ SECTOR 
SPECIFY ) ( 
PRIVATE MEDICAL SECTOR ( NAME OF PLACE ) 
PRIVATE HOSPITAL/CLINIC . . . . . 21 
PHARMAC Y . . . . . . . . . . . . . . . . . . . . 22 
PRIVATE DOCTOR. . . . . . . . . . . . . . 23 326 
. . . . . . . . . . . . . . . . 24 MOBILE CLINIC 
FIELDWORKER . . . . . . . . . . . . . . . . 25 
OTHER PRIVATE MEDICAL 
26 SECTOR 
( SPECIFY ) 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . 31 
CHURCH. . . . . . . . . . . . . . . . . . . . . . 32 
FRIEND/RELATIVE. . . . . . . . . . . . . . 33 
_______________________ OTHER 96 
( SPECIFY ) 
324 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO 326 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
325 PUBLIC SECTOR Where is that?  (5) 
Where did you obtain (CURRENT METHOD) the last time?  (5) 
Do you know of a place where you can obtain a method of family  
planning? 
GOVT. HOSPITAL . . . . . . . . . . . . . . A 
GOVT. HEALTH CENTER . . . . . . .  B 
FAMILY PLANNING CLINIC. . . . . . . C 
PROBE TO IDENTIFY EACH TYPE OF SOURCE. MOBILE CLINIC . . . . . . . . . . . . . . . . D 
FIELDWORKER . . . . . . . . . . . . . . . . E 
OTHER PUBLIC IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE NAME OF THE PLACE. _________________ F SECTOR 
SPECIFY ) ( 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC . . . . . G 
PHARMACY ( NAME OF PLACE(S )) . . . . . . . . . . . . . . . . . . H 
PRIVATE DOCTOR. . . . . . . . . . . . . . I 
MOBILE CLINIC . . . . . . . . . . . . . . . . J 
. . . . . . . . . . . . . . . . K FIELDWORKER 
OTHER PRIVATE MEDICAL 
L SECTOR 
( SPECIFY ) 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . M 
CHURCH. . . . . . . . . . . . . . . . . . . . . . N 
FRIEND/RELATIVE. . . . . . . . . . . . . . O 
OTHER _________________________X 
) ( SPECIFY 
Any other place? 
 
W-16 
(1) If Standard Days Method is commonly used, it may be added to the table before Lactational Amenorrhea. 
"Standard Days Method (use local term, such as CycleBeads™ , as appropriate) PROBE: A woman uses 
a string of colored beads to know the days she can get pregnant. On the days she can get pregnant, she 
uses a condom or does not have sexual intercourse." If Standard Days Method is added to Q. 301, it 
should also be added before LAM to Qs. 304, 314, 316, 322, and Column 1 of the calendar. 
(2) The LAM method should be deleted in countries that do not have a LAM program. In these countries, LAM 
should also be deleted as a coding category in Qs. 304, 314, 316, 322, and Column 1 of the calendar. A 
description of LAM should not be provided in Q. 301. 
(3) Studies have indicated emergency contraception can be effective up to five days. Verify country program 
recommendations and modify wording if appropriate. 
(4) Other commonly used methods may be added to the list, such as contraceptive patch, contraceptive 
vaginal ring, or sponge. Any codes added in Q. 304 must also be added to Qs. 314, 316, 322, and Column 
1 of the calendar. These methods should not be added to Q. 301. 
(5) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 
(6) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2006 
or 2007, respectively. 
(7) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2005 
or 2006, respectively. 
(8) In countries without national fieldworker programs that include family planning, Q. 326 should be deleted.  
NO. QUESTIONS AND FILTERS CODING CATEGORIES  SKIP 
326 
In the last 12 months, were you visited by a fieldworker who talked to 
you about family planning? (8) 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO





In the last 12 months, have you visited a health facility for care for 
yourself (or your children)? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO





Did any staff member at the health facility speak to you about family 
planning methods? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO









LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
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NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
410 Where did you receive antenatal 
care for this pregnancy? (2) 
Anywhere else? 
PROBE TO IDENTIFY EACH TYPE 
OF SOURCE. 
IF UNABLE TO DETERMINE 
IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE NAME 
OF THE PLACE. 
 
(NAME OF PLACE(S)) 
HOME 
 YOUR HOME . . . A 
OTHER HOME . . . B 
PUBLIC SECTOR 
GOVT. HOSPITAL C 
GOVT. HEALTH 
CENTER . . . . . D 
GOVT. HEALTH 






PRIVATE MED. SECTOR 
PVT. HOSPITAL/ 










411 How many months pregnant were 
you when you first received 
antenatal care for this pregnancy? MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
412 How many times did you receive 




DON'T KNOW . . . . . 98 
  
413 
As part of your antenatal care 
during this pregnancy, were any of 
the following done at least once: 
Was your blood pressure 
measured? 
Did you give a urine sample? 
Did you give a blood sample? 
 YES NO 
BP . . . . . . . . 1 2 URINE 
. . . . . 1 2 BLOOD . . . 1 2 
414 
During (any of) your antenatal care 
visit(s), were you told about things 
to look out for that might suggest 
problems with the pregnancy? 
YES . . . . . . . . . . . . . . 1 NO
 . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
415 
During this pregnancy, were you 
given an injection in the arm to 
prevent the baby from getting 
tetanus, that is, convulsions after 
birth? (3) 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 418)  





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
416 During this pregnancy, how many 
times did you get a tetanus 
injection? 
TIMES . . . . . . . . . .  
 DON'T KNOW . . . . .  8 
  
417 CHECK 416: 
 2 OR MORE OTHER 
TIMES  
(SKIP TO 421) 
418 At any time before this pregnancy, 
did you receive any tetanus 
injections? 
YES . . . . . . . . . . . . . . 1 
 NO. . . . . . . . . . . . . 
. 2 
(SKIP TO 421) 
 DON'T KNOW . . .  8 
419 
Before this pregnancy, how many 
times did you receive a tetanus 
injection?  
IF 7 OR MORE TIMES, 
RECORD '7'. 
TIMES . . . . . . . . . .  
 DON'T KNOW . . . . .  8 
420 
How many years ago did you 
receive the last tetanus injection 
before this pregnancy? 
YEARS 
 AGO . . . . .  
  
421 During this pregnancy, were you 
given or did you buy any iron 
tablets or iron syrup? (4) 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 423)  
 SHOW TABLETS/SYRUP. (4)  DON'T KNOW . . . . .  8   
422 
During the whole pregnancy, for 
how many days did you take the 
tablets or syrup? (4,5) 
IF ANSWER IS NOT NUMERIC, 
PROBE FOR APPROXIMATE 
NUMBER OF DAYS. 
DAYS 
 DON'T 
KNOW . . . 998 
   
423 During this pregnancy, did you take 
any drug for intestinal worms? YES . . . . . . . . . . . . . . 1 NO
 . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
424 
(6) 
During this pregnancy, did you take 
any drugs to keep you from getting 
malaria?  
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 430)  
 DON'T KNOW . . . . .  8 
  
425 
(6) What drugs did you take?  
RECORD ALL MENTIONED. 
IF TYPE OF DRUG IS NOT  
DETERMINED, SHOW 
TYPICAL ANTIMALARIAL 
DRUGS TO RESPONDENT. 
 SP/FANSIDAR . . . . .  A 
CHLOROQUINE . . . B 
 OTHER X 
 
(SPECIFY) 





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 




SP/FANSIDAR TAKEN FOR 
MALARIA PREVENTION.  
 CODE 'A' CODE 






(6) How many times did you take 
(SP/Fansidar) during this 
pregnancy?  





ANTENATAL CARE FROM  
HEALTH PERSONNEL 
DURING THIS PREGNANCY 
 CODE 'A', OTHER 
 'B' OR 'C' 
CIRCLED 
  (SKIP TO 430) 
429 
(6) Did you get the (SP/Fansidar) 
during any antenatal care visit, 
during another visit to a health 
facility or from another source? 
ANTENATAL VISIT . . 1 
ANOTHER FACILITY 
 VISIT . . . . . . . . . . 2 
 OTHER SOURCE 6 
430 When (NAME) was born, was 
he/she very large, larger than 
average, average, smaller than 
average, or very small? 
VERY LARGE . . . . . 
 1 LARGER THAN 
AVERAGE . . . . . 
 2 AVERAGE
 . . . . . . . . 3 
SMALLER THAN 
AVERAGE . . . . . 
 4 VERY SMALL
 . . . . .  5 DON'T 
KNOW . . . . .  8 
VERY LARGE . . . . . 
 1 LARGER THAN 
 AVERAGE . . . . .  2 
 AVERAGE . . . . . . . . 3 
SMALLER THAN 
 AVERAGE . . . . .  4 
VERY SMALL . . . . . 
 5 DON'T KNOW . . . 
. .  8 
VERY LARGE . . . . . 
 1 LARGER THAN 
 AVERAGE . . . . .  2 
 AVERAGE . . . . . . . . 3 
SMALLER THAN 
 AVERAGE . . . . .  4 
VERY SMALL . . . . . 
 5 DON'T KNOW . . . 
. .  8 
431 Was (NAME) weighed at birth? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 433)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 433)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 433)  
 DON'T KNOW . . . . .  8 
432 How much did (NAME) weigh? 
RECORD WEIGHT IN 
KILOGRAMS FROM HEALTH 
CARD, IF AVAILABLE. 
KG FROM CARD 
1  . 
KG FROM RECALL 
2  . 
 DON'T KNOW 99998 
   
   
KG FROM CARD 
1  . 
KG FROM RECALL 
2  . 
 DON'T KNOW 99998 
   
   
KG FROM CARD 
1  . 
KG FROM RECALL 
2  . 
 DON'T KNOW 99998 
   




Who assisted with the delivery of 
(NAME)? (2) 
Anyone else? 
PROBE FOR THE TYPE(S) OF 
PERSON(S) AND RECORD ALL 
MENTIONED. 
IF RESPONDENT SAYS NO ONE 
ASSISTED, PROBE TO   
DETERMINE WHETHER ANY 
ADULTS WERE PRESENT AT 
THE DELIVERY. 
HEALTH PERSONNEL 
DOCTOR . . . . . A 
NURSE/MIDWIFE B 
AUXILIARY  
 MIDWIFE . . . C 
OTHER PERSON 
TRADITIONAL BIRTH 






 NO ONE ASSISTED Y 
HEALTH PERSONNEL 
DOCTOR . . . . . . . . A 
 NURSE/MIDWIFE B 
AUXILIARY  
 MIDWIFE . . . C 
OTHER PERSON 
TRADITIONAL BIRTH 
ATTENDANT . . D 





 NO ONE ASSISTED Y 
HEALTH PERSONNEL 
DOCTOR . . . . . A 
NURSE/MIDWIFE B 
AUXILIARY  
 MIDWIFE . . . C 
OTHER PERSON 
TRADITIONAL BIRTH 






 NO ONE ASSISTED Y 
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
434 Where did you give birth to 
(NAME)? (2) 
PROBE TO IDENTIFY THE TYPE 
OF SOURCE. 
IF UNABLE TO DETERMINE 
IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE  
NAME OF THE PLACE. 
 
(NAME OF PLACE) 
HOME 
YOUR HOME . . . 11 
(SKIP TO 438)  
OTHER HOME . . . 12 
PUBLIC SECTOR 
GOVT. HOSPITAL 21 
GOVT. HEALTH 
CENTER . . . . . 22 
GOVT. HEALTH 






PRIVATE MED. SECTOR 
PVT. HOSPITAL/ 






 OTHER 96 
(SPECIFY) 
(SKIP TO 438) 
HOME 
 YOUR HOME . . . 11 
(SKIP TO 448)  
OTHER HOME . . . 12 
PUBLIC SECTOR 
GOVT. HOSPITAL 21 
GOVT. HEALTH 
CENTER . . . . . 22 
GOVT. HEALTH 






PRIVATE MED. SECTOR 
PVT. HOSPITAL/ 






 OTHER 96 
(SPECIFY) 
(SKIP TO 448) 
HOME 
YOUR HOME . . . 11 
(SKIP TO 448)  
OTHER HOME . . . 12 
PUBLIC SECTOR 
GOVT. HOSPITAL 21 
GOVT. HEALTH 
CENTER . . . . . 22 
GOVT. HEALTH 






PRIVATE MED. SECTOR 
PVT. HOSPITAL/ 






 OTHER 96 
(SPECIFY) 
(SKIP TO 448) 
434A 
How long after (NAME) was 
delivered did you stay there? 
IF LESS THAN ONE DAY, 
RECORD HOURS. IF 
LESS THAN ONE WEEK, 
RECORD DAYS. 
 HOURS 1 
 DAYS 2 
 WEEKS 3 
 DON'T KNOW . . 








Was (NAME) delivered by 
caesarean, that is, did they cut your 
belly open to take the baby out? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
436 I would like to talk to you about 
checks on your health after 
delivery, for example, someone 
asking you questions about your 
health or examining you. Did 
anyone check on your health while 
you were still in the facility? 
YES . . . . . . . . . . . . . . 1 
(SKIP TO 439)  
 NO . . . . . . . . . . . . . . 2 
  
437 Did anyone check on your health 
after you left the facility? YES . . . . . . . . . . . . . . 1 
(SKIP TO 439) 
 NO . . . . . . . . . . . . . . 2 




LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
438 I would like to talk to you about 
checks on your health after 
delivery, for example, someone 
asking you questions about your 
health or examining you. Did 
anyone check on your health after 
you gave birth to  
(NAME)? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 442)  
  
439 Who checked on your health at that 
time? (2) 
PROBE FOR MOST QUALIFIED 
PERSON. 
HEALTH PERSONNEL 
DOCTOR . . . . . . . . 11 
NURSE/MIDWIFE 
 12 AUXILIARY  
MIDWIFE . . . . . 13 
OTHER PERSON 
TRADITIONAL BIRTH 
 ATTENDANT 21 
COMMUNITY/ 
VILLAGE HEALTH 
 WORKER . . . 22 




440 How long after delivery did the first 
check take place? 
IF LESS THAN ONE DAY, 
RECORD HOURS. 
IF LESS THAN ONE WEEK, 
 HOURS 1 
 DAYS 2 




 RECORD DAYS.  DON'T KNOW . . .  998   
442 In the two months after (NAME) 
was born, did any health care 
provider or a traditional birth 
attendant check on his/her health? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 446)  




How many hours, days or weeks  
after the birth of (NAME) did the 
first check take place? 
IF LESS THAN ONE DAY, 
RECORD HOURS. IF 
LESS THAN ONE WEEK, 
RECORD DAYS. 
HRS AFTER 
BIRTH . . 1 
DAYS AFTER  
BIRTH . . 2 
WKS AFTER 
BIRTH . . 3 




444 Who checked on (NAME)'s health 
at that time? (2) 
PROBE FOR MOST QUALIFIED 
PERSON. 
HEALTH PERSONNEL 
DOCTOR . . . . . . . . 11 
NURSE/MIDWIFE 
 12 AUXILIARY  
MIDWIFE . . . . . 13 
OTHER PERSON 
TRADITIONAL BIRTH 
 ATTENDANT 21 
COMMUNITY/ 
VILLAGE HEALTH 
 WORKER . . . 22 





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
445 Where did this first check of 
(NAME) take place? (2) 
PROBE TO IDENTIFY THE TYPE 
OF SOURCE AND CIRCLE THE 
APPROPRIATE CODE. 
IF UNABLE TO DETERMINE 
IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE  
NAME OF THE PLACE. 
 
(NAME OF PLACE) 
HOME 
 YOUR HOME . . . 11 
OTHER HOME . . . 12 
PUBLIC SECTOR 
GOVT. HOSPITAL 21 
GOVT. HEALTH 
CENTER . . . . . 22 
GOVT. HEALTH 





PRIVATE MED. SECTOR 
PVT. HOSPITAL/ 
CLINIC . . . . . . . . 31 
OTHER PRIVATE 
 MED. 36 
 
(SPECIFY) 






446 In the first two months after 
delivery, did you receive a vitamin A 
dose like (this/any of these)? 
SHOW COMMON TYPES OF 
AMPULES/CAPSULES/SYRUPS. 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . . 8 
447 Has your menstrual period returned 
since the birth of (NAME)? YES . . . . . . . . . . . . . . 1 
(SKIP TO 449) 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 450) 
448 
Did your period return between the 
birth of (NAME) and your next 
pregnancy? 
 YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 452)  
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 452)  
449 For how many months after the 
birth of (NAME) did you not have a 
period? MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
450 CHECK 226: 










451 Have you had sexual intercourse 
since the birth of (NAME)? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 






LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
452 For how many months after the 
birth of (NAME) did you not have 
sexual intercourse? MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
MONTHS . . .  
DON'T KNOW . . 
. . . 98 
  
453 Did you ever breastfeed (NAME)? 
YES . . . . . . . . . . . . . . 1 
(SKIP TO 455)  
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
 
W-25 
454 CHECK 404: 
IS CHILD LIVING? 
 LIVING DEAD 
(SKIP TO 
 460) (GO BACK 
TO 405 IN 
NEXT COLUMN; 
OR IF NO 
MORE BIRTHS, 
GO TO 501) 
  
455 
How long after birth did you first put 
(NAME) to the breast? 
IF LESS THAN 1 HOUR,  
RECORD ‘00' HOURS. IF 
LESS THAN 24 HOURS,  
RECORD HOURS. 
OTHERWISE, RECORD DAYS. 
 IMMEDIATELY . . .  000 
 HOURS 1 




456 In the first three days after delivery,  YES . . . . . . . . . . . . . . 1 
 was (NAME) given anything to drink 
other than breast milk? 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 458)  
  
457 What was (NAME) given to drink?  
Anything else? 
RECORD ALL LIQUIDS 
MENTIONED. 
MILK (OTHER THAN 
BREAST MILK ) A PLAIN 
WATER . . . B 
SUGAR OR GLU-  
COSE WATER . . . C 
GRIPE WATER . . . D 
SUGAR-SALT-WATER 
SOLUTION . . . . .  E 
FRUIT JUICE . . . . . 
 F 
 INFANT FORMULA G 
TEA/INFUSIONS . . . H 
COFFEE . . . . . . . . . . I 
 HONEY . . . . . . . . . . J 
 OTHER X 
 
(SPECIFY) 
458 CHECK 404: 
IS CHILD LIVING?  LIVING
 DEAD 
(GO BACK TO   
405 IN NEXT   
COLUMN; OR,   
IF NO MORE   
BIRTHS, GO  TO 
501)   
 LIVING
 DEAD 
(GO BACK TO   
405 IN NEXT   
COLUMN; OR,   
IF NO MORE   
BIRTHS, GO   
TO 501)   
 LIVING
 DEAD 
(GO BACK TO   
405 IN NEXT-TO-
LAST  COLUMN 
OF NEW   
QUESTIONNAIRE;   
OR, IF NO MORE   
BIRTHS, GO  TO 501)   
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
459 Are you still breastfeeding (NAME)? 
YES . . . . . . . . . . . . . . 1 





Did (NAME) drink anything from a 
bottle with a nipple yesterday or last 
night? 
YES . . . . . . . . . . . . . . 1 NO
 . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
461  GO BACK TO 405 IN 
NEXT COLUMN; OR, IF 
NO MORE BIRTHS, GO 
TO 501. 
GO BACK TO 405 IN 
NEXT COLUMN; OR, IF 
NO MORE BIRTHS, GO 
TO 501. 
GO BACK TO 405 IN  
NEXT-TO-LAST  
COLUMN OF NEW 
QUESTIONNAIRE; OR, 
IF NO MORE BIRTHS, 
GO TO 501. 
(1) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2006 or 
2007, respectively. 
(2) Coding categories to be developed locally and revised based on the pretest; however, the broad categories must 
be maintained. 
(3) Vaccination practices may vary; this question should specify where the injection is given, e.g. arm or shoulder. 
(4) Syrup should be deleted in countries where syrup is not used. 
(5) In countries where it is important to know the number of iron tablets taken per day, an appropriate question may 
be added. 
(6) The question should be deleted in surveys in countries where there is no program for intermittent preventive 






LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 




Has (NAME) had any vaccinations 
that are not recorded on this card, 
including vaccinations given in a 
national immunization day 
campaign? 
RECORD 'YES' ONLY IF THE 
RESPONDENT MENTIONS 
AT LEAST ONE OF THE  
VACCINATIONS IN 506 THAT 
ARE NOT RECORDED AS 
HAVING BEEN GIVEN. 
YES . . . . . . . . . . . . . . 1 
(PROBE FOR 
VACCINATIONS AND 
WRITE ‘66' IN THE 
CORRESPONDING  
DAY COLUMN IN 506)     
(SKIP TO 511) 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511) 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 (PROBE FOR  
VACCINATIONS AND 
WRITE ‘66' IN THE 
CORRESPONDING  
DAY COLUMN IN 506)     
(SKIP TO 511) 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511) 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
 (PROBE FOR  
VACCINATIONS AND 
WRITE ‘66' IN THE 
CORRESPONDING  
DAY COLUMN IN 506)     
(SKIP TO 511) 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511) 
 DON'T KNOW . . . . .  8 
509 Did (NAME) ever have any 
vaccinations to prevent him/her from 
getting diseases, including 
vaccinations received in a national 
immunization day campaign? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 511)  
 DON'T KNOW . . . . .  8 
510 
510A 
Please tell me if (NAME) had any of 
the following vaccinations: (4) 
A BCG vaccination against 
tuberculosis, that is, an injection in 
the arm or shoulder that usually  
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
 causes a scar? (5)    
510B Polio vaccine, that is, drops in the 
mouth? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510E)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510E)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510E)  
 DON'T KNOW . . . . .  8 
510C 
Was the first polio vaccine given in 
the first two weeks after birth or 
later? (6) 
FIRST 2 WEEKS . . . 1 
LATER . . . . . . . . . . . . 2 
FIRST 2 WEEKS . . . 1 
LATER . . . . . . . . . . . . 2 
FIRST 2 WEEKS . . . 1 
LATER . . . . . . . . . . . . 2 
510D 
How many times was the polio 
vaccine given? 
NUMBER 
 OF TIMES . . . . .  
NUMBER 
 OF TIMES . . . . .  
NUMBER 
 OF TIMES . . . . .  
510E 
A DPT vaccination, that is, an 
injection given in the thigh or 
buttocks, sometimes at the same 
time as polio drops? (5) 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510G)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510G)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 510G)  
 DON'T KNOW . . . . .  8 
510F 
How many times was the DPT 
vaccination given? 
NUMBER 
 OF TIMES . . . . .  
NUMBER 
 OF TIMES . . . . .  
NUMBER 
 OF TIMES . . . . .  
510G 
A measles injection or an MMR 
injection - that is, a shot in the arm 
at the age of 9 months or older - to 
prevent him/her from getting 
measles? (7) 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 




Within the last six months, was 
(NAME) given a vitamin A dose like 
(this/any of these)? 
SHOW COMMON TYPES OF 
AMPULES/CAPSULES/SYRUPS. 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
512 
In the last seven days, was (NAME) 
given iron pills, sprinkles with iron, or 
iron syrup like (this/any of these)? 
SHOW COMMON TYPES OF 
PILLS/SPRINKLES/ 
SYRUPS. 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
513 
Was (NAME) given any drug for 
intestinal worms in the last six 
months? 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
514 Has (NAME) had diarrhea in the last 
2 weeks? (8) YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
515 Was there any blood in the stools? 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
516 
Now I would like to know how much 
(NAME) was given to drink during 
the diarrhea (including breastmilk).  
Was he/she given less than usual to 
drink, about the same amount, or 
more than usual to drink? 
IF LESS, PROBE: Was he/she given 
much less than usual to drink or 
somewhat less? 
 MUCH LESS . . . . .  1 
SOMEWHAT LESS 2 
ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
NOTHING TO DRINK 5 
DON'T KNOW . . . . . 8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 NOTHING TO DRINK 5 
 DON'T KNOW . . . . .  8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 NOTHING TO DRINK 5 
 DON'T KNOW . . . . .  8 
517 
When (NAME) had diarrhea, was 
he/she given less than usual to eat, 
about the same amount, more than 
usual, or nothing to eat? 
IF LESS, PROBE: Was he/she given 
much less than usual to eat or 
somewhat less? 
 MUCH LESS . . . . .  1 
SOMEWHAT LESS 2 
ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
STOPPED FOOD 5 NEVER 
GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 STOPPED FOOD 5 
 NEVER GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 STOPPED FOOD 5 
 NEVER GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
518 Did you seek advice or treatment for 
the diarrhea from any source? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 522)  
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 522)  
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
519 Where did you seek advice or 
treatment? (9) 
Anywhere else? 
PROBE TO IDENTIFY EACH 
TYPE OF SOURCE. 
IF UNABLE TO DETERMINE 
IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE NAME 
OF THE PLACE. 
 
(NAME OF PLACE(S)) 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT. HOSPITAL/ 
CLINIC . . . . . . . G 
 PHARMACY . . . H 
 PVT DOCTOR . . .  I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT. HOSPITAL/ 
CLINIC . . . . . . . G 
PHARMACY . . . H PVT 
DOCTOR . . . I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT. HOSPITAL/ 
CLINIC . . . . . . . G 
PHARMACY . . . H PVT 
DOCTOR . . . I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
   PRACTITIONER N  PRACTITIONER N  PRACTITIONER N 
   MARKET . . . . . O  MARKET . . . . . O  MARKET . . . . . O 
   OTHER X  OTHER X  OTHER X 






520 CHECK 519:  TWO OR ONLY  TWO OR ONLY  TWO OR ONLY 
















(SKIP TO 522) 
521 
Where did you first seek advice or 
treatment? 
USE LETTER CODE FROM 519. 




Was he/she given any of the 
following to drink at any time since 
he/she started having the diarrhea: 
a) A fluid made from a special 
packet called [LOCAL NAME 
FOR ORS PACKET]? 
b) A pre-packaged ORS liquid? (10) 
c) A government-recommended 
homemade fluid? (11) 
 YES NO DK 
FLUID FROM 
ORS PKT  1




 FLUID . . .  1 2 8 
 YES NO DK 
FLUID FROM 
ORS PKT1 2




 FLUID . . .  1 2 8 
 YES NO DK 
FLUID FROM 
ORS PKT 1 2
 8 ORS LQD 1
 2 8 
HOMEMADE 
 FLUID . . .  1 2 8 
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
523 Was anything (else) given to treat 
the diarrhea? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 525)  
 DON'T KNOW . . . . .  8 
524 What (else) was given to treat the 
diarrhea? 
Anything else? 
RECORD ALL TREATMENTS 
GIVEN. 
PILL OR SYRUP 
ANTIBIOTIC . . . . . A 
 ANTIMOTILITY B 




 ZINC) . . . . . . . D 
UNKNOWN PILL 
OR SYRUP . . . E 
INJECTION 
 ANTIBIOTIC . . . . .  F 
NON-ANTIBIOTIC
 G UNKNOWN 
INJECTION . . . H 
 (IV) INTRAVENOUS I 
HOME REMEDY/ 
HERBAL MED- 
 ICINE . . . . . . . . .  J 
 OTHER X 
PILL OR SYRUP 
ANTIBIOTIC . . . . . A 
 ANTIMOTILITY B 




 ZINC) . . . . . . . D 
UNKNOWN PILL 
OR SYRUP . . . E 
INJECTION 
 ANTIBIOTIC . . . . .  F 
NON-ANTIBIOTIC
 G UNKNOWN 
INJECTION . . . H 
 (IV) INTRAVENOUS I 
HOME REMEDY/ 
HERBAL MED- 
 ICINE . . . . . . . . .  J 
 OTHER X 
PILL OR SYRUP 
ANTIBIOTIC . . . . . A 
 ANTIMOTILITY B 




 ZINC) . . . . . . . D 
UNKNOWN PILL 
OR SYRUP . . . E 
INJECTION 
 ANTIBIOTIC . . . . .  F 
NON-ANTIBIOTIC G 
UNKNOWN 
INJECTION . . . H 
 (IV) INTRAVENOUS I 
HOME REMEDY/ 
HERBAL MED- 
 ICINE . . . . . . . . .  J 
 OTHER X 






525 Has (NAME) been ill with a fever at 
any time in the last 2 weeks? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 527)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 527)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 527)  
 DON'T KNOW . . . . .  8 
526 
(12) At any time during the illness, did 
(NAME) have blood taken from 
his/her finger or heel for testing? 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 NO 
. . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
 DON'T KNOW . . . . .  8 
527 Has (NAME) had an illness with a 
cough at any time in the last 2 
weeks?  
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 530)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 530)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 530)  




When (NAME) had an illness with a 
cough, did he/she breathe faster 
than usual with short, rapid breaths 
or have difficulty breathing? 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 531)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 531)  
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 531)  
 DON'T KNOW . . . . .  8 
529 Was the fast or difficult breathing 
due to a problem in the chest or to a 
blocked or runny nose? 
CHEST ONLY  . . . 1 
NOSE ONLY  . . . . .
 2 
BOTH . . . . . . . . . . . . 3 
 OTHER 6 
(SPECIFY) 
DON'T KNOW . . . . . 
 8 (SKIP TO 531) 
 CHEST ONLY  . . . 1 
 NOSE ONLY  . . . . . 2 
BOTH . . . . . . . . . . . . 3 
 OTHER 6 
(SPECIFY) 
DON'T KNOW . . . . . 
 8 (SKIP TO 531) 
 CHEST ONLY  . . . 1 
 NOSE ONLY  . . . . . 2 
BOTH . . . . . . . . . . . . 3 
 OTHER 6 
(SPECIFY) 
DON'T KNOW . . . . .  8 
(SKIP TO 531) 
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
530 CHECK 525: 
HAD FEVER? 
 YES NO OR DK 
 
(GO BACK TO 
 YES NO OR DK 
 
(GO BACK TO 
 YES NO OR DK 
 
(GO TO 503 
  503 IN NEXT 503 IN NEXT IN NEXT-TO-LAST 
  
  COLUMN; OR,   COLUMN; OR,   COLUMN OF NEW 
  IF NO MORE IF NO MORE QUESTIONNAIRE; OR, 
  BIRTHS, GO BIRTHS, GO IF NO MORE BIRTHS, 
  TO 553) TO 553) GO TO 553) 
531 
Now I would like to know how much  
(NAME) was given to drink 
(including breastmilk) during the 
illness with a (fever/cough).  
Was he/she given less than usual to 
drink, about the same amount, or 
more than usual to drink? 
IF LESS, PROBE: Was he/she given 
much less than usual to drink or 
somewhat less? 
 MUCH LESS . . . . .  1 
SOMEWHAT LESS 2 
ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
NOTHING TO DRINK 5 
DON'T KNOW . . . . . 8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 NOTHING TO DRINK 5 
 DON'T KNOW . . . . .  8 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 NOTHING TO DRINK 5 
 DON'T KNOW . . . . .  8 
532 
When (NAME) had a (fever/cough), 
was he/she given less than usual to 
eat, about the same amount, more 
than usual, or nothing to eat? 
IF LESS, PROBE: Was he/she  
 MUCH LESS . . . . .  1 
SOMEWHAT LESS 2 
ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 STOPPED FOOD 5 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 STOPPED FOOD 5 
 MUCH LESS . . . . .  1 
 SOMEWHAT LESS 2 
 ABOUT THE SAME 3 
MORE . . . . . . . . . . . . 4 
 STOPPED FOOD 5 
 given much less than usual to eat or 
somewhat less? 
 NEVER GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
 NEVER GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
 NEVER GAVE FOOD 6 
 DON'T KNOW . . . . .  8 
533 Did you seek advice or treatment for 
the illness from any source? YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 537)  
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 537)  
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 
(SKIP TO 537)  
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
 
W-33 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
534 Where did you seek advice or 
treatment? (9) 
Anywhere else? 
PROBE TO IDENTIFY EACH 
TYPE OF SOURCE. 
IF UNABLE TO DETERMINE 
IF PUBLIC OR PRIVATE 
SECTOR, WRITE THE NAME OF 
THE PLACE. 
 
(NAME OF PLACE(S)) 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT HOSPITAL/ 
CLINIC . . . . . . . G 
 PHARMACY . . . H 
 PVT DOCTOR . . .  I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT HOSPITAL/ 
CLINIC . . . . . . . G 
PHARMACY . . . H PVT 
DOCTOR . . . I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
PUBLIC SECTOR 
GOVT HOSPITAL A 
GOVT HEALTH  
CENTER . . . . . B 
GOVT HEALTH  
POST . . . . . . . C 
 MOBILE CLINIC D 







  SECTOR 
PVT HOSPITAL/ 
CLINIC . . . . . . . G 
PHARMACY . . . H PVT 
DOCTOR . . . I 
 MOBILE CLINIC J 







SHOP . . . . . . . . . M 
TRADITIONAL 
   PRACTITIONER N  PRACTITIONER N  PRACTITIONER N 
   MARKET . . . . . O  MARKET . . . . . O  MARKET . . . . . O 
   OTHER X  OTHER X  OTHER X 






535 CHECK 534:  TWO OR ONLY  TWO OR ONLY  TWO OR ONLY 

















(SKIP TO 537) 
536 
Where did you first seek advice or 
treatment? 
USE LETTER CODE FROM 534. 
FIRST PLACE . . .  FIRST PLACE . . .  FIRST PLACE . . .  
537 At any time during the illness, did 
(NAME) take any drugs for the 
illness? 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 




OR, IF NO 
MORE 
BIRTHS, GO TO 553) 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 




OR, IF NO 
MORE 
BIRTHS, GO TO 553) 
 DON'T KNOW . . . . .  8 
YES . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . 2 





OR, IF NO MORE 
BIRTHS, GO TO 553) 





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
538 What drugs did (NAME) take? (13) 
Any other drugs? 
RECORD ALL MENTIONED. 
ANTIMALARIAL DRUGS 
SP/FANSIDAR . . . A 
 CHLOROQUINE B 
 AMODIAQUINE C 
QUININE . . . . . . . D 
COMBINATION 
WITH 
 ARTEMISININ E 
OTHER ANTI- 
MALARIAL 




 PILL/SYRUP . . . G 
 INJECTION . . . H 
OTHER DRUGS 
 ASPIRIN . . . . . . .  I 
ACETA- 
 MINOPHEN . . .  J 
 IBUPROFEN . . . K 
 OTHER X 
 
(SPECIFY) 
 DON'T KNOW . . . . .  Z 
ANTIMALARIAL DRUGS 
SP/FANSIDAR . . . A 
CHLOROQUINE . B 
 AMODIAQUINE C 
QUININE . . . . . . . D 
COMBINATION 
WITH 
 ARTEMISININ E 
OTHER ANTI- 
MALARIAL 




 PILL/SYRUP . . . G 
 INJECTION . . . H 
OTHER DRUGS 
 ASPIRIN . . . . . . .  I 
ACETA- 
 MINOPHEN . . .  J 
 IBUPROFEN . . . K 
 OTHER X 
 
(SPECIFY) 
 DON'T KNOW . . . . .  Z 
ANTIMALARIAL DRUGS 
SP/FANSIDAR . . . A 
 CHLOROQUINE B 
 AMODIAQUINE C 
QUININE . . . . . . . D 
COMBINATION 
WITH 
 ARTEMISININ E 
OTHER ANTI- 
MALARIAL 




 PILL/SYRUP . . . G 
 INJECTION . . . H 
OTHER DRUGS 
 ASPIRIN . . . . . . .  I 
ACETA- 
 MINOPHEN . . .  J 
 IBUPROFEN . . . K 
 OTHER X 
 
(SPECIFY) 




 ANY CODE A-F CIRCLED? 
 YES NO 
 
(GO BACK TO 
 YES NO 
 
(GO BACK TO 
 YES NO 
 
(GO TO 503 IN 
  503 IN NEXT 503 IN NEXT NEXT-TO-LAST 
  
  COLUMN; OR,   COLUMN; OR,   COLUMN OF NEW 
  IF NO MORE IF NO MORE QUESTIONNAIRE; 
  BIRTHS, GO BIRTHS, GO OR, IF NO MORE 
   TO 553)  TO 553) BIRTHS, GO TO 553) 
540 CHECK 538: CODE 'A' CODE 'A' CODE 'A' CODE 'A'  CODE 'A' CODE 'A' 
(12)  CIRCLED NOT CIRCLED NOT  CIRCLED NOT 
 SP/FANSIDAR ('A') GIVEN 
 (SKIP TO  
CIRCLED 
542)  




(SKIP TO 542)  
541 
(12) 
How long after the fever started did 
(NAME) first take (SP/Fansidar)? SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 
DON'T KNOW . . .  8 
SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 
DON'T KNOW . . .  8 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 





LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
542 CHECK 538:  CODE 'B' CODE 'B'  CODE 'B' CODE 'B'  CODE 'B' CODE 'B' 
(12)   CIRCLED NOT  CIRCLED NOT  CIRCLED NOT 
 CHLOROQUINE ('B') GIVEN CIRCLED 
(SKIP TO 544)  
CIRCLED 
(SKIP TO 544)  
CIRCLED 
(SKIP TO 544)  
543 
(12) 
How long after the fever started did 
(NAME) first take chloroquine? 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 




AMODIAQUINE ('C') GIVEN 
 CODE 'C' CODE 'C' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 546)  
 CODE 'C' CODE 'C' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 546)  
 CODE 'C' CODE 'C' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 546)  
545 
(12) 
How long after the fever started did 
(NAME) first take amodiaquine? 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
FEVER . . . . . . . 
 2 THREE OR MORE 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
FEVER . . . . . . . 
 2 THREE OR MORE 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
FEVER . . . . . . .  2 
THREE OR MORE 
  DAYS AFTER DAYS AFTER DAYS AFTER 
   FEVER . . . . . . .  3  FEVER . . . . . . .  3  FEVER . . . . . . .  3 
   DON'T KNOW . . .  8  DON'T KNOW . . .  8  DON'T KNOW . . .  8 
546 CHECK 538:  CODE 'D' CODE 'D'  CODE 'D' CODE 'D'  CODE 'D' CODE 'D' 
(12)   CIRCLED NOT  CIRCLED NOT  CIRCLED NOT 
 QUININE ('D') GIVEN CIRCLED 
(SKIP TO 548)  
CIRCLED 
(SKIP TO 548)  
CIRCLED 
(SKIP TO 548)  
547 
(12) 
How long after the fever started did 
(NAME) first take quinine? 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
SAME DAY . . . . . . . 0 
NEXT DAY . . . . . . . 
 1 TWO DAYS 
AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 






COMBINATION WITH  
ARTEMISININ ('E') GIVEN 
 CODE 'E' CODE 'E' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 550)  
 CODE 'E' CODE 'E' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 550)  
 CODE 'E' CODE 'E' 
 CIRCLED NOT 
CIRCLED 
(SKIP TO 550)  
 
  
LAST BIRTH NEXT-TO-LAST BIRTH SECOND-FROM-LAST BIRTH 
NO. QUESTIONS AND FILTERS NAME ________________ NAME ________________ NAME _________________ 
549 
(12) 
How long after the fever started did 
(NAME) first take (COMBINATION 
WITH ARTEMISININ)? 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 




OTHER ANTIMALARIAL ('F') 
GIVEN 
 CODE 'F' CODE 'F' 





503 IN NEXT 
COLUMN; OR, 
IF NO MORE 
BIRTHS, GO TO 
553) 
 CODE 'F' CODE 'F' 





503 IN NEXT 
COLUMN; OR, 
IF NO MORE 
BIRTHS, GO TO 
553) 
 CODE 'F' CODE 'F' 





COLUMN OF NEW 
QUESTIONNAIRE; 
OR, IF NO MORE 




How long after the fever started did  
(NAME) first take (OTHER 
ANTIMALARIAL)? 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
SAME DAY . . . . . . . 
 0 NEXT DAY . 
. . . . . .  1 TWO 
DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . . 
 3 DON'T KNOW . 
. .  8 
 SAME DAY . . . . . . .  0 
NEXT DAY . . . . . . .  1 
TWO DAYS AFTER  
 FEVER . . . . . . .  2 
THREE OR MORE 
DAYS AFTER 
FEVER . . . . . . .  3 
DON'T KNOW . . .  8 
552  GO BACK TO 503 IN GO BACK TO 503 IN GO TO 503 IN  
  NEXT COLUMN; OR, IF NEXT COLUMN; OR, IF NEXT-TO-LAST  
  NO MORE BIRTHS, GO NO MORE BIRTHS, GO COLUMN OF NEW 
  TO 553. TO 553. QUESTIONNAIRE; OR, 
IF NO MORE BIRTHS, 
GO TO 553. 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
W-37 
 
553 CHECK 215 AND 218, ALL ROWS: 
NUMBER OF CHILDREN BORN IN 2005  (1) OR LATER LIVING WITH THE RESPONDENT 
ONE OR MORE NONE 556 
RECORD NAME OF YOUNGEST CHILD LIVING 
WITH HER AND CONTINUE WITH 554 
NAME ) ( 
554 CHILD USED TOILET OR LATRINE. . . 01 
PUT/RINSED 
INTO TOILET OR LATRINE. . . . . . . 02 
PUT/RINSED 
INTO DRAIN OR DITCH . . . . . . . . . 03 
THROWN INTO GARBAGE. . . . . . . . . 04 
. . . . . . . . . . . . . . . . . . . . . . . . 05 BURIED 
LEFT IN THE OPEN. . . . . . . . . . . . . . . . 06 
OTHER 96 
SPECIFY ) ( 
555 CHECK 522(a) AND 522(b), ALL COLUMNS: 
NO CHILD ANY CHILD 
RECEIVED FLUID RECEIVED FLUID 557 
FROM ORS PACKET OR FROM ORS PACKET OR 
PRE-PACKAGED ORS LIQUID  (14) PRE-PACKAGED ORS LIQUID  (14) 
556 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
The last time (NAME FROM 553) passed stools, what was done to  
dispose of the stools? 
Have you ever heard of a special product called [LOCAL NAME  
FOR ORS PACKET OR PRE-PACKAGED ORS LIQUID]  (14) you  
can get for the treatment of diarrhea? 
557 CHECK 215 AND 218, ALL ROWS: 
NUMBER OF CHILDREN BORN IN 2008  (15) OR LATER LIVING WITH THE RESPONDENT 
ONE OR MORE NONE 601 
RECORD NAME OF YOUNGEST CHILD LIVING 
WITH HER AND CONTINUE WITH 558 
( NAME ) 





a) a) 1 2 8 
b) b) 1 2 8 
c) c) 8 2 1 
d) d) 2 1 8 
NUMBER OF TIMES 
IF 7 OR MORE TIMES, RECORD '7'. DRANK MILK 
e) e) 2 1 8 
NUMBER OF TIMES 
IF 7 OR MORE TIMES, RECORD '7'. DRANK FORMULA 
f) f) 8 1 2 
g) g) 2 1 8 
NUMBER OF TIMES 
ATE YOGURT IF 7 OR MORE TIMES, RECORD '7'. 
h) h) 1 2 8 
i) i) 8 2 1 
Now I would like to ask you about liquids or foods that (NAME FROM 557) had yesterday during the day or at night. I  
am interested in whether your child had the item I mention even if it was combined with other foods.  (16) 
Infant formula? 
IF YES: How many times did (NAME) drink milk? 
IF YES: How many times did (NAME) drink infant formula? 
Milk such as tinned, powdered, or fresh animal milk? 
Plain water? 
Any other liquids? 
Yogurt? 
Any [BRAND NAME OF COMMERCIALLY FORTIFIED BABY FOOD, E.G.,  
Cerelac]?  (17) 
Bread, rice, noodles, porridge, or other foods made from grains?  (18) 
Juice or juice drinks? 
Did (NAME FROM 557) (drink/eat): 
Clear broth? 
IF YES: How many times did (NAME) eat yogurt? 
j) j) 1 2 8 
k) k) 1 2 8 
l) l) 2 8 1 
m) m) 1 2 8 
n) n) 8 2 1 
o) o) 8 2 1 
p) p) 1 2 8 
q) q) 1 2 8 
r) r) 1 2 8 
s) s) 8 2 1 
t) t) 8 2 1 
u) u) 2 8 1 
CHECK 558 (CATEGORIES "g" THROUGH "u"):   559 
AT LEAST ONE NOT A SINGLE 
561 "YES" "YES" 
Fresh or dried fish or shellfish? 
Eggs? 
White potatoes, white yams, manioc, cassava, or any other foods made from roots? 
Any dark green, leafy vegetables?  (20) 
Ripe mangoes, papayas or [INSERT ANY OTHER LOCALLY AVAILABLE  
VITAMIN A-RICH FRUITS]? 
Any other fruits or vegetables? 
Liver, kidney, heart or other organ meats? 
Any meat, such as beef, pork, lamb, goat, chicken, or duck? 
Pumpkin ,  carrots ,  squash   or   sweet   potatoes   that   are   yellow   or   orange   inside?   (19) 
Any other solid, semi-solid, or soft food? 
Any foods made from beans, peas, lentils, or nuts? 
Cheese or other food made from milk? 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
W-39 
 
560 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
( GO BACK TO 558 TO RECORD 
FOOD EATEN YESTERDAY) 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 601 
561 NUMBER OF 
TIMES. . . . . . . . . . . . . . . . . . . . . . . .  
IF 7 OR MORE TIMES, RECORD ‘7'. DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
Did (NAME) eat any solid, semi-solid, or soft foods yesterday during  
the day or at night? 
How many times did (NAME FROM 557) eat solid, semi-solid, or  
soft foods yesterday during the day or at night? 
IF ‘YES’ PROBE: What kind of solid, semi-solid or soft foods did  
( NAME) eat? 
 
W-40 
SECTION 5 FOOTNOTES 
(1) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2006 or 
2007, respectively. 
(2) To be developed locally since immunization practices may vary from country to country, as may the terms used 
for the written record and for the vaccinations. Add yellow fever, rubella, MMR, Hib (3 doses), and hepatitis B (3 
doses) in Q. 506 in countries where these vaccinations are listed on the vaccination card. 
(3) Filter should reflect the vaccination list in Q. 506. 
(4) To be developed locally since immunization practices may vary from country to country, as may the terms used 
for the vaccinations. Include question on pentavalent injection or injections for yellow fever, rubella, MMR, Hib, 
and Hepatitis B where these are included in Q. 506. 
(5) Adapt question locally after determining the most common injection site. 
(6) Delete this question in countries where Polio 0 is not part of the immunization schedule.  
(7) Adapt question locally, some countries do not give measles vaccination until 12-15 months of age. 
(8) The term(s) used for diarrhea should encompass the expressions used for all forms of diarrhea, including 
bloody stools (consistent with dysentery), watery stools, etc. 
(9) Coding categories to be developed locally and revised based on the pretest; however, the broad categories  
must be maintained. 
(10) Include in the question the common names/brands for pre-packaged ORS liquids. If pre-packaged ORS liquids 
are not available in the country, this item should be deleted. 
(11) This item should be adapted to include the terms used locally for the recommended home fluid. The ingredients 
promoted by the government for making the recommended home fluid should be reflected in the category. If the 
government does not recommend a homemade fluid, then the word "government" should be dropped from the 
question. 
(12) The question should be deleted in countries that are not affected by malaria. 
(13) Coding categories to be developed locally and revised based on the pretest. All antimalarials commonly used in 
the country should be included in the response categories. Common brand names of drugs, such as Bayer, 
Tylenol or Paracetamol, should be added to the response categories for aspirin, acetaminophen, or ibuprofen 
as appropriate. 
(14) Delete "OR PRE-PACKAGED ORS LIQUID" in countries where such liquid is not available. 
(15) Year of fieldwork is assumed to be 2010. For fieldwork beginning in 2011 or 2012, the year should be 2009 or 
2010, respectively. 
(16) A separate category: "Foods made with red palm oil, palm nut, or palm nut pulp sauce" must be added in 
countries where these items are consumed. A separate category: "Grubs, snails, insects or other small protein 
food" must be added in countries where these items are eaten.  Items in each food group should be modified to 
include only those foods that are locally available and/or consumed in the country.  Local terms should be used. 
(17) In the case of fortified foods, the interviewer should ask to see the package and/or brand label (if available), to 
confirm that the food is fortified. 
(18) Grains include millet, sorghum, maize, rice, wheat, or other local grains.  Start with local foods, e.g. ugali, 
nshima, fufu, chapati, then follow with bread, rice, noodles, etc. 
(19) Items in this category should be modified to include only vitamin A rich tubers, starches, or red, orange, or 
yellow vegetables that are consumed in the country. 
(20) These include cassava leaves, bean leaves, kale, spinach, pepper leaves, taro leaves, amaranth leaves, or 







NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
614 
615 
DAYS AGO. . . . . . . . . . . . 1 
IF LESS THAN 12 MONTHS, ANSWER MUST BE RECORDED 
. . . . . . . . . 2 WEEKS AGO IN DAYS, WEEKS OR MONTHS. 
IF 12 MONTHS (ONE YEAR) OR MORE, ANSWER MUST BE 
RECORDED IN YEARS. . . . . . . . 3 MONTHS AGO 
627 . . . . . . . . . 4 YEARS AGO 
Now I would like to ask you some questions about your recent sexual activity.  Let me assure you again that your answers are  
completely confidential and will not be told to anyone.  If we should come to any question that you don't want to answer, just let me  
know and we will go to the next question.    







NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
627 
In total, with how many different people have you had sexual 
intercourse in your lifetime? 
IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
IF NUMBER OF PARTNERS IS 95 OR MORE, WRITE 
'95'. 
NUMBER OF PARTNERS 
 IN LIFETIME . . . . . . . . . . . . . .  
 DON'T KNOW . . . . . . . . . . . . . . . . . .  98 
   
628 PRESENCE OF OTHERS DURING THIS SECTION 
 YES NO 
CHILDREN <10 . . . . . . . . . . . . 1 2 MALE 
ADULTS . . . . . . . . . . . . 1 2 FEMALE 
ADULTS . . . . . . . . . 1 2 
 
629 Do you know of a place where a person can get condoms? 
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
 632 
630 Where is that? (3) 
Any other place? 
PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, 
WRITE THE NAME OF THE PLACE. 
 
(NAME OF PLACE(S)) 
PUBLIC SECTOR 
GOVERNMENT HOSPITAL . . . . . . .  A 
GOVT. HEALTH CENTER . . . . . . .  B 
FAMILY PLANNING CLINIC . . . . . . . C 
 MOBILE CLINIC . . . . . . . . . . . . . . . . D 
 FIELDWORKER . . . . . . . . . . . . . . . . E 
OTHER PUBLIC 
 SECTOR F 
 
(SPECIFY) 
PRIVATE MEDICAL SECTOR 
 PRIVATE HOSPITAL/CLINIC . . . . . G 
 PHARMACY . . . . . . . . . . . . . . . . . . H 
PRIVATE DOCTOR . . . . . . . . . . . . . . I 
 MOBILE CLINIC . . . . . . . . . . . . . . . . J 
 FIELDWORKER . . . . . . . . . . . . . . . . K 
OTHER PRIVATE MEDICAL 




SHOP . . . . . . . . . . . . . . . . . . . . . . . . M 
CHURCH . . . . . . . . . . . . . . . . . . . . . . N 
FRIENDS/RELATIVES . . . . . . . . . . . . O 




631 If you wanted to, could you yourself get a condom? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 1 NO . . . . . . . . . . . . . . . . . . . . . . . 
. . . . .  2 




Do you know of a place where a person can get female condoms?  
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
 701 





Where is that? (3) 
Any other place? 
PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, 
WRITE THE NAME OF THE PLACE. 
 
(NAME OF PLACE(S)) 
PUBLIC SECTOR 
GOVERNMENT HOSPITAL . . . . . . .  A 
GOVT. HEALTH CENTER . . . . . . .  B 
FAMILY PLANNING CLINIC . . . . . . . C 
 MOBILE CLINIC . . . . . . . . . . . . . . . . D 
 FIELDWORKER . . . . . . . . . . . . . . . . E 
OTHER PUBLIC 
 SECTOR F 
 
(SPECIFY) 
PRIVATE MEDICAL SECTOR 
 PRIVATE HOSPITAL/CLINIC . . . . . G 
PHARMACY . . . . . . . . . . . . . . . . . . . . H 
PRIVATE DOCTOR . . . . . . . . . . . . . . I 
 MOBILE CLINIC . . . . . . . . . . . . . . . . J 
 FIELDWORKER . . . . . . . . . . . . . . . . K 
OTHER PRIVATE MEDICAL 




SHOP . . . . . . . . . . . . . . . . . . . . . . . . M 
CHURCH . . . . . . . . . . . . . . . . . . . . . . N 
FRIENDS/RELATIVES . . . . . . . . . . . . O 






If you wanted to, could you yourself get a female condom? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 NO
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 2 
 DON'T KNOW/UNSURE . . . . . . . . . . . . 8 
 
(1) The question should be deleted in countries where polygyny is not practiced. 
(2) In countries with an active female condom program, the wording of the question should be modified to 
include reference to both the male and female condom. 
(3) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 







NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
709 CHECK 704: . . . . . . . . . . . . . . . . . . A NOT MARRIED 
WANTS TO HAVE WANTS NO MORE/ FERTILITY-RELATED REASONS 
A/ANOTHER CHILD NONE . . . . . . . . . . . . . . B NOT HAVING SEX 
INFREQUENT SEX. . . . . . . . . . . . . . C 
MENOPAUSAL/HYSTERECTOMY D 
CAN'T GET PREGNANT. . . . . . . . .  E 
NOT MENSTRUATED SINCE 
LAST BIRTH . . . . . . . . . . . . . . . . F 
BREASTFEEDING . . . . . . . . . . . . . . G 
UP TO GOD/FATALISTI C H . . . . . . . . .  
OPPOSITION TO USE 
RESPONDENT OPPOSED. . . . . . .  I 
HUSBAND/PARTNER OPPOSE D . . .  J 
OTHERS OPPOSED . . . . . . . . . . . . K 
RELIGIOUS PROHIBITION. . . . . . .  L 
RECORD ALL REASONS MENTIONED. LACK OF KNOWLEDGE 
KNOWS NO METHOD. . . . . . . . . . . . M 
KNOWS NO SOURCE. . . . . . . . . . . . N 
METHOD-RELATED REASONS 
SIDE EFFECTS/HEALTH 
CONCERN S . . . . . . . . . . . . . . . . . . O 
LACK OF ACCESS/TOO FAR. . . . . P 
. . . . . . . . . . . . Q COSTS TOO MUCH 
PREFERRED METHOD 
NOT AVAILABLE. . . . . . . . . . . . . . R 
NO METHOD AVAILABLE S . . . . . . .  
INCONVENIENT TO USE T . . . . . . .  
INTERFERES WITH BODY'S 
Any other reason? 
You have said that you do not  
want any (more) children. 
Can you tell me why you are not  
using a method to prevent  
pregnancy? 
Any other reason? 
You have said that you do  
not want (a/another) child  
soon.  
Can you tell me why you are  
not using a method to  
prevent pregnancy? 
. . . . . . . U NORMAL PROCESSES 
X _______________________ OTHER 
) SPECIFY ( 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . Z 
710 CHECK 303: USING A CONTRACEPTIVE METHOD? 
NO, YES, NOT 
NOT CURRENTLY USING CURRENTLY USING 712 ASKED 
711 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
712 CHECK 216: 
NO LIVING CHILDREN HAS LIVING CHILDREN 
714 NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 
NUMBER. . . . . . . . . . . . . . . . . .  
96 _______________________ OTHER 714 
) SPECIFY ( 
PROBE FOR A NUMERIC RESPONSE. 
Do you think you will use a contraceptive method to delay or avoid  
pregnancy at any time in the future? 
If you could choose exactly the  
number of children to have in  
your whole life, how many would  
that be? 
If you could go back to the  
time you did not have any  
children and could choose  
exactly the number of children  
to have in your whole life, how  




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
713 BOYS GIRLS EITHER 
NUMBER 
96 _______________________ OTHER 
( SPECIFY ) 
714 YESNO 
2 RADIO. . . . . . . . . . . . . . . . . . . . . . 1 
TELEVISION 2 . . . . . . . . . . . . . . . . 1 
2 NEWSPAPER OR MAGAZINE. . . 1 
COUNTRY-SPECIFIC QUESTIONS ON MEDIA MESSAGES  715 
ABOUT FAMILY PLANNING. 
716 CHECK 601: 
YES, NO, YES, 
NOT IN 801 CURRENTLY LIVING 
UNION WITH A MAN MARRIED 
CHECK 303: USING A CONTRACEPTIVE METHOD? 717 
NOT 
CURRENTLY CURRENTLY 
USING USING 720 
OR NOT ASKED 
718 1 . . . . . . . . .  MAINLY RESPONDENT 
. . . . .  2 MAINLY HUSBAND/PARTNER 
. . . . . . . . . . . . . . . . 3 JOINT DECISION 
6 OTHER 
SPECIFY ( ) 
How many of these children would you like to be boys, how many  
would you like to be girls and for how many would it not matter if it’s  
a boy or a girl? 
In the last few months have you: 
Heard about family planning on the radio? 
Seen anything about family planning on the television? 
Read about family planning in a newspaper or magazine? 
Would you say that using contraception is mainly your decision,  
mainly your (husband's/partner's) decision, or did you both decide  
together? 
CHECK 304: 719 
NEITHER HE OR SHE 
STERILIZED STERILIZED 801 
720 SAME NUMBER. . . . . . . . . . . . . . . . . . 1 
. . . . . . . . . . . . . . . . 2 MORE CHILDREN 
FEWER CHILDREN. . . . . . . . . . . . . . . . 3 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
Does your (husband/partner) want the same number of children that  







NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
813 THROUGHOUT THE YEAR. . . . . . . . .  1 
SEASONALLY/PART OF THE YEAR 2 
ONCE IN A WHILE. . . . . . . . . . . . . . . . 3 
814 CASH ONLY . . . . . . . . . . . . . . . . . . . . 1 
CASH AND KIND. . . . . . . . . . . . . . . . . . 2 
IN KIND ONLY. . . . . . . . . . . . . . . . . . . . 3 
. . . . . . . . . . . . . . . . . . . . . . 4 NOT PAID 
815 CHECK 601: 
CURRENTLY 
MARRIED/LIVING NOT IN UNION 
WITH A MAN 823 
816 CHECK 814: 
CODE 1 OR 2 
CIRCLED OTHER 819 
817 RESPONDENT . . . . . . . . . . . . . . . . . . 1 
HUSBAND/PARTNER. . . . . . . . . . . . . . 2 
RESPONDENT AND 
3 HUSBAND/PARTNER JOINTLY . . .  
OTHER 6 
) SPECIFY ( 
818 MORE THAN HI M . . . . . . . . . . . . . . . . . . 1 
LESS THAN HIM. . . . . . . . . . . . . . . . . . 2 
ABOUT THE SAME. . . . . . . . . . . . . . . . 3 
HUSBAND/PARTNER HAS 
820 . . . . . . . . . . . . . . . . 4 NO EARNINGS 
Do you usually work throughout the year, or do you work seasonally,  
or only once in a while? 
Are you paid in cash or kind for this work or are you not paid at all? 
Who usually decides how the money you earn will be used: you,  
your (husband/partner), or you and your (husband/partner) jointly? 
Would you say that the money that you earn is more than what your  
husband/partner) earns, less than what he earns, or about the  ( 
same? 
DON'T   KNOW . . . . . . . . . . . . . . . . . . . .  8 
819 RESPONDENT . . . . . . . . . . . . . . . . . . 1 
HUSBAND/PARTNER. . . . . . . . . . . . . . 2 
RESPONDENT AND 
. . .  HUSBAND/PARTNER JOINTLY 3 
HUSBAND/PARTNER HAS 
  NO EARNINGS . . . . . . . . . . . . . . . . 4 
OTHER 6 
SPECIFY ) ( 
820 RESPONDENT . . . . . . . . . . . . . . . . . . 1 
HUSBAND/PARTNER. . . . . . . . . . . . . . 2 
RESPONDENT AND 
3 . . .  HUSBAND/PARTNER JOINTLY 
SOMEONE ELSE. . . . . . . . . . . . . . . . . . 4 
OTHER . . . . . . . . . . . . . . . . . . . . . . . . 6 
821 RESPONDENT . . . . . . . . . . . . . . . . . . 1 
HUSBAND/PARTNER. . . . . . . . . . . . . . 2 
RESPONDENT AND 
HUSBAND/PARTNER JOINTLY . . .  3 
SOMEONE ELSE. . . . . . . . . . . . . . . . . . 4 
. . . . . . . . . . . . . . . . . . . . . . . . 6 OTHER 
822 RESPONDENT . . . . . . . . . . . . . . . . . . 1 
HUSBAND/PARTNER. . . . . . . . . . . . . . 2 
RESPONDENT AND 
HUSBAND/PARTNER JOINTLY . . .  3 
SOMEONE ELSE. . . . . . . . . . . . . . . . . . 4 
OTHER . . . . . . . . . . . . . . . . . . . . . . . . 6 
Who usually makes decisions about health care for yourself: you,  
your (husband/partner), you and your (husband/partner) jointly, or  
someone else? 
Who usually makes decisions about making major household  
purchases? 
Who usually makes decisions about visits to your family or  
relatives? 
Who usually decides how your (husband's/partner's) earnings will be  
used: you, your (husband/partner), or you and your  
( husband/partner) jointly? 
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823 Do you own this or any other house either alone or jointly with 
someone else? ALONE ONLY . . . . . . . . . . . . . . . . . . . . 1 
JOINTLY ONLY . . . . . . . . . . . . . . . . . . 2 
BOTH ALONE AND JOINTLY . . . . . . .  3 DOES 
NOT OWN . . . . . . . . . . . . . . . . 4 
 
824 Do you own any land either alone or jointly with someone else? 
ALONE ONLY . . . . . . . . . . . . . . . . . . . . 1 
JOINTLY ONLY . . . . . . . . . . . . . . . . . . 2 
BOTH ALONE AND JOINTLY . . . . . . .  3 DOES 
NOT OWN . . . . . . . . . . . . . . . . 4 
 
825 PRESENCE OF OTHERS AT THIS POINT (PRESENT AND 




CHILDREN < 10 . . . . .  1 
HUSBAND . . . . . . . . . 
 1 OTHER MALES . . . . 
.  1 OTHER FEMALES















In your opinion, is a husband justified in hitting or beating his wife in 
the following situations: 
If she goes out without telling him? 
If she neglects the children? 
If she argues with him? 
If she refuses to have sex with him? 
If she burns the food? 
YES 
GOES OUT . . . . . . . . .  1 
NEGL. CHILDREN . . . 
 1 
ARGUES . . . . . . . . . . . . 1 
REFUSES SEX . . . . .  1 


















SECTION 9.  HIV/AIDS  
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
901 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 937 
902 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
903 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
904 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
905 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
906 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(1) 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
907 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
908 
YES NO DK 
DURING PREG. . . . . .  8 2 1 
Now I would like to talk about something else.  Have you ever heard  
of an illness called AIDS? 
Can people reduce their chance of getting the AIDS virus by having  
just one uninfected sex partner who has no other sex partners? 
Can people get the AIDS virus from mosquito bites? 
Can people reduce their chance of getting the AIDS virus by using a  
condom every time they have sex? 
Can people get the AIDS virus by sharing food with a person who  
has AIDS? 
Can people get the AIDS virus because of witchcraft or other  
supernatural means? 
Is it possible for a healthy-looking person to have the AIDS virus? 
Can the virus that causes AIDS be transmitted from a mother to her  
baby: 
During pregnancy? 
DURING   DELIVERY . . .  1 2 8 
2 . . .  1 BREASTFEEDING 8 
CHECK 908: 
909 AT LEAST  OTHER 
ONE 'YES' 911 
910 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
NO BIRTHS CHECK 208 AND 215: 911 
(2) 
LAST BIRTH BEFORE LAST BIRTH SINCE 
JANUARY 2008  (3 JANUARY 2008  ) (3) 926 
CHECK 408 FOR LAST BIRTH: 912 
(2) NO HAD  
ANTENATAL ANTENATAL  




(2) DK NO YES 
    
8 2 AIDS FROM MOTHER1 
1 8 2 THINGS TO DO 
1 8 TESTED FOR AIDS 2 
During   delivery? 
By breastfeeding? 
Are there any special drugs that a doctor or a nurse can give to a  
woman infected with the AIDS virus to reduce the risk of  
transmission to the baby? 
CHECK FOR PRESENCE OF OTHERS. BEFORE CONTINUING, MAKE EVERY EFFORT TO ENSURE PRIVACY.  
926 
Getting tested for the AIDS virus? 
During any of the antenatal visits for your last birth were you given  
any information about: 
Babies getting the AIDS virus from their mother? 
Things that you can do to prevent getting the AIDS virus? 
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915 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
916 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO 920 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
917 PUBLIC SECTOR 
(2) GOVERNMENT HOSPITAL. . . . . . . 11 
GOVT. HEALTH CENTER PROBE TO IDENTIFY THE TYPE OF SOURCE. . . . . . . . 12 
STAND-ALONE VCT CENTER . . . 13 
FAMILY PLANNING CLINIC. . . . . . . 14 
MOBILE CLINIC IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, . . . . . . . . . . . . . . . . 15 
WRITE THE NAME OF THE PLACE. FIELDWORKER . . . . . . . . . . . . . . . . 16 
SCHOOL BASED CLINIC. . . . . . . . . 17 
OTHER PUBLIC 
) 18 NAME OF PLACE ( SECTOR 
( SPECIFY ) 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR. . . . . . . . . . . . 21 
STAND-ALONE VCT CENTER . . . . .22 
PHARMAC Y . . . . . . . . . . . . . . . . . . . . 23 
MOBILE CLINIC . . . . . . . . . . . . . . . . 24 
FIELDWORKER . . . . . . . . . . . . . . . . 25 




SPECIFY ) ( 
OTHER SOURCE 
HOME. . . . . . . . . . . . . . . . . . . . . . . . 31 
CORRECTIONAL FACILITY. . . . . . . 32 
Were you offered a test for the AIDS virus as part of your antenatal  
care? 
I don't want to know the results, but were you tested for the AIDS  
virus as part of your antenatal care? 
Where was the test done? (4) 
OTHER 96 
) SPECIFY ( 
918 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 924 
919 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  924 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
CHECK 434 FOR LAST BIRTH: 920 
(2) ANY CODE  OTHER 926 
21-36 CIRCLED 
921 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(2) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
922 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) 926 NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
923 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
924 1 927 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
925 
(2) . . . . . . . . . . . .  MONTHS AGO 932 
. . . . . . . . . 95 TWO OR MORE YEARS 
I don't want to know the results, but did you get the results of the  
test? 
All women are supposed to receive counseling after being tested.  
After you were tested, did you receive counseling? 
Between the time you went for delivery but before the baby was  
born, were you offered a test for the AIDS virus? 
I don't want to know the results, but were you tested for the AIDS  
virus at that time? 
I don't want to know the results, but did you get the results of the  
test? 
Have you been tested for the AIDS virus since that time you were  
tested during your pregnancy? 
How many months ago was your most recent HIV test? 
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926 
I don't want to know the results, but have you ever been tested to 
see if you have the AIDS virus? 
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
 930 
927 How many months ago was your most recent HIV test? 
 MONTHS AGO . . . . . . . . . . . .  
 TWO OR MORE YEARS. . . . . . . . . 95 
   
928 
I don't want to know the results, but did you get the results of the 
test? 
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
 
929 Where was the test done? (4) 
PROBE TO IDENTIFY THE TYPE OF SOURCE. 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, 
WRITE THE NAME OF THE PLACE. 
 
(NAME OF PLACE) 
PUBLIC SECTOR 
GOVERNMENT HOSPITAL . . . . . . . 11 
 GOVT. HEALTH CENTER  . . . . . . . 12 
STAND-ALONE VCT CENTER . . . . . 13 
FAMILY PLANNING CLINIC . . . . . . . 14 
MOBILE CLINIC . . . . . . . . . . . . . . 
. . 15 FIELDWORKER . . . . . . . . . . . . . . 
. . 16 SCHOOL BASED CLINIC . . . . . . . . 
. 17 OTHER PUBLIC 
 SECTOR 18 
 
(SPECIFY) 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR . . . . . . . . . . . . 21 
STAND-ALONE VCT CENTER . . . . . 22 
PHARMACY . . . . . . . . . . . . . . . . . . . . 23 
MOBILE CLINIC . . . . . . . . . . . . . . . . 24 
FIELDWORKER . . . . . . . . . . . . . . . . 25 







HOME . . . . . . . . . . . . . . . . . . . . . . . . 31 
CORRECTIONAL FACILITY . . . . . . . 32 




  932 
 
930 Do you know of a place where people can go to get tested for the 
AIDS virus? 
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
931 PUBLIC SECTOR 
A GOVERNMENT HOSPITAL. . . . . . .  
B  . . . . . . . GOVT. HEALTH CENTER 
STAND-ALONE VCT CENTER. . . . . C 
FAMILY PLANNING CLINIC. . . . . . . D PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
MOBILE CLINIC . . . . . . . . . . . . . . . . E 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE . . . . . . . . . . . . . . . . F FIELDWORKER 
SECTOR, WRITE THE NAME OF THE PLACE. OTHER PUBLIC 
SECTOR G 
( SPECIFY ) 
PRIVATE MEDICAL SECTOR ( NAME OF PLACE(S )) 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR. . . . . . . . . . . . H 
I STAND-ALONE VCT CENTER. . . . .  
PHARMAC Y . . . . . . . . . . . . . . . . . . . . J 
MOBILE CLINIC . . . . . . . . . . . . . . . . K 




SPECIFY ( ) 
X OTHER 
SPECIFY ( ) 
932 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
933 YES, REMAIN A SECRET . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
Where is that?  (4) 
Any other place? 
Would you buy fresh vegetables from a shopkeeper or vendor if you  
knew that this person had the AIDS virus? 
If a member of your family got infected with the AIDS virus, would  
you want it to remain a secret or not?  
. . . . . . . . .  DK/NOT SURE/DEPENDS 8 
934 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
. . . . . . . . .  DK/NOT SURE/DEPENDS 8 
935 SHOULD BE ALLOWED. . . . . . . . . . . . 1 
SHOULD NOT BE ALLOWED. . . . . . .  2 
DK/NOT SURE/DEPENDS . . . . . . . . .  8 
936 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(2) 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 
DK/NOT SURE/DEPENDS 8 . . . . . . . . .  
CHECK 901: 937 
HEARD ABOUT NOT HEARD 
AIDS ABOUT AIDS 
YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CHECK 613: 938 
HAS HAD SEXUAL NEVER HAD SEXUAL 
INTERCOURSE INTERCOURSE 946 
Apart from AIDS, have  
you heard about other  
infections that can be  
transmitted through  
sexual contact? 
Have you heard about infections  
that can be transmitted through  
sexual contact? 
If a member of your family became sick with AIDS, would you be  
willing to care for her or him in your own household? 
In your opinion, if a female teacher has the AIDS virus but is not  
sick, should she be allowed to continue teaching in the school? 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
CHECK 937: HEARD ABOUT OTHER SEXUALLY TRANSMITTED INFECTIONS? 939 
941 NO YES 
940 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
941 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
942 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
943 CHECK 940, 941, AND 942: 
HAS NOT HAD AN HAS HAD AN 
INFECTION 946 INFECTION OR 
( ANY 'YES' ) DOES NOT KNOW 
944 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO 946 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
945 PUBLIC SECTOR 
A GOVERNMENT HOSPITAL. . . . . . .  
GOVT. HEALTH CENTER . . . . . . .  B 
STAND-ALONE VCT CENTER . . . C 
FAMILY PLANNING CLINIC. . . . . . . D PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
MOBILE CLINIC . . . . . . . . . . . . . . . . E 
Now I would like to ask you some questions about your health in the  
last 12 months. During the last 12 months, have you had a disease  
which you got through sexual contact? 
Sometimes women experience a bad-smelling abnormal genital  
discharge. 
During the last 12 months, have you had a bad-smelling abnormal  
genital discharge? 
Sometimes women have a genital sore or ulcer.  During the last 12  
months, have you had a genital sore or ulcer? 
The last time you had (PROBLEM FROM 940/941/942), did you  
seek any kind of advice or treatment? 
Where did you go?  (4) 
Any other place? 
IF   UNABLE   TO   DETERMINE   IF   PUBLIC   OR   PRIVATE FIELDWORKER . . . . . . . . . . . . . . . .  F 
SECTOR, WRITE THE NAME OF THE PLACE. OTHER PUBLIC 
SECTOR G 
) ( SPECIFY 
( NAME OF PLACE(S )) 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR. . . . . . . . . . . . H 
STAND-ALONE VCT CENTER I . . .  
. . . . . . . . . . . . . . . . . . J PHARMACY 
MOBILE CLINIC . . . . . . . . . . . . . . . . K 
. . . . . . . . . . . . . . . . L FIELDWORKER 
OTHER PRIVATE MEDICAL 
SECTOR M 
) SPECIFY ( 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . N 
OTHER X 
( SPECIFY ) 
946 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(2) NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
947 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
If a wife knows her husband has a disease that she can get during  
sexual intercourse, is she justified in asking that they use a condom  
when they have sex? 
Is a wife justified in refusing to have sex with her husband when she  
knows he has sex with other women?  (5) 
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(1) If Qs. 903, 905 and/or 906 do not apply to the local context, replace the question using a specific local      
misconception. At least two questions related to misconceptions are needed. 
(2) The question may be considered for deletion in countries with a very low HIV prevalence. 
(3) Year of fieldwork is assumed to be 2010. For fieldwork in 2011 or 2012, the year should be 2009 and 
2010,  respectively. 
(4) Coding categories to be developed locally and revised based on the pretest; however, the broad 
categories must be maintained. 
(5) In polygynous societies, the phrase 'other women' should be replaced by the phrase 'women other than 
his wives.' 
948 CHECK 601: 
(2) CURRENTLY MARRIED/ 
LIVING WITH A MAN NOT IN UNION 1001 
949 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DEPENDS/NOT SURE. . . . . . . . . . . . . . 8 
950 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(2) NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
DEPENDS/NOT SURE. . . . . . . . . . . . . . 8 
Could you ask your (husband/partner) to use a condom if you  
wanted him to? 





SECTION 10. OTHER HEALTH ISSUES 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
1001 
NUMBER OF INJECTIONS. . .  
IF NUMBER OF INJECTIONS IS 90 OR MORE,  NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 1004 
OR DAILY FOR 3 MONTHS OR MORE, RECORD '90'. 
IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
1002 
NUMBER OF INJECTIONS. . .  
IF NUMBER OF INJECTIONS IS 90 OR MORE,  
OR DAILY FOR 3 MONTHS OR MORE, RECORD '90'. NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 1004 
IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
1003 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
1004 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO 1006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
1005 NUMBER OF  
CIGARETTES. . . . . . . . . . . . . .  
1006 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
1008 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
1 7 . . . . . . . . . . . . . . . . . . . . . . . . . . A PIPE 
Now I would like to ask you some other questions relating to health  
matters.  Have you had an injection for any reason in the last 12  
months? 
IF YES: How many injections have you had? 
Among these injections, how many were administered by a doctor, a  
nurse, a pharmacist, a dentist, or any other health worker? 
The last time you got an injection from a health worker, did he/she  
take the syringe and needle from a new, unopened package? 
Do you currently smoke cigarettes? 
In the last 24 hours, how many cigarettes did you smoke? 
Do you currently smoke or use any (other) type of tobacco?  (1) 
00 
CHEWING TOBACCO. . . . . . . . . . . . . . B 
SNUFF RECORD ALL MENTIONED. . . . . . . . . . . . . . . . . . . . . . . . . C 
OTHER X 
) SPECIFY ( 
1008 
NOT A BIG BIG 
PROB- PROB- 
LEM LEM 
1 PERMISSION TO GO. . .  2 
1 . . . . .  GETTING MONEY 2 
. . . . . . . . . . . . 1 DISTANCE 2 
2 GO ALONE. . . . . . . . . . . . 1 
1009 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 NO 1011 
Not wanting to go alone? 
Are you covered by any health insurance?  (2) 
Getting money needed for advice or treatment? 
The distance to the health facility? 
Many different factors can prevent women from getting medical  
advice or treatment for themselves.  When you are sick and want to  
get medical advice or treatment, is each of the following a big  
problem or not? 
Getting permission to go to the doctor? 




(1) Add local terms. 
(2) If a health service prepayment plan or other types of plans are available in the country, add those types 
of plans to the question.  
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
1010 MUTUAL HEALTH ORGANIZATION/ 
COMMUNITY-BASED HEALTH 
. . . . . . . . . . . . . . . . . . A INSURANCE RECORD ALL MENTIONED. 
HEALTH INSURANCE THROUGH 
EMPLOYER . . . . . . . . . . . . . . . . . . . . B 
SOCIAL SECURITY . . . . . . . . . . . . . . . . C 
OTHER PRIVATELY PURCHASED  
COMMERCIAL HEALTH INSURANCE D 
X OTHER 
( SPECIFY ) 
RECORD THE TIME. 
HOUR . . . . . . . . . . . . . . . . . . . .  
MINUTES . . . . . . . . . . . . . . . . . .  




INTERVIEWER'S OBSERVATIONS TO BE FILLED 
IN AFTER COMPLETING INTERVIEW 



































INSTRUCTIONS: 1 2 
NAME OF EDITOR: DATE: 
 
W-62 
ONLY ONE CODE SHOULD APPEAR IN ANY BOX. 








Z DON'T KNOW 
* Year of fieldwork is assumed to be 2010. For fieldwork beginning 
in 2011 or 2012, the years should be adjusted. 
** Response categories may be added for other methods, including  
fertility awareness methods. 
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3 January 2012 
DEMOGRAPHIC AND HEALTH SURVEYS 
MODEL MAN'S QUESTIONNAIRE 
[NAME OF COUNTRY] 




 CLUSTER NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 HOUSEHOLD NUMBER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . .  
NAME AND LINE NUMBER OF MAN 
   

















 NEXT VISIT: DATE 





1 COMPLETED 4 REFUSED 
2 NOT AT HOME 5 PARTLY COMPLETED 7 OTHER 
3 POSTPONED 6 INCAPACITATED  
(SPECIFY) 
 COUNTRY-SPECIFIC INFORMATION: LANGUAGE OF QUESTIONNAIRE, LANGUAGE OF INTERVIEW, NATIVE 
LANGUAGE OF RESPONDENT, AND WHETHER TRANSLATOR USED 






















   
 
 (1) This section should be adapted for country-specific survey design. 
Note: Questions with blue highlighting in the question number column are HIV related questions that may be deleted 
in some circumstances (see footnotes). Questions with yellow highlighting in the question number column are other 
questions that may be deleted in some circumstances (see footnotes). 
SECTION 1.  RESPONDENT'S BACKGROUND 
INTRODUCTION AND CONSENT 
INFORMED CONSENT 
Hello.  My name is _______________________________________.  I am working with (NAME OF ORGANIZATION).  We are conducting a 
survey about health all over (NAME OF COUNTRY).  The information we collect will help the government  to plan health services.  Your 
household was selected for the survey.  The questions usually take about 20 minutes.  All of the answers you give will be confidential and will 
not be shared with anyone other than members of our survey team.  You don't have to be in the survey, but we hope you will agree to answer 
the questions since your views are important.  If I ask you any question you don't want to answer, just let me know and I will go on to the next 
question or you can stop the interview at any time. 
In case you need more information about the survey, you may contact the person listed on the card that has already been given to your 
household. 
Do you have any questions? May I begin the interview now? 
 SIGNATURE OF INTERVIEWER:  DATE: 
 RESPONDENT AGREES TO BE INTERVIEWED . . . . .  RESPONDENT DOES NOT AGREE TO BE INTERVIEWED . . .  END 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
101 RECORD THE TIME. 
HOUR . . . . . . . . . . . . . . . . . . . .  




102 In what month and year were you born? 
 MONTH . . . . . . . . . . . . . . . . . .  
 DON'T KNOW MONTH . . . . . . . . . 
. . . 98 
YEAR . . . . . . . . . . . .  
 DON'T KNOW YEAR . . . . . . . . . . . . 9998 
  





How old were you at your last birthday? 
COMPARE AND CORRECT 102 AND/OR 103 IF INCONSISTENT. 
AGE IN COMPLETED YEARS 
   
104 Have you ever attended school? 
 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2  
108 
105 What is the highest level of school you attended: primary, 
secondary, or higher? (1) PRIMARY . . . . . . . . . . . . . . . . . . . . . . 
1 SECONDARY . . . . . . . . . . . . . . . . . . . . 2 
HIGHER . . . . . . . . . . . . . . . . . . . . . . . . 3 
 
106 
What is the highest (grade/form/year) you completed at that level?  
(1) 
IF COMPLETED LESS THAN ONE YEAR AT THAT LEVEL, 
RECORD '00'. 




(1) Revise according to the local education system. 
(2) Each card should have four simple sentences appropriate to the country (e.g., "Parents love their 
children.", "Farming is hard work.", "The child is reading a book.", "Children work hard at school.").  Cards 
should be prepared for every language in which respondents are likely to be literate. 
(3) The question may be considered for deletion in countries with a very low HIV prevalence. 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
107 CHECK 105: 
PRIMARY SECONDARY 
OR HIGHER 110 
108 . . . . . . . . . . . . 1 CANNOT READ AT ALL 
ABLE TO READ ONLY PARTS OF 
SHOW CARD TO RESPONDENT.  (2) SENTENCE. . . . . . . . . . . . . . . . . . . . 2 
3 ABLE TO READ WHOLE SENTENCE 
IF RESPONDENT CANNOT READ WHOLE SENTENCE, PROBE: NO CARD WITH REQUIRED 
LANGUAGE 4 
) SPECIFY LANGUAGE ( 
5 . . . . . . .  BLIND/VISUALLY IMPAIRED 
CHECK 108: 109 
CODE '1' OR '5' CODE '2', '3' 
OR '4' CIRCLED 111 
CIRCLED 
110 AT LEAST ONCE A WEEK. . . . . . . . .  1 
. . . . . . .  LESS THAN ONCE A WEEK 2 
NOT AT ALL . . . . . . . . . . . . . . . . . . . . 3 
111 AT LEAST ONCE A WEEK. . . . . . . . .  1 
LESS THAN ONCE A WEEK 2 . . . . . . .  
NOT AT ALL . . . . . . . . . . . . . . . . . . . . 3 
112 1 AT LEAST ONCE A WEEK. . . . . . . . .  
LESS THAN ONCE A WEEK . . . . . . .  2 
. . . . . . . . . . . . . . . . . . . . 3 NOT AT ALL 
Do you watch television, at least once a week, less than once a  
week or not at all? 
Now I would like you to read this sentence to me. 
Can you read any part of the sentence to me? 
Do you read a newspaper or magazine, at least once a week, less  
than once a week or not at all? 
Do you listen to the radio, at least once a week, less than once a  
week or not at all? 
113 COUNTRY - SPECIFIC   QUESTION   ON   RELIGION , 
IF APPROPRIATE. 
COUNTRY-SPECIFIC QUESTION ON ETHNICITY, 114 
IF APPROPRIATE. 
115 
(3) NUMBER OF TIMES . . . . . . .  
NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 201 
116 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
In the last 12 months, how many times have you been away from  
home for one or more nights? 
In the last 12 months, have you been away from home for more  







NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
215 CHECK 214:  
( YOUNGEST) CHILD OTHER 
IS AGE 0-2 YEARS 
216 
WRITE NAME OF (YOUNGEST) CHILD 
( ) NAME OF (YOUNGEST) CHILD 
217 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . 8 219 DON'T KNOW 
218 PRESENT . . . . . . . . . . . . . . . . . . . . . . 1 
NOT PRESENT . . . . . . . . . . . . . . . . . . 2 
219 HOSPITAL/HEALTH FACILITY . . . . .  1 
OTHER . . . . . . . . . . . . . . . . . . . . . . . . 2 
220 MORE THAN USUAL . . . . . . . . . . . . . . 1 
ABOUT THE SAME   . . . . . . . . . . . . . . 2 
LESS THAN USUAL   . . . . . . . . . . . . . . 3 
. . . . . . . . . . . . . . 4 NOTHING TO DRINK 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
When (NAME)'s mother was pregnant with (NAME), did she have  
any antenatal check-ups? 
301 
Was (NAME) born in a hospital or health facility? 
When a child has diarrhea, how much should he or she be given to  
drink: more than usual, about the same as usual, less than usual, or  
nothing to drink at all? 
Were you ever present during any of those antenatal check-ups? 
What is the name of your (youngest) child? 
 
M-7 
SECTION 3.  CONTRACEPTION 
301 
Now I would like to talk about family planning - the various ways or methods that a couple can use to delay or avoid a pregnancy. 
Have you ever heard of (METHOD)? (1) 
01 Female Sterilization. PROBE: Women can have an operation to 
avoid having any more children. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




02 Male Sterilization. PROBE: Men can have an operation to avoid 
having any more children. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




03 IUD. PROBE: Women can have a loop or coil placed inside them by a 
doctor or a nurse.  
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO





Injectables. PROBE: Women can have an injection by a health 
provider that stops them from becoming pregnant for one or more 
months. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO





Implants. PROBE: Women can have one or more small rods placed 
in their upper arm by a doctor or nurse which can prevent pregnancy 
for one or more years. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




06 Pill. PROBE: Women can take a pill every day to avoid becoming 
pregnant.  
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




07 Condom. PROBE: Men can put a rubber sheath on their penis before 
sexual intercourse. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




08 Female Condom. PROBE: Women can place a sheath in their 
vagina before sexual intercourse. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO






Lactational Amenorrhea Method (LAM). (2) YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO





Rhythm Method. PROBE: To avoid pregnancy, women do not have 
sexual intercourse on the days of the month they think they can get 
pregnant. 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




11 Withdrawal. PROBE: Men can be careful and pull out before climax. YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO




12 Emergency Contraception. PROBE: As an emergency measure, 
within three days after they have unprotected sexual intercourse, 
women can take special pills to prevent pregnancy. (3) 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . NO






13 Have you heard of any other ways or methods that women or men 












NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
302 YES NO 
2 RADIO. . . . . . . . . . . . . . . . . . . . 1 
TELEVISION  2 . . . . . . . . . . . . . . 1 
1 2 NEWSPAPER OR MAGAZINE 
303 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
304 
1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 306 
305 JUST BEFORE HER  
. . . . . . . . . . . . . . 1 PERIOD BEGINS 
DURING HER PERIOD . . . . . . . . . . . . 2 
RIGHT AFTER HER  
PERIOD HAS ENDED. . . . . . . . . . . . 3 
HALFWAY BETWEEN  
TWO PERIODS  . . . . . . . . . . . . . . 4 
OTHER 6 
) SPECIFY ( 




8 2 1   WOMAN'S BUSINESS 
b) WOMEN MAY BECOME 
   PROMISCUOUS 1 2 8 
307 CHECK 301 (07): KNOWS MALE CONDOM  
I will now read you some statements about contraception. Please tell  
me if you agree or disagree with each one. 
Contraception is a woman’s business and a man should not  
have to worry about it. 
Women who use contraception may become promiscuous. 
From one menstrual period to the next, are there certain days when  
a woman is more likely to become pregnant when she has sexual  
relations? 
Now I would like to ask you about a woman's risk of pregnancy. 
In the last few months have you: 
Heard about family planning on the radio? 
In the last few months, have you discussed family planning with a  
health worker or health professional? 
Is this time just before her period begins, during her period, right  
after her period has ended, or halfway between two periods? 
Seen anything about family planning on the television? 
Read about family planning in a newspaper or magazine? 
YES NO 311 
308 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO 311 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
309 PUBLIC SECTOR 
GOVERNMENT HOSPITAL. . . . . . .  A 
GOVT. HEALTH CENTER . . . . . . .  B 
C FAMILY PLANNING CLINIC. . . . . . .  
PROBE TO IDENTIFY EACH TYPE OF SOURCE. . . . . . . . . . . . . . . . . D MOBILE CLINIC 
FIELDWORKER . . . . . . . . . . . . . . . . E 
OTHER PUBLIC IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, 
WRITE THE NAME OF THE PLACE. SECTOR F 
( ) SPECIFY 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC . . . . . G 
PHARMACY . . . . . . . . . . . . . . . . . . H 
( NAME OF PLACE(S )) PRIVATE DOCTOR. . . . . . . . . . . . . . I 
. . . . . . . . . . . . . . . . J MOBILE CLINIC 
. . . . . . . . . . . . . . . . K FIELDWORKER 
OTHER PRIVATE MEDICAL 
SECTOR L 
( SPECIFY ) 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . M 
CHURCH. . . . . . . . . . . . . . . . . . . . . . N 
FRIENDS/RELATIVES. . . . . . . . . . . . O 
OTHER X 
( SPECIFY ) 
Do you know of a place where a person can get condoms? 
Where is that?  (4) 




(1) If Standard Days Method is commonly used, it may be added to the table before Lactational Amenorrhea. 
"Standard Days Method (use local term, such as CycleBeads™ , as appropriate) PROBE: A woman uses a 
string of colored beads to know the days she can get pregnant. On the days she can get pregnant, she uses a 
condom or does not have sexual intercourse."  
(2) The LAM method should be deleted in countries that do not have a LAM program. In these countries, LAM 
should also be deleted as a coding category in Q. 439. A description of LAM should not be provided in Q. 301. 
(3) Studies have indicated emergency contraception can be effective up to five days. Verify country program 
recommendations and modify wording if appropriate. 
(4) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 
(5) The question should be deleted in countries where female condoms are not actively promoted. 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
310 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CHECK 301 (08): KNOWS FEMALE CONDOM  311 
(5) 
YES NO 401 
312 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(5) 401 NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
313 PUBLIC SECTOR 
(5) GOVERNMENT HOSPITAL. . . . . . .  A 
B GOVT. HEALTH CENTER . . . . . . .  
C FAMILY PLANNING CLINIC. . . . . . .  
PROBE TO IDENTIFY EACH TYPE OF SOURCE. MOBILE CLINIC . . . . . . . . . . . . . . . . D 
FIELDWORKER . . . . . . . . . . . . . . . . E 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE OTHER PUBLIC 
SECTOR, WRITE THE NAME OF THE PLACE. SECTOR F 
) SPECIFY ( 
PRIVATE MEDICAL SECTOR 
( NAME OF PLACE(S )) PRIVATE HOSPITAL/CLINIC . . . . . G 
PHARMACY. . . . . . . . . . . . . . . . . . . . H 
PRIVATE DOCTOR. . . . . . . . . . . . . . I 
MOBILE CLINIC . . . . . . . . . . . . . . . . J 
. . . . . . . . . . . . . . . . K FIELDWORKER 
OTHER PRIVATE MEDICAL 
SECTOR L 
) SPECIFY ( 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . M 
CHURCH. . . . . . . . . . . . . . . . . . . . . . N 
Any other place? 
If you wanted to, could you yourself get a condom? 
Do you know of a place where a person can get female condoms?  
Where is that?  (4) 
FRIEND/RELATIVE . . . . . . . . . . . .  O 
OTHER X 
( SPECIFY ) 
314 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 















417 When was the last time you had 
sexual intercourse with this person? 
 DAYS 
 AGO 1 
WEEKS 
 AGO 2 
MONTHS 





 AGO 1 
WEEKS 
 AGO 2 
MONTHS 





The last time you had sexual 
intercourse (with this second/third 
person), was a condom used? (2) 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 420)  
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 420)  
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 420)  
419 Was a condom used every time you 
had sexual intercourse with this 
person in the last 12 months? 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
YES . . . . . . . . . . . . . . 1 
 NO . . . . . . . . . . . . . . 2 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
411 
MONTH . . . . . . . . . . . . . . . . . .  
411 A 
. . . . . . . . . . . . 98 DON'T KNOW MONTH 
YEAR. . . . . . . . . . . .  
. . . . . . . . . . . . 9998 DON'T KNOW YEAR 
412 
AGE . . . . . . . . . . . . . . . . . . . .  
CHECK FOR THE PRESENCE OF OTHERS. 413 
BEFORE CONTINUING, MAKE EVERY EFFORT TO ENSURE PRIVACY. 
414 NEVER HAD SEXUAL 
INTERCOURSE . . . . . . . . . . . . . . . .00 501 
. . . . . . . . . . . .  AGE IN YEARS 
FIRST TIME WHEN STARTED 
LIVING WITH (FIRST) 
WIFE/PARTNER. . . . . . . . . . . . . . . . 95 
415 Now I would like to ask you some questions about your recent sexual activity.  Let me assure you again that your answers are  
completely confidential and will not be told to anyone.  If we should come to any question that you don't want to answer, just let me  
know and we will go to the next question. 
In what month and year did you start living with your (wife/partner)? 
Now I would like to ask about your first (wife/partner).  In what  
month and year did you start living with her? 
How old were you when you first started living with her? 
Now I would like to ask some questions about sexual activity in  
order to gain a better understanding of some important life issues. 




DAYS AGO. . . . . . . . . . . . 1 
IF LESS THAN 12 MONTHS, ANSWER MUST BE RECORDED 
IN DAYS, WEEKS OR MONTHS. . . . . . . . . . 2 WEEKS AGO 
IF 12 MONTHS (ONE YEAR) OR MORE, ANSWER MUST BE 
RECORDED IN YEARS. MONTHS AGO . . . . . . . 3 
430 YEARS AGO . . . . . . . . . 4 




What was your relationship to this 
person with whom you had sexual 
intercourse? (3) 
IF GIRLFRIEND: 
Were you living together as if 
married? 
IF YES, CIRCLE '2'. 
IF NO, CIRCLE '3'. 
WIFE . . . . . . . . . . . . . . 1 
LIVE-IN PARTNER . . . . 2 
GIRLFRIEND NOT  
LIVING WITH  
 RESPONDENT. . . . 3 
CASUAL  
ACQUAINTANCE . . .  
CLIENT/PROSTITUTE 
OTHER ______________ 6 
(SPECIFY) 
(SKIP TO 423) 
WIFE . . . . . . . . . . . . . . 1 
LIVE-IN PARTNER . . . . 2 
GIRLFRIEND NOT  
LIVING WITH  
 RESPONDENT. . . . 3 
CASUAL  
ACQUAINTANCE . . .  
CLIENT/PROSTITUTE 
OTHER ______________ 6 
(SPECIFY) 
(SKIP TO 423) 
WIFE . . . . . . . . . . . . . . 1 
LIVE-IN PARTNER . . . . 2 
GIRLFRIEND NOT  
LIVING WITH  
 RESPONDENT. . . . 3 
CASUAL  
ACQUAINTANCE . . .  
CLIENT/PROSTITUTE 
OTHER ______________ 6 
(SPECIFY) 
(SKIP TO 423) 
421 CHECK 410:  MARRIED  MARRIED 
ONLY MORE ONCE 
THAN  
 MARRIED  MARRIED 
ONLY MORE ONCE 
THAN  
 MARRIED  MARRIED 
ONLY MORE ONCE 
THAN  






  (SKIP (SKIP (SKIP 
  TO 423) TO 423) TO 423) 
422 CHECK 414: FIRST TIME FIRST TIME FIRST TIME 
  WHEN STARTED WHEN STARTED WHEN STARTED 
   LIVING WITH OTHER  LIVING WITH OTHER  LIVING WITH OTHER 
   FIRST    FIRST    FIRST   
  
 WIFE   WIFE   WIFE  
  (SKIP TO 424) (SKIP TO 424) (SKIP TO 424) 
423 How long ago did you first have 
sexual intercourse with this 
(second/third) person? 
DAYS 
 AGO 1 
WEEKS 
 AGO 2 
MONTHS 
 AGO 3 
YEARS 






 AGO 1 
WEEKS 
 AGO 2 
MONTHS 
 AGO 3 
YEARS 






 AGO 1 
WEEKS 
 AGO 2 
MONTHS 
 AGO 3 
YEARS 






How many times during the last 12 
months did you have sexual 
intercourse with this person? 
IF NON-NUMERIC ANSWER, 
PROBE TO GET AN ESTIMATE. 
IF NUMBER OF TIMES IS  
95 OR MORE, WRITE '95'. 
NUMBER OF 
TIMES 
  NUMBER OF 
TIMES 











425 How old is this person? 
AGE OF 
PARTNER 


















426 Apart from (this person/these two 
people), have you had sexual 
intercourse with any other person in 
the last 12 months? 
YES . . . . . . . . . . . . . . 1 
(GO BACK TO 417 
IN NEXT COLUMN) 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 428) 
YES . . . . . . . . . . . . . . 1 
(GO BACK TO 417 
IN NEXT COLUMN) 
 NO . . . . . . . . . . . . . . 2 
(SKIP TO 428) 
 
427 
In total, with how many different 
people have you had sexual 
intercourse in the last 12 months?  
IF NON-NUMERIC ANSWER, 
PROBE TO GET AN ESTIMATE. 
IF NUMBER OF PARTNERS IS 95 
OR MORE, WRITE '95'. 
    NUMBER OF 
PARTNERS 
LAST 12 
MONTHS . . .  






NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
CHECK 420 (ALL COLUMNS):  428 
AT LEAST ONE PARTNER  NO PARTNERS 
IS PROSTITUTE ARE PROSTITUTES 430 
429 CHECK 420 AND 418 (ALL COLUMNS):  
CONDOM USED WITH 433 
EVERY PROSTITUTE 
OTHER 
430 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  432 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
431 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
434 NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
432 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 434 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
433 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW . . . . . . . . . . . . . . . . . . 8 
434 NUMBER OF PARTNERS 
. . . . . . . . . . . . . .  IN LIFETIME 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 98 IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
IF NUMBER OF PARTNERS IS 95 OR MORE, 
WRITE '95'. 
In total, with how many different people have you had sexual  
intercourse in your lifetime? 
434 
In the last 12 months, did you pay anyone in exchange for having  
sexual intercourse? 
Have you ever paid anyone in exchange for having sexual  
intercourse? 
The last time you paid someone in exchange for having sexual  
intercourse, was a condom used?  (2) 
Was a condom used during sexual intercourse every time you paid  
someone in exchange for having sexual intercourse in the last 12  
months? 




NO CONDOM CONDOM  
438 USED USED 
436 . . . . . . . . . . . . . . . . . . . . . . 01 BRAND A 
(2) . . . . . . . . . . . . . . . . . . . . . . 02 BRAND B 
. . . . . . . . . . . . . . . . . . . . . . 03 BRAND C 
OTHER 96 
IF BRAND NOT KNOWN, ASK TO SEE THE PACKAGE. ( SPECIFY ) 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 98 
You told me that a condom was used the last time you had sex.   




(1) Delete Qs. 405-409 in countries where polygyny is not practiced and replace with Q. 605 from the Woman's 
Questionnaire with the word 'HUSBAND'S' replaced with 'WIFE'S' and 'HE' replaced with 'SHE'. 
(2) In countries with an active female condom program, the wording of the question should be modified to 
include reference to both the male and female condom. 
(3) High polygyny high HIV prevalence countries may want to add line number of wife from Q. 407 here in the 
response category. 
(4) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 
(5) The LAM method coding category should be deleted in countries that do not have a LAM program. 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
437 PUBLIC SECTOR 
(2) GOVERNMENT HOSPITAL. . . . . . . 11 
. . . . . . . 12 PROBE TO IDENTIFY TYPE OF SOURCE. GOVT. HEALTH CENTER 
FAMILY PLANNING CLINIC. . . . . . . 13 
. . . . . . . . . . . . . . . . 14 MOBILE CLINIC IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE  
SECTOR, WRITE THE NAME OF THE PLACE. . . . . . . . . . . . . . . . . 15 FIELDWORKER 
OTHER PUBLIC 
SECTOR 16 
( SPECIFY ) 
PRIVATE MEDICAL SECTOR ) NAME OF PLACE ( 
. . . . . 21 PRIVATE HOSPITAL/CLINIC 
. . . . . . . . . . . . . . . . . . 22 PHARMACY 
PRIVATE DOCTOR. . . . . . . . . . . . . . 23 
. . . . . . . . . . . . . . . . 24 MOBILE CLINIC 
FIELDWORKER . . . . . . . . . . . . . . . . 25 
OTHER PRIVATE MEDICAL 
SECTOR 26 
( SPECIFY ) 
OTHER SOURCE 
SHOP. . . . . . . . . . . . . . . . . . . . . . . . 31 
. . . . . . . . . . . . . . . . . . . . 32 CHURCH 
FRIEND/RELATIVE. . . . . . . . . . . . . . 33 
OTHER 96 
SPECIFY ) ( 
438 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
. . . . . . . . . . . . . . . . . . 8 501 DON'T KNOW 
From where did you obtain the condom the last time?  (4) 
The last time you had sex did you or your partner use any method  
( other than a condom) to avoid or prevent a pregnancy? 
439 . . . . . . . . .  A FEMALE STERILIZATION 
(5) MALE STERILIZATION . . . . . . . . . . . . B 
IUD. . . . . . . . . . . . . . . . . . . . . . . . . . . . C 
PROBE: INJECTABLES . . . . . . . . . . . . . . . . . . D 
. . . . . . . . . . . . . . . . . . . . . . E IMPLANTS 
PILL. . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
FEMALE CONDOM . . . . . . . . . . . . . . G 
DIAPHRAGM . . . . . . . . . . . . . . . . . . . . H RECORD ALL MENTIONED. 
FOAM/JELLY . . . . . . . . . . . . . . . . . . . . I 
LAM. . . . . . . . . . . . . . . . . . . . . . . . . . . . J 
RHYTHM METHOD. . . . . . . . . . . . . . . . K 
WITHDRAWAL . . . . . . . . . . . . . . . . . . L 
OTHER MODERN METHOD . . . . . . .  X 
OTHER TRADITIONAL METHOD. . . . . Y 
What method did you or your partner use? 








(1) The wording of this question should be modified in countries where polygyny is not practiced. 
In Q. 503, change question to 'Is your (wife/partner) currently pregnant?' 
In Q. 504, change '(child/children)' to '(child)' and change '(wife/(wives)/partner(s))' to 
'(wife/partner)'. In Q. 505, change response category 4 from 'WIFE (WIVES)/PARTNER(S) 
STERILIZED' to 'WIFE/PARTNER STERILIZED'. 
(2) This question should be deleted in countries where polygyny is not practiced.  
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
509 CHECK 203 AND 205: 
HAS LIVING CHILDREN NO LIVING CHILDREN 
NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 601 
NUMBER. . . . . . . . . . . . . . . . . .  
96 601 _______________________ OTHER 
( SPECIFY ) 
PROBE FOR A NUMERIC RESPONSE. 
510 EITHER GIRLS BOYS 
NUMBER 
OTHER _______________________ 96 
( SPECIFY ) 
How many of these children would you like to be boys, how many  
would you like to be girls and for how many would it not matter if it’s  
a boy or a girl? 
If you could go back to the  
time you did not have any  
children and could choose  
exactly the number of children  
to have in your whole life, how  
many would that be? 
If you could choose exactly the  
number of children to have in  








NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
612 Do you own this or any other house either alone or jointly with 
someone else? ALONE ONLY . . . . . . . . . . . . . . . . . . . . 1 
JOINTLY ONLY . . . . . . . . . . . . . . . . . . 2 
 BOTH ALONE AND JOINTLY . . . . .  3 
 DOES NOT OWN . . . . . . . . . . . . . . . . 4 
 
613 Do you own any land either alone or jointly with someone else? 
ALONE ONLY . . . . . . . . . . . . . . . . . . . . 1 
JOINTLY ONLY . . . . . . . . . . . . . . . . . . 2 
 BOTH ALONE AND JOINTLY . . . . .  3 
 DOES NOT OWN . . . . . . . . . . . . . . . . 4 
 
614 
In your opinion, is a husband justified in hitting or beating his wife in 
the following situations: 
If she goes out without telling him? 
If she neglects the children? 
If she argues with him? 
If she refuses to have sex with him? 
If she burns the food? 
 YES NO DK 
GOES OUT . . . . . . . . . 1 2 8 NEGL. CHILDREN 
. . . 1 2 8 
 ARGUES . . . . . . . . . . . . 1 2 8 
REFUSES SEX . . . . .  1 2
 8 BURNS FOOD . . . . . . .  1






SECTION 7.  HIV/AIDS  
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
701 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
723 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
702 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
703 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
704 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
705 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(1) NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
706 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
707 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
2 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
708 
DK NO YES 
8 2 DURING PREG. . . . . .  1 
Now I would like to talk about something else. Have you ever heard  
of an illness called AIDS? 
Can people reduce their chance of getting the AIDS virus by having  
just one uninfected sex partner who has no other sex partners? 
Can people reduce their chance of getting the AIDS virus by using a  
condom every time they have sex? 
Can people get the AIDS virus by sharing food with a person who  
has AIDS? 
Can people get the AIDS virus because of witchcraft or other  
supernatural means? 
Can people get the AIDS virus from mosquito bites? 
Is it possible for a healthy-looking person to have the AIDS virus? 
During pregnancy? 
D rin   liv r ? 
Can the virus that causes AIDS be transmitted from a mother to her  
baby: 
DURING   DELIVERY .   .   .   1 2 8 
1 2 8 . . .  BREASTFEEDING 
709 CHECK 708: 
OTHER AT LEAST  
ONE 'YES' 711 
710 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
711 
712 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
716 NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
713 
. . . . . . . . . . . .  MONTHS AGO 
. . . . . . . . . 95 TWO OR MORE YEARS 
714 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CHECK FOR PRESENCE OF OTHERS. BEFORE CONTINUING, MAKE EVERY EFFORT TO ENSURE PRIVACY.  
How many months ago was your most recent HIV test? 
I don't want to know the results, but have you ever been tested to  
see if you have the AIDS virus? 
I don't want to know the results, but did you get the results of the  
test? 
gde u ey 
By breastfeeding? 
Are there any special drugs that a doctor or a nurse can give to a  
woman infected with the AIDS virus to reduce the risk of  




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
715 PUBLIC SECTOR 
GOVERNMENT HOSPITAL . . . . . . . 11 
 . . . . . . . 12 GOVT. HEALTH CENTER PROBE TO IDENTIFY THE TYPE OF SOURCE. 
STAND-ALONE VCT CENTER . . . 13 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, FAMILY PLANNING CLINIC . . . . . . . 14 
WRITE THE NAME OF THE PLACE. . . . . . . . . . . . . . . . . 15 MOBILE CLINIC 
. . . . . . . . . . . . . . . . 16 FIELDWORKER 
SCHOOL BASED CLINIC . . . . . . . . . 17 
OTHER PUBLIC 
SECTOR 18 
) SPECIFY ( ) NAME OF PLACE ( 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR . . . . . . . . . . . . 21 
STAND-ALONE VCT CENTER . . . 22 
PHARMAC Y . . . . . . . . . . . . . . . . . . . . 23 
MOBILE CLINIC . . . . . . . . . . . . . . . . 24 
. . . . . . . . . . . . . . . . 25 FIELDWORKER 
SCHOOL BASED CLINIC . . . . . . . . . 26 
OTHER PRIVATE MEDICAL 
27 SECTOR 
) SPECIFY ( 
OTHER SOURCE 
HOME . . . . . . . . . . . . . . . . . . . . . . . . 31 
CORRECTIONAL FACILITY . . . . . . . 32 
96 OTHER 
( SPECIFY ) 
716 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
718 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 NO 
Where was the test done?  (3) 
Do you know of a place where people can go to get tested for the  
AIDS virus? 
718 
717 PUBLIC SECTOR 
A GOVERNMENT HOSPITAL . . . . . . .  
B  . . . . . . . GOVT. HEALTH CENTER 
STAND-ALONE VCT CENTER . . . C 
FAMILY PLANNING CLINIC . . . . . . . D PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
. . . . . . . . . . . . . . . . E MOBILE CLINIC 
. . . . . . . . . . . . . . . . F FIELDWORKER IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE SECTOR, 
WRITE THE NAME OF THE PLACE. OTHER PUBLIC 
SECTOR G 
) ( SPECIFY 
( NAME OF PLACE ) PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR . . . . . . . . . . . . H 
I . . .  STAND-ALONE VCT CENTER 
PHARMAC Y . . . . . . . . . . . . . . . . . . . . J 
. . . . . . . . . . . . . . . . K MOBILE CLINIC 
FIELDWORKER . . . . . . . . . . . . . . . . L 
OTHER PRIVATE MEDICAL 
M SECTOR 
SPECIFY ( ) 
OTHER X 
( SPECIFY ) 
718 YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . .  NO 2 
DON'T KNOW . . . . . . . . . . . . . . . . . . . . 8 
Would you buy fresh vegetables from a shopkeeper or vendor if you  
knew that this person had the AIDS virus? 
Any other place? 




NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
 
M-24 
731 Where did you go? (3) 
Any other place? 
PROBE TO IDENTIFY EACH TYPE OF SOURCE. 
IF UNABLE TO DETERMINE IF PUBLIC OR PRIVATE  SECTOR, 
WRITE THE NAME OF THE PLACE. 
 
(NAME OF PLACE(S)) 
PUBLIC SECTOR 
GOVERNMENT HOSPITAL . . . . . . .  A 
GOVT. HEALTH CENTER . . . . . . .  B 
 STAND-ALONE VCT CENTER . . . C 
FAMILY PLANNING CLINIC . . . . . . . D 
 MOBILE CLINIC . . . . . . . . . . . . . . . . E 
 FIELDWORKER . . . . . . . . . . . . . . . . F 
OTHER PUBLIC 
 SECTOR G 
 
(SPECIFY) 
PRIVATE MEDICAL SECTOR 
PRIVATE HOSPITAL/CLINIC/ 
PRIVATE DOCTOR . . . . . . . . . . . . H 
 STAND-ALONE VCT CENTER . . .  I 
 PHARMACY . . . . . . . . . . . . . . . . . . J 
 MOBILE CLINIC . . . . . . . . . . . . . . . . K 
 FIELDWORKER . . . . . . . . . . . . . . . . L 
OTHER PRIVATE MEDICAL 




SHOP . . . . . . . . . . . . . . . . . . . . . . . . N 





(2) If a wife knows her husband has a disease that she can get during 
sexual intercourse, is she justified in asking that they use a condom 
when they have sex? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 NO
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 2 DON'T KNOW . . . . . . . . . . . . . . . . 
. . . . 8 
 
733 
Is a wife justified in refusing to have sex with her husband when she  
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1  
 knows her husband has sex with other women? (4) NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 2 DON'T KNOW . . . . . . . . . . . . . . . . 
. . . . 8 
 
(1) If Qs. 703, 705 and/or 706 do not apply to the local context, replace the question using a specific 
localmisconception. At least two questions related to misconceptions are needed. 
(2) The question may be deleted in countries with a very low HIV prevalence. 
(3) Coding categories to be developed locally and revised based on the pretest; however, the broad categories 
must be maintained. 





SECTION 8. OTHER HEALTH ISSUES 
NO. QUESTIONS AND FILTERS CODING CATEGORIES SKIP 
801 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(1) NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
805 DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
802 AGE IN 
(1) COMPLETED YEARS. . . . . . .  
DURING CHILDHOOD (<5 YEARS) 
DON'T KNOW. . . . . . . . . . . . . . . . . .  
803 TRADITIONAL PRACTITIONER/ 
(1) FAMILY/FRIEND . . . . . . . . . . . . . . 1 
HEALTH WORKER/PROFESSIONAL 2 
. . . . . . . . . . . . . . . . . . . . . . . . 3 OTHER 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
804 HEALTH FACILITY. . . . . . . . . . . . . . . . 1 
(1) HOME OF A HEALTH WORKER/ 
PROFESSIONAL. . . . . . . . . . . . . . . . 2 
CIRCUMCISION DONE AT HOME 3 . . .  
. . . . . . . . . . . . . . . . . . . . 4 RITUAL SITE 
OTHER HOME/PLACE . . . . . . . . . . . . 5 
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
805 
NUMBER OF INJECTIONS. . .  
IF NUMBER OF INJECTIONS IS 90 OR MORE,  NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 808 
OR DAILY FOR 3 MONTHS OR MORE  RECORD '90'. 
Some men are circumcised, that is, the foreskin is completely  
removed from the penis. Are you circumcised? 
How old were you when you got circumcised? 
Who did the circumcision? 
Where was it done? 
Now I would like to ask you some other questions relating to health  




IF YES: How many injections have you had? 
,
IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
806 
NUMBER OF INJECTIONS. . .  
IF NUMBER OF INJECTIONS IS 90 OR MORE,  
OR DAILY FOR 3 MONTHS OR MORE, RECORD '90'. NONE. . . . . . . . . . . . . . . . . . . . . . . . . . 00 808 
IF NON-NUMERIC ANSWER, PROBE TO GET AN ESTIMATE. 
807 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DON'T KNOW. . . . . . . . . . . . . . . . . . . . 8 
808 1 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 810 
809 NUMBER OF  
CIGARETTES. . . . . . . . . . . . . .  
810 YES. . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
812 NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
811 . . . . . . . . . . . . . . . . . . . . . . . . . . A PIPE 
CHEWING TOBACCO. . . . . . . . . . . . . . B 
SNUFF RECORD ALL MENTIONED. . . . . . . . . . . . . . . . . . . . . . . . . C 
X OTHER 
) SPECIFY ( 
What (other) type of tobacco do you currently smoke or use?  (2) 
Among these injections, how many were administered by  
a doctor, a nurse, a pharmacist, a dentist, or any other health  
worker? 
The last time you got an injection from a health worker, did he/she  
take the syringe and needle from a new, unopened package? 
Do you currently smoke cigarettes? 
In the last 24 hours, how many cigarettes did you smoke? 
Do you currently smoke or use any (other) type of tobacco?  (2) 
 
M-26 
NO. QUESTIONS AND FILTERS CODING CATEGORIES  SKIP 
812 Are you covered by any health insurance? (3) YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 1 NO . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . 2 
 
 814 
813 What type of health insurance are you covered by? (3) 
RECORD ALL MENTIONED. 
MUTUAL HEALTH ORGANIZATION/ 
COMMUNITY-BASED HEALTH  
 INSURANCE  . . . . . . . . . . . . . . . . . . A 
HEALTH INSURANCE THROUGH 
EMPLOYER . . . . . . . . . . . . . . . . . . . . B 
SOCIAL SECURITY . . . . . . . . . . . . . . . . C 
OTHER PRIVATELY PURCHASED  
COMMERCIAL HEALTH INSURANCE D 




814 RECORD THE TIME.    
HOUR . . . . . . . . . . . . . . . . . . . .  




(1) Question may be omitted depending on the practice of male circumcision in specific countries. 
Translation of circumcision should indicate removal of the foreskin and not merely coming of age ceremonies. 
(2) Add local terms. 
(3) If a health service prepayment plan or other types of plans are available in the country, add those types of 
plans to the question.  
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INTERVIEWER'S OBSERVATIONS TO BE FILLED 
IN AFTER COMPLETING INTERVIEW 
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